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Diencephalic development requires the transcription factors Pax6 and Barhl2 in 
order to proceed correctly. Both genes are necessary for the normal development of 
the organizer region known as the zona limitans intrathalamica (ZLI). The ZLI goes 
on to pattern the diencephalon via its secretion of the morphogen Shh, which inhibits 
the expression of Pax6. These findings suggest that interactions between Pax6, 
Barhl2 and Shh may be involved in the control of diencephalic development. This 
project aims to characterise these interactions and investigate their roles. 
 
The expression domains of Pax6 and Barhl2 were mapped during the early 
development of the mouse diencephalon. Qualitative approaches were employed to 
confirm the high complementarity of their expression domains and obtain evidence 
of a mutually repressive relationship existing between the two genes. The findings 
from a quantitative analysis suggested that this inhibition is incomplete within the 
thalamus. Investigations using the Pax6-null mutant mouse confirmed that in the 
absence of Pax6 the thalamic Barhl2 expression domain expands beyond the 
ventricular zone, the site of thalamic neurogenesis. 
 
The influence of Shh signalling on the expression of Pax6 and Barhl2 was 
investigated via a gain-of-function approach utilising in utero electroporation to 
activate the Shh pathway. This led to a downregulation of both Pax6 and Barhl2 
within the thalamus. 
 
In Shh loss-of-function experiments drug treatment with the Shh antagonist 
vismodegib led to an upregulation of Barhl2 and the loss of the GABAergic pTh-R 
in the Pax6-null mutant thalamus, but not in the wild type thalamus, suggesting that 
Pax6 and Shh may be required to inhibit Barhl2 in order for GABAergic 
neurogenesis to proceed. Barhl2 expression was detected in the Shh-null mutant 
mouse confirming that, in contrast with their homologues in Drosophila, Shh may be 




Together these findings have been used to develop a novel model of thalamic 
development in which Barhl2 induces ZLI development, inhibition of Barhl2 by 
Pax6 restricts its expansion, and secretion of Shh by the ZLI then goes on to inhibit 
Pax6 and Barhl2 in the pTh-R while mutual repression between Pax6 and Barhl2 
































Early in embryonic development the forebrain is formed into two distinct regions- 
the telencephalon, which gives rise to structures including the cerebral cortex, and 
the diencephalon, from which the thalamus develops. The thalamus serves to receive 
input from sensory neurons and then relay it to the appropriate region of the cerebral 
cortex. During development cells are induced to differentiate into different types of 
neuron. This process is controlled by transcription factors- proteins which act within 
individual cells to initiate or suppress gene expression. The genes encoding these 
proteins can also be controlled in this manner and can be involved in complex 
interactions with each other. Development is also influenced by another class of 
proteins known as the morphogens, which are secreted by specialised regions of 
tissue known as organizer regions. Morphogens direct the differentiation of cells in 
the surrounding tissue via effects they exert on the expression of transcription 
factors. Within the mammalian diencephalon an organizer region known as the zona 
limitans intrathalamica (ZLI) secretes the morphogen Sonic hedgehog (Shh). The 
transcription factors Pax6 and Barhl2 are both strongly expressed within the 
developing diencephalon and appear to suppress each other’s expression in addition 
to interacting with Shh. For this project changes in the expression of Pax6 and 
Barhl2 were observed throughout the development of the mouse diencephalon in 
order to characterise the relationships between them. Pax6-null and Shh-null mutant 
mice were used to investigate the effects of gene deletion, and drug treatment with 
the Shh-blocking drug vismodegib was utilised to examine the influence of Shh on 
expression of Pax6 and Barhl2. The technique of in utero electroporation was used 
to increase levels of Shh in cells of the embryonic diencephalon and observe the 
resulting changes in gene expression. Results suggested that interactions between 
Pax6 and Barhl2 are required to allow the ZLI to develop correctly and that Shh from 
the ZLI then goes on to suppress the expression of both genes, allowing the most 
ventral region of the thalamus to develop, while in other regions neurogenesis 
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1.1 Early development of the mammalian forebrain 
During the early development of the vertebrate embryo the process of gastrulation 
causes the cells to segregate into three germ layers. The innermost of these is the 
endoderm, the outermost is the ectoderm, and the third layer, the mesoderm, lies 
between them. The ectoderm is the germ layer which is fated to give rise to the skin 
and also to the central nervous system via the process of neurulation (Tam and 
Behringer 1997, Vieira et al 2010).  
In the embryo of the house mouse (Mus musculus) neurulation begins at around the 
seventh day of gestation (Theiler 1989). A dorsal region of ectoderm, known as the 
neural plate, is fated to become neurectoderm (Rubenstein et al 1998, Patthey and 
Gunhaga 2011). The neural plate develops a furrow, known as the neural fold, and 
begins to fold inwards. The two edges of the neural plate move towards each other 
and eventually fuse, forming a closed tube of neuroepithelium which then detaches 
from the surface epithelium. This structure is the neural tube and it is fated to 
develop into the central nervous system- the brain, spinal cord and neural retinae- 
while the surface ectoderm develops into the skin and ectodermal appendages 
(Weinstein and Hemmati-Brivanlou 1999, Colas and Schoenwolf 2001, Copp et al 
2003) (Fig 1.1). 
As the neural tube closes it begins to undergo further changes in gross morphology 
as the structures of the central nervous system develop and become distinct from one 
another. The neural tube develops constrictions along its rostrocaudal axis, dividing 
it into regions which correspond with the positions of the prosencephalon, 
mesencephalon, rhombencephalon and spinal cord (Fig. 1.2A). Later in development 
the prosencephalon develops a constriction which divides it into the more rostral 
telencephalon and the more caudal diencephalon (Fig. 1.2B). The diencephalon itself 
later becomes regionalized into three molecularly distinct areas of neuroepithelium 
known as the prethalamus, thalamus and pretectum (Keynes and Lumsden 1990, 
Altmann and Brivanlou 2001, Puelles and Rubinstein 2003, Lim and Golden 2007, 
Puelles et al 2013) (Fig. 1.2C). Of these structures, the thalamus plays particularly 
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important roles in the adult brain, and is perhaps most commonly described as the 
structure which serves to relay sensory input, bar olfaction (Shepherd 2005), to the 
appropriate region of the cerebral cortex (Jones 2002, Sherman and Guillery 2002). 
As the telencephalon grows in size it begins to envelop the diencephalon (Price et al 
2011) (Fig. 1.2D) and in coronal sections cut from embryonic brain tissue it can be 
distinguished as two telencephalic vesicles lateral to the ventricle of the 
diencephalon, while the pretectum, thalamus and prethalamus respectively can be 
seen running from dorsal to ventral (Paxinos and Franklin 2001) (Fig. 1.3). 
 
Fig. 1.1: Schematic illustrating the process of neurulation. A. The neural plate is a 
region of ectoderm fated to become the central nervous system. Neurulation begins 
with the development of the neural fold. B. The neural plate becomes furrowed and 
its edges move towards each other. C. The edges of the neural plate become fused, 




Fig. 1.2: Schematic illustrating the early regionalisation of the neural tube following 
closure. A. The neural tube begins to develop constrictions along its rostrocaudal 
axis. Initially three constrictions develop, and these correspond with the caudal 
extent of the prosencephalon, mesencephalon and rhombencephalon respectively. 
B. Later in development the prosencephalon differentiates into the more rostral 
telencephalon and the more caudal diencephalon and an addition constriction 
develops at the boundary between these two regions. C. Later still the diencephalon 
differentiates into the pretectum, thalamus and prethalamus and further constrictions 
form between these regions. D. Schematic to illustrate the positions these brain 
regions occupy in relation to each other within the mouse embryo following the 





Fig. 1.3: Schematic illustrating the arealisation of the diencephalon into three 
molecularly and morphologically distinct regions- the pretectum, thalamus and 
prethalamus- and how these regions appear in relation to each other in coronal 
sections. 
1.2 Organizers: the zona limitans intrathalamica 
The arealisation of embryonic tissues is controlled in part by the action of organizers- 
specialised regions of tissue which direct the development of surrounding tissues via 
the actions of signalling molecules which they secrete. Known as morphogens, these 
signalling molecules diffuse into the surrounding tissue and direct its differentiation 
by inducing changes in gene expression (Shimamura et al 1995, Rhinn et al 2006, 
Wilson and Houart 2009, Scholpp and Lumsden 2010). 
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The vertebrate forebrain is known to contain several organizers. The roofplate, which 
runs along the dorsal midline of the neural tube at the region where its edges fuse 
during neurulation, secretes Wnts and bone morphogenetic proteins (BMPs) 
(Chizhikov and Millen 2005). Fibroblast growth factors (FGFs) are secreted from the 
anterior neural ridge, an organizer region situated at the rostral extent of the 
prosencephalon (Wilson and Houart 2009). The floor plate, running along the ventral 
midline of the neural tube, secretes Sonic hedgehog (Shh) (Kiecker and Lumsden 
2004). For a brief period during the early development of the embryo a narrow 
wedge-shaped region of Shh-secreting cells extends from the floor plate into the 
diencephalon. This is an additional organizer region known as the zona limitans 
intrathalamica (ZLI) (Vieira et al 2010, Kiecker and Lumsden 2012, Robertshaw 
and Kiecker 2012) (Fig. 1.4). 
 
Fig. 1.4: Schematic illustrating the position of organizers within the developing vertebrate 
brain and examples of the morphogens they are known to secrete. 
The ZLI develops from progenitor cells in the alar plate (Staudt and Houart 2007) 
and begins to form at the point where the prechordal plate, situated ventral the 
notochord (Rubenstein et al 1998), meets the epichordal region of the neural plate, 
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dorsal to the notochord (Larsen et al 2001). The formation of the ZLI may be 
induced by interactions between the transcription factors Sine oculis-related 
homeobox 3 (Six3) in the prechordal plate and Iroquois homeobox 3 (Irx3) in the 
epichordal plate, and mutual inhibition between the two transcription factors may 
also act to establish a boundary between their domains and serve to correctly position 
the ZLI (Kobayashi et al 2002). The possibility of interactions between prechordal 
and epichordal tissues playing a role in ZLI induction is supported by experiments in 
which the grafting of a region of prechordal tissue into the epichordal plate leads to 
the induction of ectopic ZLI-like structures at the borders of the graft (Vieira et al 
2005). 
One model for ZLI development, based on observations in zebrafish, implicates two 
transcription factors of the Orthodentical homeobox (Otx) family, Otx1l and Otx2 
along with an Iroquois related homeobox (Irx) transcription factor, Irx1b. Otx1l and 
Otx2 are expressed within the presumptive ZLI and thalamus, conferring the 
neuroepithelium in this region with the competence to develop into the ZLI. Irx1b is 
expressed in the presumptive thalamus, and serves to inhibit Shh expression, and ZLI 
development, in this region of neuroepithelium. Otx1l and Otx2 therefore act to 
induce ZLI development, while Irx1b serves to restrict its expansion into more 
caudal regions of the diencephalic neuroepithelium (Scholpp et al 2007). 
The ZLI extends dorsally towards the roofplate but does not extend into the roofplate 
itself. Retinoic acid, a metabolite of retinol, acts as a signalling molecule in several 
developmental processes (Duester 2008). Studies in chick have shown that it is 
synthesised in the epithalamus during ZLI development and that it may serve to 
inhibit the extension of the ZLI into the most dorsal regions of the diencephalon 
(Guinazu et al 2007). 
As the ZLI develops from the point at which the prechordal and epichordal plates 
meet, it extends along the boundary between the prethalamus and thalamus (Larsen 
et al 2001). Lineage tracing experiments in chick have been used to demonstrate that 
the ZLI is a lineage restriction compartment (Larsen et al 2001). The establishment 
of lineage restriction serves to stabilise the position of the ZLI in order to establish 
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the concentration gradients of Shh required for the correct patterning of the 
surrounding neuroepithelium (Scholpp and Lumsden 2010). 
 
The role of the ZLI as a local organizer region acting via the secretion of Shh has 
been confirmed with Shh gain-of-function and loss-of-function experiments in chick 
(Kiecker and Lumsden 2004). In the mouse embryo the ZLI begins to form at 
approximately E10.5 (Shimamura et al 1995) and expression data for Shh over a 
series of developmental stages suggest that the ZLI is maintained until E14.5 (Visel 
et al 2004, Lim and Golden 2007). 
 
The differentiation of the diencephalon into three morphologically distinct regions of 
differing molecular character is due to the fact that Shh signalling from the ZLI does 
not influence the rostrocaudal patterning of the diencephalon in a symmetrical 
fashion. Shh is known to upregulate the expression of its receptor Ptch1 (Marigo et al 
1996). Ptch1 and a second bona fide Shh target gene, NK2 homeobox2 (Nkx2-2) 
(Barth and Wilson 1995, Shimamura et al 1995) are both expressed in the 
neuroepithelium immediately adjacent to the ZLI, suggesting that tissues both rostral 
and caudal to the ZLI are competent to respond to the Shh signal (Kiecker and 
Lumsden 2004). This observation suggests that it is the differing molecular character 
of the regions fated to become the thalamus and prethalamus which allows the tissues 
to give differing responses to the Shh signal, and that these regions of 
neuroepithelium must become molecularly distinct prior to ZLI formation. 
 
Candidates for the factors conferring differential competence have been selected 
from transcription factors which are expressed as the neural plate is patterned and 
diencephalic structures are first specified. Fez family zinc finger 1 (FezF1) is known 
to be required for the specification of the prethalamus (Hirata et al 2006) while 
Distal-less homeobox 1 (Dlx1) and Distal-less homeobox 2 (Dlx2), have also been 
suggested as transcription factors which are required for its specification (Bulfone et 
al 1993). Irx3 is required for the specification of the thalamus (Kiecker and Lumsden 
2004, Robertshaw et al 2013) while Early B cell factor 1 (Ebf1) has been suggested 




The position of the ZLI and other structures within the embryonic mouse brain are 
detailed in Figs. 1.5 and 1.6. 
 
 
Fig. 1.5: A. Schematic of the E12.5 mouse brain, dorsal view, rostral to right, to 




Fig. 1.6: A. Schematic of the E12.5 mouse brain as viewed from the left-hand side, 
rostral to right, to illustrate the coronal plane of section. B. The structures visible in a 
caudal coronal section. C. The structures visible in a medial coronal section. D. The 
structures visible in a rostral coronal section. 
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1.3 Morphogens: Sonic hedgehog 
Shh is one of three mammalian homologues of the Drosophila morphogen hedgehog 
(Hh) (Echelard et al 1993, Chang et al 1994, Ingham and McMahon 2001). Loss of 
Shh leads to a very severe embryonic lethal mutant phenotype with morphological 
abnormalities including truncated limbs, fused digits, and cyclopia- the most severe 
form of holoprosencephaly (Chang et al 1996, Roessler et al 1996). Shh plays 
important roles in the development of limbs and digits (Riddle et al 1993, Chang et 
al 1994, Hill 2007) and is essential for the correct development of the central nervous 
system (CNS) (Echelard et al 1993, Chiang et al 1996). Elevated levels of Shh 
activity have also been implicated in some carcinomas (Oro et al 1997, Katoh and 
Katoh 2005, Peng and Joyner 2015) and components of the Hedgehog pathway have 
been studied as drug targets for chemotherapeutic agents (Dormoy et al 2012, Kieran 
2014, Robinson et al 2015). The importance of Shh in a wide range of developmental 
processes and pathologies has led to it becoming the best studied ligand of the 
vertebrate Hedgehog pathway. 
Secreted Shh molecules are able to bind to the transmembrane receptor proteins 
Ptch1 and Patched homologue 2 (Ptch2) on the surface of the target cell (Motoyama 
et al 1998, Fuse et al 1999). Ptch1 is the only one of these two receptors expressed 
by cells of the developing CNS (Carpenter et al 1998). Within the developing CNS 
Ptch1 acts to inhibit Smo, a G protein-coupled receptor (Ruiz-Gómez et al 2007), by 
controlling its location within the cell (Taipale et al 2002). In the absence of Shh, 
Smo is located on the membrane of vesicles within the cytoplasm. When Shh binds to 
Ptch1 these vesicles translocate to the cell’s primary cilium and fuse with the cell 
membrane, resulting in an accumulation of Smo at the primary cilium, the site at 
which Smo is active in the Shh pathway (Corbit et al 2005). 
Active Smo regulates the expression of Shh target genes via interactions with the 
GLI-Kruppel family member (Gli) transcription factors, Gli2 and Gli3. A third Gli 
transcription factor, Gli1, is also expressed in mammalian cells but does not appear 
to interact with Smo to as great an extent as Gli2 and Gli3. Gli1-null mouse mutants 
are viable and resemble wild type mice while loss of Gli2 is embryonic lethal (Park 
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et al 2000, Bai et al 2002) and loss of Gli3 leads to perinatal lethality (Hui and 
Joyner 1993, Maynard et al 2002). 
The mechanisms of the interactions between Gli2, Gli3 and Smo are not well 
understood but it is known that in the absence of Shh, when Smo is inactive, Gli2 and 
Gli3 are phosphorylated. This enables the proteolytic cleavage of Gli2 and Gli3, 
leading to the formation of their repressor forms, known as Gli2R and Gli3R, which 
diffuse into the nucleus and inhibit the transcription of Shh target genes. When Shh 
binds to Ptch1 and Smo is active at the primary cilium, this phosphorylation is 
inhibited and Gli2 and Gli3 remain in their activator forms, referred to as Gli2A and 
Gli3A, which activate the transcription of Shh target genes. (Briscoe and Thérond 
2013) (Fig. 1.7). 
Tissues in range of secreted morphogen signal need to be competent to respond to it, 
and the expression of different transcription factors within those tissues mediates the 
response to the signal. In addition to this, cells are able to produce different 
responses to different concentrations of a given morphogen, with the concentration 
of a given morphogen being required to reach a particular threshold, with a cell being 
exposed to the morphogen for a minimum length of time, in order to activate or 
inhibit the transcription of each of the morphogen’s target genes (Ashe and Briscoe 
2006, Rogers and Schier 2011). This phenomenon is known as graded signalling and 
it is a property of Shh signalling which has been studied and quantified extensively in 
a range of experimental models and embryonic tissues (Patten and Placzek 2000, 






Fig. 1.7: A simplified schematic illustrating the Shh signalling pathway. A. When Shh 
is not bound to the receptor Ptch1, the receptor Smo is largely confined to the 
membranes of intracellular vesicles. Gli1 and Gli2 are phosphorylated, enabling 
proteolytic cleavage to their repressor forms, Gli2R and Gli3R, which translocate to 
the nucleus and represses the transcription of Shh target genes. B. When Shh binds 
to Ptch1 Smo translocates to the primary cilium, the phosphorylation of Gli2 and Gli3 
is inhibited and they remain in their activator forms, Gli2A and Gli3A, translocate to 
the nucleus and induce the transcription of Shh target genes. 
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The effects of graded Shh signalling at different points along the Shh morphogen 
gradient have perhaps been studied most comprehensively in the spinal cord, where 
graded Shh signalling leads to the specification of different neuronal progenitor pools 
(Briscoe and Ericson 1999, Ribes and Briscoe 2009, Balaskas et al 2012, Cohen et al 
2013) but graded Shh signalling has also been observed within the developing 
diencephalon, where it serves to pattern the thalamus (Vue et al 2009). 
Graded Shh signalling has been shown to be required for the specification of the 
glutamatergic pTh-C and the GABAergic pTh-R, the latter of which is closer to the 
ZLI and is exposed to a higher concentration of Shh. Activating the Shh pathway in 
via ectopic expression of Smo causes an expansion of the pTh-R at the expense of the 
pTh-C, with GABAergic neurons being specified instead of glutamatergic neurons 
(Vue et al 2009) while loss of Shh leads to an absence of the pTh-R (Szabó et al 
2009, Vue et al 2009). 
1.4 Transcription factors: Paired-box gene 6 
Paired-box gene 6 (Pax6) is a member of the Paired-box (Pax) family of 
transcription factors which are characterised by the presence of two DNA binding 
domains: the paired box and the homeobox (Hill et al 1991). Pax6 is highly 
conserved between species, with the Drosophila homologue eyeless (ey) exhibiting 
94% amino acid sequence identity with that of murine Pax6 (Quiring et al 1994), and 
the amino acid sequence of murine Pax6 being identical to that of human PAX6  
(Ton et al 1991, Gehring and Ikeo 1999). In mouse the gene encoding Pax6 is 
located on chromosome 2 (Walther et al 1991). The onset of Pax6 expression in the 
mouse embryo is the two-cell stage (Guo et al 2010, Tang et al 2011), approximately 
E1.5 (Theiler 1989). 
Loss of Pax6 results a very severe perinatal lethal phenotype. The external 
morphology is greatly altered, with Pax6-null mouse embryos being reduced in size 
overall and exhibiting severe craniofacial defects including a shortened snout 
(Kaufman et al 1994, Favor et al 2001). These craniofacial abnormalities cause null 
mutant mouse pups to die shortly after birth as a result of being unable to breathe 
while suckling (Hill et al 1991). Heterozygous mouse mutants have not been studies 
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as extensively but in humans the loss of one copy of PAX6 is linked to aniridia (Ton 
et al 1991) and defects of neural development (Sisodiya et al 2001). 
Pax6-null mouse mutants also fail to develop eyes (Hill et al 1991). This is due to 
Pax6 being required for the induction of eye development (Collinson et al 2000, 
Chow and Lang 2001), a function which is conserved across vertebrate and 
invertebrate species. Ectopic expression of human PAX6 in the Drosophila embryo is 
sufficient to induce the development of ectopic compound eyes (Halder et al 1995). 
Pax6 is widely expressed throughout the vertebrate CNS (Walther and Gruss 1991, 
Kawakami et al 1997, Duan et al 2013) and the loss of Pax6 has been implicated in 
many defects in neural development. The gross morphology of the forebrain is 
greatly altered, with the forebrain being greatly reduced in size overall (Quinn et al 
2007) and the neuroepithelium being reduced in thickness (Jones et al 2002, Quinn et 
al 2007). Within the diencephalon the lumen of the diencephalon expands laterally 
(Schmahl et al 1993) as a result of two diencephalic structures, the paraventricular 
nucleus and the caudal zona incerta, failing to develop correctly (Stoykova et al 
1996).  
Many other processes of neural development are disrupted as a result of loss of Pax6, 
including axon guidance (Jones et al 2002, Pratt et al 2000a, Manuel et al 2008, 
Georgala et al 2011) and the control of cell cycle exit (Sansom et al 2009, Farhy et al 
2013, Mi et al 2013, Manuel et al 2015). Pax6 has been shown to be essential for the 
correct patterning of the forebrain, with numerous roles in the control of diencephalic 
patterning. The loss of Pax6 also disrupts the specification of several diencephalic 
structure- for example, Pax6 is required for the formation of the boundary between 
the mesencephalon and pretectum (Mastick et al 1997, Warren and Price 1997) while 
the differentiation of the pTh-C is disrupted in the Pax6-null mutant (Pratt et al 
2000a). 
Pax6 is required for the development and shaping of the ZLI. The Shh promoter 
(Mutoh et al 2011) is regulated by Pax6, which binds to the promoter and indirectly 
inhibits the expression of Shh. In regions of neuroepithelium adjacent to the ZLI this 
inhibition serves to limit ZLI expansion (Caballero et al 2014). Loss of Pax6 results 
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in the ZLI becoming greatly expanded along the rostrocaudal axis (Grindley et al 
1997, Pratt et al 2000a). 
The specification of the thalamus also requires the expression of Pax6. The thalamus 
develops in a region of the forebrain which expresses both Pax6 and Irx3. Expression 
of both transcription factors is required to confer thalamic competence on the cells of 
the diencephalon. Ectopic expression of Irx3 within the Pax6-positive telencephalon 
is sufficient to induce the expression of thalamic markers, while ectopic expression 
of Pax6 and Irx3 has the same effect on cells of the mesencephalon (Robertshaw et 
al 2013). 
Ectopic expression of Shh within the thalamus has been shown to downregulate Pax6 
expression (Kiecker and Lumsden 2004, Vieira et al 2005).  Pax6 is expressed in 
pTh-C (Kiecker and Lumsden 2004) but is absent from the pTh-R (Vue et al 2007, 
Suzuki-Hirano et al 2011). While cells of the Pax6-expressing pretectum and 
prethalamus can differentiate into GABAergic neurons (Virolainen et al 2012) Pax6 
expression in the thalamus inhibits the differentiation of GABAergic neurons (Szabó 
et al 2009, Vue et al 2009). This inhibition must therefore be suppressed in order for 
the pTh-R to develop, and experiments in chick have confirmed that Shh serves to 
inhibit Pax6 expression in the presumptive pTh-R, thereby playing a role in allowing 
the development of the pTh-R to proceed (Robertshaw et al 2013). In Pax6-null 
mouse mutants the pTh-R, like the ZLI, undergoes an expansion along the 
rostrocaudal axis, and is specified at the expense of the pTh-C, possibly as a 
consequence of increased levels of Shh protein and an increase in its inhibition of 
Pax6 expression (Caballero et al 2014). 
1.5 Transcription factors: Bar homeobox-like 2 
The Bar homeobox-like transcription factors, Bar homeobox-like 1 (Barhl1) and Bar 
homeobox-like 2 (Barhl2), are the respective vertebrate homologues of the 
Drosophila Bar transcription factors, Bar homeobox 1 (BarH1) and Bar homeobox 2 
(BarH2) (Schumacher et al 2011). The name Bar refers to the implication of the two 
Drosophila genes in the development of the “Bar-eye” Drosophila mutant phenotype 
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in which the eyes are reduced in size along the anteroposterior axis and exhibit a 
characteristic “bar” shape. 
The Bar-eye phenotype was first described in Drosophila when it was observed as a 
consequence of a spontaneous mutation and found to be a sex-linked condition (Tice 
1914). The Bar-eye phenotype was found to be caused by a duplication of a region of 
the X chromosome. The severity of the phenotype was found to increase with greater 
numbers of duplications, with narrower eyes observed in flies with greater numbers 
of duplications (Sturtevant 1925). Later studies referred to this region of the X 
chromosome as the Bar locus and considered it as the location of a hypothetical gene 
named Bar. The Bar locus is now known to be the region of the X chromosome 
within which both BarH1 and BarH2 are located (Kojima et al 1991)  
Overexpression of BarH1 and BarH2 in Drosophila gives rise to the Bar-eye 
phenotype by disrupting the patterning of the retina. The Drosophila compound eye 
consists of 750-800 cone-shaped structures known as ommatidia, which develop in 
evenly-spaced rows across the eye field during development (Ready et al 1974, 
Reifegerste and Moses 1999, Kumar 2011, Sato et al 2013). Each ommatidium 
contains a cluster of photoreceptor cells at its basal extent. Eight Drosophila 
photoreceptor subtypes have been identified and these are termed R1-R8. In 
Drosophila the first subtype to differentiate is R8 (Jarman et al 1994, Hsiung and 
Moses 2002). The differentiation of R8 induces the induction of R1-7 in adjacent 
cells, leading to the development of an individual photoreceptor cluster (Hsiung and 
Moses 2002, Sato et al 2013). R8 photoreceptors, and in turn photoreceptor clusters, 
develop in rows during a wave of neurogenesis which moves across the eye field 
from dorsal to ventral. The modulation of this process during eye development 
results in the formation of a compound eye with ommatidia which are evenly spaced 
(Brennan and Moses 2000, Sato et al 2013). 
The differentiation of R8 requires the proneural transcription factor atonal (ato) 
(White and Jarman 2000). Expression of ato is inhibited by BarH1 and BarH2. 
Overexpression of the Drosophila Bar genes acts via transcriptional repression of ato 
to reduce the rate of neurogenesis and slow the process by which rows of ommatidia 
form, resulting in an eye which is reduced in size along the dorsoventral axis. 
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Gain-of-function experiments in Drosophila have shown that overexpression of 
BarH1 is sufficient to induce the development of the Bar phenotype, with increased 
levels of BarH1 leading to an increase in the transcriptional inhibition of ato 
(Higashijima et al 1992). Conversely, loss of BarH1 and BarH2 results in the rough 
eye phenotype with affected flies exhibiting ectopic ommatidia outside the eye field 
and a consequent alteration in the gross morphology of the eye. Ommatidia also 
appear crowded together rather than being evenly spaced (Lim and Choi 2003). 
As with Pax6, homologues of the Drosophila BarH genes have been identified in a 
wide range of invertebrate and vertebrate species and found to be highly conserved 
(Reig et al 2007). Drosophila phenotypes caused by mutations in BarH1 and BarH2 
are sex-linked due to both genes being located on the X chromosome. In mouse 
Barhl1 is located on chromosome 2 (Bulfone et al 2000) while Barhl2 is located on 
chromosome 5 (Mouse Genome Informatics Scientific Curators 2002) and conditions 
in which the two murine homologues are implicated are therefore not sex-linked. The 
onset of Barhl2 expression in the mouse embryo is not currently known, with the 
earliest reported expression being at E9.5 (Yokoyama et al 2009). 
In Drosophila BarH1 and BarH2 exhibit functional redundancy (Higashijima et al 
1992) but loss-of-function experiments have suggested that this is not the case with 
murine Barhl1 and Barhl2, with loss of Barhl2 resulting in a much more severe 
phenotype than that caused by loss of Barhl1. While the Barhl1-null mutant mouse is 
viable, exhibiting progressive hearing loss but apparently phenotypically normal in 
all other respects studied (Li et al 2002), loss of Barhl2 causes postnatal lethality at 
around P21, with mouse null mutants failing to thrive and exhibiting ataxia and 
numerous CNS defects (Ding et al 2012) 
Barhl1 has been found to be required for the maintenance, but not the induction, of 
hair cells in the cochlea (Li et al 2002) and while it is expressed in the diencephalon 
and rhombencephalon (Gray et al 2004) loss of Barhl1 does not seem to affect neural 
development to as great an extent as loss of Barhl2. 
Loss of Barhl2 disrupts neuronal subtype specification in specific regions of the 
vertebrate CNS. In the developing mouse spinal cord, where Barhl2 is normally 
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strongly expressed (Saba et al 2003), it serves to specify dl1 interneuron subtype: the 
loss of Barhl2 leads to an increase in the number of contralaterally-projecting 
interneurons with a reduction in the number that project ipsilaterally (Ding et al 
2012). In the murine retina Barhl2 is required for amacrine cell (AC) subtype 
specification: loss of Barhl2 leads to the specification of increased numbers of 
cholinergic ACs at the expense of glycinergic and GABAergic ACs and Barhl2-null 
mice exhibit abnormal retinal electrophysiology (Ding et al 2012). The premature 
expression of Barhl2 in the zebrafish retina induces the differentiation of GABAergic 
ACs at the expense of non-GABAergic ACs and photoreceptors (Jusuf et al 2012). 
Barhl2 appears to play several important roles in the patterning of the forebrain. In 
mouse it is strongly expressed in a region corresponding with the developing ZLI at 
E10.5 (Suzuki-Hirano et al 2011) and in Xenopus Barhl2 has been shown to be 
required for the initiation of the ZLI, with morpholino knockdown of Barhl2 
inhibiting its formation (Juraver-Geslin et al 2014).  While the expression of Barhl2 
has yet to be mapped comprehensively within the vertebrate forebrain, it has been 
suggested as a marker of the presumptive diencephalon (Colombo et al 2006) and 
used as such in fate-mapping studies in zebrafish (Staudt and Houart 2007). 
Barhl2 is also known to be strongly expressed within the murine thalamus. While its 
expression has not been described in full it appears to be expressed within the 
thalamic ventricular zone in a domain with a shape comparable to that of Pax6. 
Outside the thalamus it appears to be expressed in Pax6-negative regions of the 
forebrain such as the eminentia thalami and subpallium, while it is not expressed in 
Pax6-positive regions such as the prethalamus and pallium (Suzuki-Hirano et al 
2011). 
The proteins encoded by the BarH genes and their vertebrate homologues are 
characterised by the presence of a homeobox along with either one or two FIL 
domains- DNA-binding regions which are rich in the amino acids phenylalanine, 
isoleucine, and leucine, referred to by their single-letter amino acid codes as F, I and 
L respectively (Reig et al 2007). Transcription factors containing FIL domains act as 
transcriptional repressors (Smith and Jaynes 1996) via a mechanism involving their 
recruitment of homologues of the Drosophila co-repressor Groucho (Muhr et al 
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2001, Bae et al 2003). The resulting interactions lead to the formation of a large 
nucleoprotein complex, known as the Groucho repressosome, which serves to inhibit 
promoter function (Courey and Jia 2001). 
In Drosophila the formation of the Groucho repressosome is likely to be the 
mechanism by which BarH1 and BarH2 inhibit the expression of ato (Higashijima et 
al 1992) and this is because LIM domains have the ability to bind to motifs encoding 
bHLH transcription factors, of which ato is one example. 
The potential for Barhl1 to inhibit the transcription of antiproneural bHLH 
transcription factors in vertebrates has been considered. Experiments in mice have 
shown that ectopic expression of Barhl1 inhibits the transcription of Achaete-scute 
complex homolog 1 (Ascl1), the mammalian homologue of ato (Gradwohl et al 
1996), but that, perhaps surprisingly, Barhl1 upregulates the expression of 
Neurogenin2 (Ngn2) (Saito et al 1998). 
It is not known if Barhl2 interacts with any proneural bHLH transcription factors in 
the developing vertebrate CNS or if it serves any functions comparable with those of 
Barhl1, but a number of proneural bHLH transcription factors are known to be 
expressed within the thalamic ventricular zone in domains similar in shape and 
position to that of the thalamic Barhl2 domain.  While Ascl1 is not expressed in the 
murine pTh-C (Osório et al 2010), it is expressed in the pTh-R (Caballero et al 
2014), while Neurogenin1 (Ngn1) (Vue et al 2007), Ngn2 (Gradwohl et al 1996, 
Osório et al 2010, Suzuki-Hirano et al 2011) and Oligodendrocyte transcription 
factor 3 (Olig3) (Gray et al 2004) are among the bHLH transcription factors known 
to be expressed in the ventricular zone of the pTh-C. 
Barhl2 is also known to modulate Wnt signalling during the early development of the 
diencephalon. In the canonical Wnt pathway, the binding of secreted Wnt proteins to 
the membrane-bound receptors of the Frizzled class prevents the degradation of 
intracellular β-catenin, instead allowing it to accumulate within the nucleus. Nuclear 
β-catenin can then bind to transcription factors and induce or inhibit the transcription 
of Wnt target genes (Rao and Kühl 2010). Studies in Xenopus have shown that by 
acting upstream of the enzyme Caspase3, Barhl2 is able to prevent the degradation 
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and nuclear accumulation of β-catenin, thereby inhibiting canonical Wnt pathway 
activity. This effect of Barhl2 serves to modulate Caspase3-mediated apoptosis and 
the rate of proliferative cell division (Juraver-Geslin et al 2011). Wnt3a is among the 
morphogens known to be secreted by the ZLI in addition to Shh (Shimogori et al 
2010) but it not clear what the relationship between Barhl2 and Wnt signalling from 
the ZLI is, or if any interactions between the transcription factor and the signalling 
pathway exist in this context. 
1.6 Developing a model for the control of diencephalic development 
Pax6, Barhl2 and Shh all play important roles in diencephalic development. 
Interactions between the three genes may therefore serve to modulate the 
developmental processes in which they are involved. By investigating these 
relationships it may be possible to develop a model for the control of some processes 
of diencephalic patterning, and to build on what is already known about the 
interactions between the three genes. 
 
The correct development of the diencephalon has been shown to require signalling 
by Shh secreted from the ZLI (Kiecker and Lumsden 2004, Vieira et al 2005).  Both 
Pax6 and Barhl2 are required for the development of the ZLI, with Barhl2 being 
required to initiate its development (Juraver-Geslin et al 2014) and Pax6 to inhibit its 
expansion (Caballero et al 2014). Pax6 is also known to interact with Shh, indirectly 
inhibiting its expression via the Shh promoter (Caballero et al 2014). 
 
The relationship between Barhl2 and Shh is not as well understood. In Drosophila 
Hh is required to initiate the expression of BarH1 and BarH2 before each gene 
begins to regulate and maintain its own expression (Lim and Choi 2004). In the 
vertebrate CNS the nature of the interactions of Shh with Barhl1 and Barhl2 has yet 
to be determined and the requirement for Barhl2 in ZLI development suggests that 
Barhl2 acts upstream of Shh in this context (Juraver-Geslin et al 2014). 
The potential for interactions between Pax6 and Barhl2 has not been investigated in 
depth but there is limited evidence that the two transcription factors may act to 
inhibit each other’s expression. Target screens of murine Pax6 and human PAX6 
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have identified thirteen different binding sites for Barhl2, suggesting that it may be 
among the genes which interact directly with Pax6 (Coutinho et al 2011). In Xenopus 
embryos, inhibition of Barhl2 activity at the neural plate stage appears to cause an 
expansion of the Pax6 expression domain, suggesting that Barhl2 may act to inhibit 
Pax6 expression (Offner et al 2005). While Pax6 and Barhl2 are both expressed 
within the murine thalamus, there is limited evidence that they are not co-expressed 
within other regions of the vertebrate forebrain (Suzuki-Hirano et al 2010). This may 
suggest the possibility of a mutually repressive relationship existing between the two 
genes, with the potential for a different relationship existing between them in the 
thalamus. 
While Barhl1 is known to interact with the proneural bHLH transcription factors 
Ascl1 and Ngn2 (Saito et al 1998), the potential for Barhl2 to exert a comparable 
influence on the expression of proneural bHLH transcription factors has yet to be 
investigated. Along with homeobox and LIM domains of the Barhl2 protein 
exhibiting structures similar to those of the Barhl1 protein (Reig et al 2007), the 
expression of Barhl2 in a domain comparable to those of Ngn1, (Vue et al 2007), 
Ngn2 (Gradwohl et al 1996, Osório et al 2010, Suzuki-Hirano et al 2011) and Olig3 
(Gray et al 2004) may suggest a role for Barhl2 in the control of bHLH transcription 
factor expression during thalamic neurogenesis. 
Barhl2 has only recently been considered as a candidate for the control of 
diencephalic patterning (Suzuki-Hirano et al 2011). Studies of Barhl2 expression and 
function have been carried out on a diverse range of animal models, and within each 
model, a wide range of tissues from different CNS structures. 
This project aims to investigate the potential for interactions between Pax6 and 
Barhl2 and to identify and characterise any relationships which are found to exist 
between the two genes, and between their expression and the activity of Shh. The 
spatiotemporal dynamics of Pax6 and Barhl2 will be mapped throughout the early 
stages of diencephalic development in order to obtain evidence for any potential 
interactions between the two genes, in particular the existence of co-expression 
within the thalamus, or complementarity between the two genes’ domains elsewhere. 
Barhl2 expression in the Pax6-null mutant mouse will be observed in order to 
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identify any changes which may be due to the loss of Pax6, and its expression will be 
observed in the Shh-null mutant in order to gain further insight into its interactions 
with Shh. A Shh loss-of-function approach will be taken via the use of drug treatment 
to suppress Shh activity in order to observe the effects on the expression of Pax6 and 
Barhl2. Finally, the technique of in utero electroporation will be used in a Shh gain-
of-function approach in order to examine the effects of Shh pathway activation in 
different regions of the diencephalon, and the possibility that its effects on the 
expression of Pax6 and Barhl2 are context-dependent. 
The findings from these investigations will be considered together in an attempt to 
develop models for the control of diencephalic development based upon interactions 

















2. Materials and methods 
2.1 Mice 
Mice were bred in accordance with the guidelines of the UK Animals (Scientific 
Procedures) Act 1986. 
Wild type mice used were of the Mus musculus strain Crl:CD1(ICR), referred to here 
as CD-1® (Charles River Laboratories International, Inc. 2011). Pax6 Sey mutant 
mice used were of the SeyEd strain in which the mutant Sey allele encodes a non-
functioning form of Pax6 (Hill et al 1991). Pax6Sey/+ mice were maintained on a CD-
1® background. Pax6+/Sey males were crossed with Pax6+/Sey females to generate 
litters comprising embryos of the genotypes Pax6+/+, Pax6+/Sey and Pax6Sey/Sey. 
Crosses were set up and female mice checked by technicians for the presence of a 
semen plug in the cervix. The day on which the plug was found (the plug date) was 
taken to be the day of conception, E0.5. Pregnant mice were culled at E9.5-E13.5 and 
embryos harvested. Harvested embryos were staged more precisely by their external 
morphology according to the Theiler Staging Criteria for mouse embryo 
development (Richardson et al 2014). 
Pax6Sey/Sey embryos harvested at E11.5 or later were identified by the absence of eyes 
(Hill et al 1991) while Pax6Sey/Sey embryos harvested at E10.5 and earlier, before the 
developing eye becomes a visible feature of the external anatomy (Richardson et al 
2014), were genotyped. Tissue samples were taken from the tail tip or limb bud of 
the embryo and treated using a version of the HotSHOT protocol (Truett et al 2000) 
to lyse the cells and release the genomic DNA. Tissue samples were placed in 0.5ml 
polymerase chain reaction (PCR) tubes, and 75µl of 25mM NaOH with 0.2mM 
ethylenediaminetetraacetic acid (EDTA) adjusted to pH 12 was added. This mixture 
was then heated to 95°C for 30 minutes before 75µl of 40mM Tris-HCl (pH 7.5) 
(Table 2.7) was added to neutralise the mixture. PCR was then employed to amplify 
a 282bp region of Pax6 containing the single base affected in the SeyEd mutation 
(forward primer: 5’-TTAGGAAGGCTTTGTGGAGGC-3’, reverse primer: 5’-




Reaction component Volume (µl) 
Genomic DNA 1.00 
Forward primer 200 ng/µl (Eurofins MWG Operon) 0.25 
Reverse primer 200 ng/µl (Eurofins MWG Operon) 0.25 
Deoxynucleotide triphosphate (dNTP) mix (10mM) (New 
England Biolabs) 2.00 
GoTaq®  DNA polymerase (Promega) 0.20 
10x GoTaq®  buffer (Promega) 4.00 
Double distilled water 12.30 
Total volume 20.00 
  
Table 2.1: Formula for the PCR reaction for the genotyping of SeyEd embryos. 
The PCR product was then digested with the restriction enzyme DdeI (New England 
Biolabs, catalogue number R0175S) for two hours at 37°C 9 (Table 2.2). 
Reaction component Volume (µl) 
PCR product 5.0 
DdeI (New England Biolabs) 0.5 
CutSmart® Buffer (New England Biolabs) 2.0 
Double distilled water 12.5 
Total volume 20.0 
 
Table 2.2: Formula for the SeyEd genotyping PCR product digest reaction. 
Digested DNA samples were analysed using agarose gel electrophoresis performed 
with 50ml of 4% NuSieve agarose containing 1µl GelRed™ fluorescent nucleic acid 
stain (Biotium) in TBE running buffer. Digestion of DNA the Pax6+ allele resulted 
in bands of 199bp and 83bp while bands of 199bp, 180bp, 83bp and 19 bp were 
observed following digestion of the fragment from mice carrying the SeyEd allele. 
Shh-null mutant embryos (Chiang et al 1996) and control littermates were kindly 
provided by Professor Robert Hill at the MRC Human Genetics Unit, University of 
Edinburgh, as whole embryos in methanol. Shh-null mutant embryos were identified 
as those exhibiting cyclopia (Chiang et al 1996, Roessler et al 1996). 
38 
 
2.2 Tissue fixation and preparation 
Harvested embryonic tissue was washed in phosphate buffered saline (PBS), made 
by adding one PBS tablet (Oxoid) to 100ml of double distilled water. Embryonic 
tissue was fixed in a solution of 4% paraformaldehyde (PFA) (Fisher Scientific) in 
PBS with gentle rocking at 4°C overnight. 
For samples to be processed as whole mounts, tissue was washed in a solution of 
0.1% Tween-20 (Fisher Scientific) in PBS- a solution referred to here as PBT. The 
samples were then dehydrated by washing in a series of increasingly concentrated 
solutions of methanol diluted in PBT, at concentrations of 25%, 50% and 75% 
respectively. Following these washes tissue samples were stored in 100% methanol 
at -20°C. Prior to processing the tissue samples were rehydrated by washing in a 
series of increasingly dilute solutions of methanol in PBT, at concentrations of 75%, 
50% and 25% respectively before being washed in PBT. 
For samples which were to be sectioned prior to further processing tissue was 
transferred to a solution of 30% sucrose in PBS with gentle rocking at room 
temperature (RT) until the tissue sank to the bottom of the solution. Sucrose-sunk 
tissue was placed into a truncated cryostat mould (Polysciences Inc) filled with a 1:1 
mixture of 30% sucrose dissolved in PBS and optimal cutting temperature (OCT) 
cryosectioning compound (Sakura, Fisher Scientific). Tissue was manipulated into 
the desired orientation before the mould was placed into a container of dry ice to 
freeze the OCT/30% sucrose in PBS mixture and the tissue sample within. Mounted 
embryos were stored at -80°C. 
Tissue samples intended to be treated with in situ hybridization alone, and with a 
single riboprobe, were cryosectioned at a thickness of 10µm. Tissue samples 
intended to be treated with both in situ hybridization and immunohistochemistry, or 
with in situ hybridization using two different riboprobes, were sectioned at a greater 
thickness of 16µm as a compromise to allow for the lengthier and more destructive 
protocols. 
All tissue sections were mounted on Superfrost™ Plus slides (Fisher) and air dried at 
room temperature (RT) for a minimum of one hour before being processed or placed 
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into storage at -20°C for later use. Slides kept in storage at -20° were warmed to RT 
and left to dry at RT for at least one hour prior to processing in order to allow 
condensation to evaporate. 
2.3 Preparation of plasmid DNA 
Plasmid DNA was amplified in Escherichia coli (E.coli) cells. 100µl of competent 
E.coli cells (Promega) were thawed on ice for 30 minutes before being transferred to 
a sterile 15ml tube. 
The majority of the plasmid DNA to be amplified was sourced from the plasmid 
bank at the laboratory of the Genes and Development Group, The University of 
Edinburgh. The plasmid DNA stocks in this resource are dissolved in double distilled 
water before being stored at -20°C. For these plasmids, 1-2µl of plasmid DNA was 
added to the tube containing the competent cells. A small number of plasmids were 
received by mail in the form of DNA solution applied to sterile filter paper and 
allowed to dry. For these plasmids the region of filter paper marked as the site of the 
DNA solution was excised and placed in 500µl of double distilled water in a 1.5ml 
microcentrifuge tube in order to elute the DNA. 1-2µl of the elute was added to the 
tube containing the competent cells. Other plasmids were sourced from the plasmid 
bank at the Laboratory for The Mechanisms of Thalamus Development, The RIKEN 
Brain Science Institute. The plasmids in this resource are added to a solution of 80% 
glycerol in double distilled water before being stored at -80°C as glycerol stocks. For 
these plasmids a small sample was taken by scratching the surface of the glycerol 
stock with a sterile pipette tip and dropping this into the 15ml tube containing the 
competent cells. 
The mixture of competent cells and plasmid stock DNA was mixed gently and then 
incubated on ice for 30 minutes before cells were transformed using the heat shock 
method (Froger and Hall 2007). The tube was transferred to a thermostatically 
controlled water bath and incubated at 42°C for 45 seconds before being placed back 
on ice. 450µl of Super Optimal Concentration (SOC) medium (Sigma) was added to 




For plasmids received by mail, 200µl of the SOC medium culture was plated on agar 
containing the antibiotic to which the plasmid was resistant. The streak plate method 
was used to ensure it would be possible to distinguish and pick a single colony from 
the bacterial lawn (Sanders 2012). Plated cells were incubated at 37°C for 18 hours. 
Following incubation a sterile pipette tip was used to pick a single colony and this 
was incubated in 450µl of SOC medium at 37°C for 2 hours to generate a starter 
culture. For plasmids sourced from the plasmid banks, this step was omitted and the 
initial culture in SOC medium was used as a starter culture. 
The starter culture was then added to 200ml of Luria Bertani (LB) broth containing 
the appropriate antibiotic in a conical flask of a volume of at least 400ml. the mixture 
was incubated at 37°C in a shaking incubator, at a speed of at least 180RPM and for 
a time period of no longer than 16 hours. 
Bacterial cells were harvested by centrifuging the mixture at 6,000RPM at a 
temperature of 4°C for 15 minute. The liquid fraction was discarded. A maxiprep 
was performed on the remaining bacterial pellet to lyse the cells, release the cell 
contents and purify the plasmid DNA, using maxiprep kits (Qiagen, Viogene) and 
following the manufacturers’ protocols. 
LB broth was prepared by adding two LB broth tablets (Sigma) per 100ml of double 
distilled water and sterilising the resulting solution in an autoclave at a temperature 
of at least 140°C. 1ml of 100mg/ml ampicillin solution (Sigma) or 1ml of 50mg/ml 
kanamycin powder (Sigma) in double distilled water was added per 1l of autoclaved 
solution once cooled. Transformed E.coli cells were cultured in LB broth containing 
the antibiotic to which the plasmid DNA was resistant. 
Purified plasmid DNA was stored at -20°C. 
2.4 Preparation of single-stranded RNA riboprobes 
DNA plasmids were first linearized in order to produce a template for the RNA 
riboprobe. A sample of plasmid DNA solution was added to a 1.5ml microcentrifuge 
tube with double distilled water and the appropriate restriction enzyme (various 
manufacturers) and buffer (various manufacturers). The resulting solution was at 
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37°C for two hours (see Table 2.3 for the volumes of the reaction components). The 
template DNA was then purified with the use of the phenol-chloroform extraction 
method (Chomczynski and Sacchi 2006) or the QIAquick Gel Extraction Kit 
(Qiagen).  
Reaction component Volume (µl) 
Plasmid DNA 10.5 
Restriction endonuclease enzyme (various manufacturers) 5.0 
Enzyme buffer (various manufacturers) 10.0 
Double distilled water  164.5 
Total volume  190.0 
 
Table 2.3: Formula for the DNA plasmid linearization reaction. 
To synthesise a riboprobe using the template DNA, template DNA was added to a 
1.5ml centrifuge tube with the appropriate RNA polymerase enzyme (T3, T7 or SP6) 
(Roche) and enzyme buffer (Roche), RNA nucleotide mix labelled with digoxigenin 
(DIG), 2, 4-dinitrophenyl (DNP) or fluorescein (FL) (Roche) and double distilled 
water. The solution was incubated at 37°C for two hours. DNAseI enzyme (Roche) 
was the added and the mixture incubated at 37°C for 15 minutes. (Table 2.4) 
Reaction component Volume (µl) 
Template DNA 10 
RNA polymerase (T3, T7, SP6) 2 
RNA polymerase buffer (Roche) 2 
RNA nucleotide labelling mix (DIG, DNP or FL) (Roche) 2 
Double distilled water 12 
Total volume 28 
 
Table 2.4: Formula for the reaction for the synthesis of and RNA riboprobe from a 
DNA template. 
To precipitate the labelled riboprobe out of the aqueous solution, 2.5µl of 4M lithium 
chloride (LiCl) and 2µl of 0.2M EDTA were added, along with 75µl of chilled 
ethanol for probes labelled with DIG or DNP, or 75µl of chilled isopropanol for 
probes labelled with FL. The solution was then stored at -80 overnight in order to 
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allow a high proportion of the labelled RNA to precipitate out of the solution. The 
solution was then centrifuged at 13,000RPM and 4°C for 30 minutes in order to 
collect the labelled RNA precipitate as a pellet.  
The liquid fraction was discarded and the pellet was washed to remove residual LiCl 
with the addition of 200µl of 70% ethanol in double distilled water followed by 
centrifugation at 13,000 at RT for five minutes. The washing step was repeated once 
before the washed RNA pellet was air dried at 37°C for 10 minutes and the RNA 
then resuspended in 50µl of double distilled water. 
Labelled riboprobes were stored at -20°C.  
2.5 In situ hybridization 
The required concentration for each riboprobe was determined by performing the in 
situ protocols as described below with the probe at dilutions of 1:500, 1:1,000, 
1:2,000, 1:5,000 and 1:10,000 in hybridization buffer (Table 2.5). The dilution which 
produced an acceptably strong in situ signal with an acceptably low level of 
background staining was used for all further experiments using the same probe. 
Probes were diluted to the required concentration in 200µl of hybridization buffer 
(Table 2.5) per slide. The diluted probe was heated to 85°C for 10 minutes in order to 
denature any ribonuclease enzymes (RNAses) which may be present as 
contaminants. The diluted probe was then pipetted onto slide-mounted tissue sections 
and coverslips were applied. Slides were placed into an airtight box humidified with 
formamide wash buffer (Table 2.5) and incubated overnight at 70°C. 
Following the hybridization step sections were washed in formamide wash buffer at 
70°C for 15 minutes in order to dissolve the hybridization buffer and allow 
coverslips to be removed without causing damage to the tissue sections. Two further 
washes in formamide wash buffer were performed at 70°C for 30 minutes. 
For chromogenic in situ hybridization, sections were then washed in MABT (Table 
2.6) two times for 30 minutes at RT. Slides were transferred to a box humidified with 
PBS and sections were outlined with a hydrophobic barrier pen (Vector Laboratories)  
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Solution Reagent Quantity 
5M EDTA EDTA (Fisher) 36.53g 
  Double distilled water 250ml 
  Total volume 250ml 
pH adjusted to 8.0 with NaOH to allow EDTA to dissolve. Autoclaved. Stored at RT. 
10x salt 
NaCl (Fisher) 28.50g 
Tris HCl (Fisher) 3.510g 
Tris base (Fisher) 0.355g 
NaH2PO4·2H2O 1.950g 
Na2HPO4 1.775g 
0.5M EDTA 25ml 
Double distilled water 
To total 
volume 
Total volume 250ml 
pH adjusted to 8.0 with NaOH. Autoclaved. Stored at RT. 
Hybridization buffer 
10x salt 20ml 
Deionized formamide (Sigma- Aldrich) 5ml 
50% dextran sulphate (Fisher) 2ml 
tRNA from bakers’ yeast (Roche)  10mg/ml 
in double distilled water 
1ml 
Denhardt’s Solution (Life Technologies) 100µl 
Double distilled autoclaved water 900µl 
Total volume 10ml 
Prepared in a fume hood. tRNA first denatured by heating to 85°C for ten minutes. Stored at -
20°C. 
20x SSC buffer 
NaCl 175.3g 
Sodium citrate 88.2g 
Double distilled water 1,000ml 
Total volume 1,000ml 
Autoclaved. Stored at RT. 
Formamide wash buffer 




Tween-20 (Fisher) 300 µl 
Formamide (Fisher) 150ml 
Total volume 300ml 
Prepared in a fume hood. Heated to hybridization temperature before use. 
 




before a blocking solution of 20% sheep serum in PBS with 0.1% blocking reagent 
(Roche) (Table 2.6) was pipetted onto each slide. After an hour at RT the solution 
was gently shaken off the slides before anti-DIG alkaline phosphatase enzyme 
(Roche) at a concentration of 1:1,500 in blocking solution was added. The sections 
were incubated in the diluted antibody at 4°C overnight. Sections were then washed 
in MABT for 15 minutes RT five times before being washed in pre-staining buffer 
(Table 2.6) twice at RT for ten minutes. The slides were returned to the box 
humidified with PBS and staining buffer (Table 2.6) and from this stage onwards 
were covered to protect them from light. Slides were incubated at until the colour 
reaction had proceeded to the point where an acceptably strong in situ signal with an 
acceptably low level of background could be observed with brightfield microscopy. 
To arrest the colour reaction slides were washed in PBS. Sections were then covered 
with a 1:1 solution of glycerol and PBS before coverslips were applied and the slides 
were sealed with nail polish. Sealed slides were covered to protect them from light 
and stored at 4°C. 
For fluorescence in situ hybridization, following the two 30 minute washes with 
formamide wash buffer tissue sections were washed twice in TNT wash buffer 
(Table 2.7) at RT for 30 minutes. Slides were transferred to a box humidified with 
PBS. Sections were outlined with a hydrophobic barrier pen (Vector Laboratories) 
and 100µl of blocking solution (Table 2.7) was pipetted onto each slide. After an 
incubation period of one hour at room temperature the blocking solution was gently 
shaken off the slides before anti-DIG (Roche), anti-DNP (Roche) or anti-FL (Roche) 
antibodies bound to horseradish peroxidase was pipetted onto each slide at a dilution 
of 1:500 in blocking solution (Table 2.7). Slides were incubated in the diluted 
antibody at 4°C overnight. Sections were then washed four times in TNT at RT for 
15 minutes. Slides were returned to the humidified box and incubated in fluorophore 
solution (Table 2.7) for 15 minutes at RT. From this step onwards slides were 
covered to protect them from light. Sections were then washed in TNT four times for 
15 minutes at RT. Slides were counterstained via incubation in 4',6-diamidino-2-
phenylindole (DAPI) solution (table 2.7) for 10 minutes at RT before slides were 
rinsed in PBS. Sections were covered with ProLong™ Gold Antifade mounting 
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medium (Life Technologies), coverslips were applied and slides were sealed with 
nail polish. Sealed slides were stored at 4°C. 
For double fluorescence in situ hybridization, a DIG-labelled probe was used along 
with a second probe labelled with either DNP or FL. Probes were diluted to the 
required concentration in hybridization buffer and in situ hybridization was 
performed as described above using the anti-DIG antibody and cyanine-3-tyramide 
as the fluorophore. Following the fluorophore incubation step slides were rinsed in 
TNT wash buffer and then incubated in 10mM HCl at RT for 30 minutes in order to 
denature the horseradish peroxidase. Slides were then washed four times in TNT 
buffer for 15 minutes at RT before being incubated in the second antibody (anti-FL 
or anti-DNP as appropriate) overnight at 4°C. Following this step slides were washed 
in TNT 4 times at RT for 15 minutes before being incubated in a fluorophore 
solution containing fluorescein for 15 minutes at room temperature. Following this 
step further washes in TNT wash buffer followed by counterstaining with DAPI were 
performed as described above. Sections were covered with ProLong™ Gold Antifade 
mounting medium, coverslips were applied and slides were sealed with nail polish. 
Sealed slides were stored at 4°C. 
2.6 Fluorescence immunohistochemistry 
Tissue sections were cryosectioned at a thickness of 16µm. All steps were performed 
with the slides covered to protect them from light. Following fluorescence in situ 
hybridization as described above, with slides incubated in a fluorophore solution 
containing cyanine-3-tyramide, slides were washed in cold running water for 10 
minutes. Antigen retrieval was then performed by placing the slides into a 10mM 
solution of sodium citrate and gently heating them with low power microwave 
radiation for twenty minutes. Slides were left to cool to room temperature before 
being washed in PBT. Slides were transferred to a box humidified with PBS and 
incubated in a blocking solution consisting of 10% donkey serum (Sigma) in PBS for 
one hour. Slides were then incubated in a solution of the primary antibody- either 
Rabbit Poly Pax-6 (Covance Research Products) or Rabbit anti-GFP (Abcam) - at a 




Solution Reagent Quantity 
5xMABT 
Maleic acid 58.05g 
NaOH Approximately 32.00g 
NaCl 43.08g 
Tween-20 (Fisher) 5ml 
Double distilled water To total volume 
Total volume 1,000ml 
Maleic acid is added to approximately 800ml water first, followed by NaOH to adjust pH to 7.5 
before other components are added and more water is added to total volume. 5x MABT is a 
stock solution stored diluted fivefold in water to 1xMABT before use. Stored at 4°C to inhibit 
growth of fungal contamination. 
Blocking solution for 
chromogenic in situ 
hybridization 
1xMABT 4ml 
Sheep serum (Sigma-Aldrich) 1ml 
Blocking reagent (Roche) 100µg 
Total volume 5ml 
Prepared immediately prior to use. Stirred with a magnetic stirrer for at least one hour at RT 
in order to allow blocking reagent to dissolve. 
1M Tris HCL pH 9.5 
Tris-HCl 157.56g 
Double distilled water 1,000ml 
Total volume 1,000ml 
pH adjusted with NaOH to pH 9.5 for chromogenic in situ hybridization. Autoclaved. Stored at 
RT. 
Pre-staining buffer 5M NaCl 6ml 
  1M MgCl2 15ml 
  1M Tris-HCl pH9.5 30ml 
  Tween-20 (Fisher) 300µl 
  Double distilled water To total volume 
  Total volume 300ml 
Prepared immediately prior to use. 
Staining buffer 5M NaCl 2ml 
  
1M Tris-HCL pH 9.5 10ml 





1M MgCl2 4.5ml 
Tween-20 (Fisher) 90µl 






Reagents added in order given. Solution is stirred with a magnetic stirrer and heated to 85°C 
until PVA dissolves. Solution is cooled to RT with stirring before the remaining reagents are 
added. Prepared immediately prior to use.  
 




Solution Reagent Quantity 
1M Tris HCL Tris-HCl 157.56g 
  Double distilled water 1,000ml 
  Total volume 1,000ml 
pH adjusted with NaOH to 7.5 for fluorescence in situ hybridization. 
Autoclaved. Stored at RT. 
TNT wash buffer 
1M Tris-HCl pH 7.5 100.00ml 
5M NaCL 30.00ml 
Tween-20 2.25ml 
Double distilled water To total volume 
Total volume 1,000ml 
Prepared immediately prior to use. 
Blocking solution 
1M Tris HCl pH 7.5 500µl 
5M NaCl 150µl 




  Total volume 5ml 
Prepared immediately prior to use. Stirred with a magnetic stirrer for at 
least one hour at RT in order to allow blocking reagent to dissolve. 
Fluorophore 
solution 



















DAPI prepared at a dilution of 1:1000 in PBS. Prepared immediately prior 
to use. 100µl is used per slide. 
 




RT for 15 minutes. Slides were then incubated in a solution of the secondary 
antibody, goat anti-rabbit Alexa-Fluor 488® (Abcam), at a dilution of 1:400 
overnight at 4°C. Slides were then washed in PBT for 15 minutes and then incubated 
in counterstain solution (Table 2.7) for 10 minutes. Following two five minute 
washes in PBS sections were mounted with ProLong™ Gold Antifade mounting 
medium (Life Technologies) and the edges of the coverslips were sealed with nail 
polish. Sealed slides were stored at 4°C. 
2.7 Vismodegib drug treatment 
Administration of the drug and the control solution was performed in accordance 
with the UK Scientific Procedures Act (1986) by the technicians at Biological 
Research Resources, Hugh Robson Building. The harvesting, fixation and mounting 
of treated embryos were carried out by Idoia Quintana-Urzainqui. 
Vismodegib (GDC-0449) powder (Selleckchem) was dissolved in a methylcellulose 
vehicle solution prior to administration (Lipinski et al 2010). To prepare the vehicle 
water was first purified by reverse osmosis. 20ml of purified water was heated to 
85°C. 0.25mg of methylcellulose powder (Sigma-Aldrich) was added and the water 
stirred to evenly disperse the powder. 20ml of chilled purified water was then added 
to the suspension with stirring. The solution was stored at 4°C overnight or until the 
solution appeared clear. The clear solution was then allowed to reach RT before 
100µl of Tween-80 (Fisher) was added. Once the Tween-80 had dissolved purified 
water was added to adjust the total volume of the solution to 50ml. The solution was 
filtered with the use of a syringe to pass the solution through disposable 0.4M filter 
units (Whatman). The vehicle solution was stored at 4°C for up to 1 month. 
To prepare the vismodegib solution, the vehicle was allowed to equilibrate to RT. 
Vismodegib powder was added and the solution was sonicated in a bath sonicator for 
5 minutes at a temperature not exceeding 37°. The solution was stored at 4°C for up 
to two weeks. 
Vismodegib was administered at a dose of 4mg per animal. Control animals were 
administered with the vehicle only. The solutions were administered to pregnant 
49 
 
females at E9.5 by oral gavage and treated animals were closely monitored for 
adverse effects. Animals were culled at E12.5 and embryos harvested. 
2.8 In utero electroporation 
All surgical procedures were performed in accordance with the UK Scientific 
Procedures Act (1986). The method described here is a version of the 
transillumination electroporation method developed by Matsui et al (2011) with 
modifications in accordance with UK Home Office guidelines. 
Timed matings were set up with mice of the CD-1® strain. Surgery was performed at 
E12.5. Prior to surgery all tools and working surfaces were sterilised. Animals were 
anaesthetised with gaseous isofluorane administered with medical oxygen via an 
anaesthetic rig. Anaesthetised animals were then transferred to a thermostatically-
controlled heatpad, at which point anaesthesia and oxygen were administered via a 
facemask. A bright LED light source was positioned above the animal in order to 
illuminate the lower abdomen. 
Pain relief was administered as a subcutaneous injection of buprenorphine diluted in 
sterile water for injections and given at a dose of 0.1 mg/kg of bodyweight. The 
lower abdomen was clipped to remove fur and washed with Dermastel antiseptic 
detergent (Tristel). The surgeon washed their hands with Dermastel before drying 
them with sterilised paper towels. Sterile nitrile gloves were worn during surgery. A 
window was made in a sterilised paper towel and this positioned over the animal 
with the window above the animal’s lower abdomen. 
An incision was made in the skin of the lower abdomen to expose the muscle layer. 
A second incision was made along the non-vascularised linea alba of the muscle 
layer, a site chosen to minimise blood loss. The body cavity was flushed with sterile 
PBS warmed to 37°C and administered via a sterile Pasteur pipette. 
The whelps of one uterine horn were gently lifted out of the body cavity and kept 
moist with sterile PBS. A single whelp was held in the fingers of the surgeon’s non-
dominant hand and was viewed under the bright LED light in order to locate the 
position of the dorsal midline of the telencephalon and that of the diencephalon 
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immediately behind it. When these structures could be clearly seen the embryo was 
manipulated to orient the rostral limit of the forebrain towards the surgeon’s 
dominant hand. Gentle pressure was applied to the whelp with fingers in order in 
order to position the embryo close to the uterine wall without causing damage to the 
embryo, the amniotic sac or other tissues. 
Plasmid DNA was administered via a glass micropipette with a cut tip not exceeding 
a diameter of 40µm (Matsui et al 2011). The cShh pXeX plasmid (Agarwala et al 
2001) was co-electroporated with the pTP6 Tau GFP plasmid (Pratt et al 2000b). 
Control embryos were injected with pTP6 Tau GFP alone. The micropipette was 
filled with plasmid DNA solution at a concentration of no less than 1µg/µl for each 
plasmid and Fast Green FCF (Sigma-Aldrich) at a concentration of 10% in double 
distilled autoclaved water. The micropipette was then fitted into the pipette holder of 
a pneumatic picopump (World Precision Instruments). Using the dominant hand the 
surgeon inserted the tip of the micropipette through the uterine wall and the rostral 
extent of the left-hand telencephalic vesicle (Fig. 2.1A) until the tip of the 
micropipette could be seen within the third ventricle (Fig. 2.1B). The picopump was 
operated via a footpump control to administer the plasmid DNA (Fig. 2.1C). The 
presence of Fast Green within the third ventricle was taken as an indication of DNA 
having been administered successfully (Matsui et al 2011). 
The pipette was removed and warmed sterile PBS was applied to the whelp in order 
to increase electrical conductivity. Platinum paddle electrodes (Nepagene) were 
placed in contact with the whelp, with the anode at the left-hand side of the 
diencephalon and the cathode on the right-hand side, and in such a way as to avoid 
passing current through the placenta (Fig. 2.1D). Gentle pressure was applied to the 
electrodes in order to position them close to the diencephalic tissues without causing 
damage to the whelp. The electroporator (Nepagene) was operated with a footpump 
control to administer five pulses of square wave electrical current at 30V. The treated 
whelp was then moistened with warmed sterile PBS. 
The microinjection and electroporation procedures were repeated for further embryos 




Fig. 2.1: Schematic to illustrate the positioning of the micropipette and electrodes for 
in utero electroporation. A. The ventral midline of the telencephalon is located and 
the embryo is manipulated to ensure that the rostral extent of the brain is facing the 
hand the surgeon will use to inject the DNA and apply the current (in this case the 
right hand). B. The pipette is inserted until the tip can be seen within the third 
ventricle. C. The third ventricle is filled with DNA solution via a picopump and the 
capillary is removed before the electrodes are applied. D. The anode is placed at the 
left-hand side of the diencephalon while the cathode is placed at the opposite side 
before the current is applied. E. 24 hours after surgery animals are sacrificed, 
embryos are harvested and the embryonic brain tissue is isolated. Successfully 
electroporated embryos are identified by the use of fluorescence microscopy to 
detect GFP expression. F. In tissue sections the electroporated cells can then be 
visualised following the use of in situ hybridization or immunohistochemistry to 
detect the protein or mRNA expressed by the electroporation construct(s). 
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process was then repeated for the embryos inside the whelps of the second uterine 
horn before this was also replaced in the body cavity. The whelps adjacent to the 
cervix were not treated in order to avoid tissue damage and haemorrhaging that can 
be caused by manipulation of the tissue at the point. 
Prior to suturing approximately 1ml of sterile PBS was administered into the body 
cavity in order to replace fluid lost during surgery. The muscle layer was closed with 
Vicryl Rapide™ dissolving suture in size 5-0 (Ethicon) applied in a series of 
individual stitches along the length of the incision. The skin was closed with surgical 
clips (BD™ or Autoclip™). Administration of anaesthesia was halted and the animal 
transferred to a cage containing clean bedding material, fresh high-protein rodent 
chow and fresh water. Post-operative pain relief was administered as Buprenorphine 
in the form of edible jelly. The cage was placed on a thermostatically-controlled heat 
pad for two hours in order to optimise the animal’s recovery. Cages were then 
transferred from the heat pad to the temperature and humidity-controlled CD-1® 
facility where animals were then monitored at regular intervals. 
Animals were culled 24 hours after surgery, at E13.5. Embryos were harvested and 
dissected to isolate embryonic brain tissue. Brain tissue and this was observed under 
fluorescence in order to detect GFP expression as a sign of a successfully 
electroporated embryo and an indicator of the electroporated region (Fig. 2.1E). 
2.9 Imaging 
Brightfield images of tissue sections treated with chromogenic in situ hybridization 
were imaged with the Leica DMLB microscope and Leica AS Application Suite 
software. Tissue sections treated with fluorescence in situ hybridization and 
fluorescence immunohistochemistry were imaged with the Leica DM5500 
fluorescence microscope and Leica AF6000 software. For whole embryos treated 
with chromogenic in situ hybridization, brightfield images were recorded with the 
Leica M165C microscope and Leica AS Application Suite software. For tissue 
sections treated with fluorescence techniques, widefield images were recorded with 
the Leica and Leica Advanced Fluorescence software. Confocal images were 
recorded using the Nikon A1R-FLIM confocal microscope and Nikon Elements 
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software. Images were recorded at a bit depth of 16 bits and a resolution of 
1028x1028 pixels and were saved as stacks, with one image per channel (Pax6 
immunostaining at 488nm, Barhl2 in situ hybridization staining at 554nm, DAPI 
staining at 350nm). The “Grab large image free shape” function of Elements was 
used to compile a tiled image from several square images recorded at different 
regions of the tissue section. Confocal images were recorded at the Image Analysis, 
MultiPhoton, and Confocal Technologies (IMPACT) imaging facility, The 
University of Edinburgh. 
2.10 Quantification of image data 
Quantification was performed on tiled confocal images of images of medial sections 
of the diencephalon (Fig.1.5C). To ensure that the data from each image would be 
comparable images featuring comparable morphology were chosen to be analysed, 
with the morphology taken as a guide to the position of the section along the 
rostrocaudal axis of the diencephalon. In all sections chosen the prethalamus, 
identified by Pax6 expression, and the ZLI and eminentia thalami, identified by 
Barhl2 expression, were visible features. 
One suitable image was selected from each of the three different embryos treated at 
each developmental stage from E10.5 to E13.5. Confocal images were rendered as 12 
bit greyscale images in Fiji (Schindelin et al 2012) with pixel values ranging from 0 
(black) to 4096 (white). The pixel values correlate with the intensity of the 
fluorescence, with an area of neuroepithelium with no signal corresponding to a pixel 
with a value of 0 and an area with the most intense signal possible being 4096. 
For embryos harvested at E10.5-E12.5, the segmented line tool was used to draw a 
line of 25 pixels in width along the ventricular surface of the diencephalon, running 
from the dorsal midline of the diencephalon to the dorsal extent of the ZLI. The 
intensity plot tool was then used to record the greyscale values of the pixels along 
this line (Fig. 2.2A).  
For embryos harvested at E13.5, the neuroepithelium of the pretectum becomes 





Fig. 2.2: Selection of the area of neuroepithelium along which expression gradients 
were quantified using Fiji. A: For sections from embryos at E10.5-E12.5 a 25 pixel 
line was drawn along the ventricular surface from the dorsal midline to the caudal 
extent of the ZLI, as marked by Barhl2 expression. B: For embryos harvested at 
E13.5 a 25 pixel line was drawn along the ventricular surface from the dorsal midline 
to the caudal extent of the ZLI. C: A 10 pixel line was drawn along the ventricular 
surface from the dorsal midline to the point at which the neuroepithelium begins to 
thicken. 
Thickness. To account for this change in morphology, the segmented line tool was 
used to draw a line of 25 pixels in width as described above, and a second line of 10 
pixels in width was also drawn from the dorsal midline to the point at which the 
diencephalic neuroepithelium begins to thicken. (Fig. 2.2B-C). Intensity plot data 
was recorded for both lines. The data recorded along the length of the 10 pixel line 
was used to quantify the gradient along with the data recorded along the length of the 
25 pixel line from the point at which the 10 pixel line ended to the caudal extent of 
the ZLI as marked by Barhl2 expression. Values were recorded for the Pax6 
immunostaining channel (488nm) and the Barhl2 in situ channel (554nm) on the left-
hand side of each image. This was repeated for both channels on the right-hand side 
of each image. 
Intensity plot data was pasted into a Microsoft Excel spreadsheet. Values were 
grouped into bins of five and a mean value for each bin was recorded. Using Excel, 
these mean values were then plotted against distance from the dorsal midline in order 
to produce a line graph illustrating changes in the relative intensity of the signal 
across the neuroepithelium. This was repeated for Pax6 and Barhl2, on both the left-
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hand and right-hand sides of each embryo, to take the possibility of sections being 
asymmetrical into account. A linear regression trend line was calculated for each plot 
and the gradient of this was recorded. The data from all three embryos was used to 






















3. Expression of Pax6 and Barhl2 in the wild type mouse diencephalon 
3.1 Introduction 
Published in situ hybridization data for Pax6 (Anderson et al 2002, Moreno et al 
2014) and Barhl2 (Suzuki-Hirano et al 2011) suggest that their expression domains 
may complement each other in several regions of the forebrain, with the notable 
exception of the thalamus and pretectum, in which both genes appear to be 
expressed. Within these adjacent diencephalic regions Pax6 is expressed in a 
gradient running from dorsal to ventral and from caudal to rostral (Mastick et al 
1997). Strong Barhl2 expression has also been reported within the thalamus during 
some early stages of its development (Suzuki-Hirano et al 2011) but its expression 
within the developing diencephalon has yet to be described in full. 
A high degree of complementarity between the two genes’ expression domains 
would suggest the existence of a mutually repressive relationship between the two 
genes. The existence of a different relationship is may be suggested by their 
expression within the thalamic neuroepithelium. 
In order to identify potential relationships between Pax6 and Barhl2 within the 
diencephalon it was first necessary to map their expression comprehensively and 
over a range of developmental stages. By observing changes in the expression of 
Pax6 in relation to changes in the expression of Barhl2, and vice versa, it should be 
possible to gain an overview of the spatiotemporal dynamics of the two genes’ 
expression and to then use this in order to identify any potential relationships 
between them. 
The expression of Pax6 and Barhl2 was investigated at developmental stages from 
E8.5 to E13.5, the period of development in which the diencephalic neuroepithelium 
differentiates into that of the pretectum, thalamus and prethalamus and in which the 
majority of thalamic neurogenesis occurs. First, chromogenic in situ hybridization 
was used to comprehensively map the expression domains of Pax6 and Barhl2. 
Fluorescence in situ hybridization was then employed along with fluorescence 
immunohistochemistry in order to investigate the complementarity of the genes’ 
expression domains and the possibility of their co-expression within some regions of 
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neuroepithelium and individual cells of the diencephalon. Finally, image data 
obtained from the fluorescence in situ hybridization and fluorescence 
immunohistochemistry experiments were analysed quantitatively: in order to 
investigate the presence of expression gradient changes in the relative intensities of 
the in situ hybridization and immunohistochemistry signals were measured at points 
along the dorsoventral axis of the pretectum and thalamus. 
Together the results from these experiments were used to predict the nature of the 
different relationships which may exist between Pax6 and Barhl2 within different 
regions of the diencephalic neuroepithelium. 
3.2 Qualitative analysis: mapping Pax6 and Barhl2 in the wild-type 
prosencephalon 
3.2.1 Introduction 
OCT-mounted wild-type embryos aged between E8.5 and E13.5 were cryosectioned 
in the coronal plane. For each embryo alternate sections were mounted on two 
different sets of slides in order to collect two series of sections from the same 
embryo, with each individual section from the first series being adjacent to the 
corresponding section from the second series. Chromogenic in situ hybridization was 
carried out on both series of sections, with a digoxigenin (DIG)-labelled riboprobe 
for Pax6 for the first series and DIG-labelled riboprobe for Barhl2 for the second 
series. Treated sections were imaged using bright-field microscopy. 
3.2.2 Results 
Both Pax6 and Barhl2 are strongly expressed within the diencephalon during its 
formation and during the early stages of its development. The expression of both 
genes is highly dynamic, with their expression domains undergoing many spatial 
changes as diencephalic development progresses. The expression domains take on 
distinctive shapes which appear to closely correspond with the shapes and positions 
of particular diencephalic structures as they develop. The degree to which Pax6 and 
Barhl2 are co-expressed seems to vary greatly with the developmental stage and 
position, and in particular with the position in relation to that of the ZLI. 
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At E8.5 (Fig. 3.2.1) the neural tube is still in the process of closing, with the edges of 
the neural plate moving towards each other before fusing to form the roofplate. By 
E8.5 the neural tube has fused along the length of the developing spinal cord, 
mesencephalon and rhombencephalon, but remains open along the entire 
rostrocaudal extent of the prosencephalon (arrows, Fig. 3.2.1A). 
By this point in development it appears that the prosencephalon has begun to 
subdivide into the more rostral telencephalon and the more caudal diencephalon and 
the two sub-regions appear to be morphologically distinct. At this stage the forming 
telencephalon begins to envelop the diencephalon (Price et al 2011) and in sections 
cut in the coronal plane this may be the structure that can be distinguished as two 
vesicles forming to the left and right of the third ventricle, the lumen of the 
developing diencephalon (Fig. 3.2.1C). 
At this stage Pax6 is already strongly expressed within the prosencephalon in a 
domain spanning its rostrocaudal extent, but its expression is confined to the alar 
plate, the anlage of the pallium (Fig. 3.2.1D). 
At E8.5 the Barhl2 domain is visible as a narrow band of expression situated within 
the prosencephalic Pax6 domain, but this domain is much narrower than that of 
Pax6, with its caudal limit at the approximate location of the midbrain-hindbrain 
boundary (MHB) and its rostral limit at the point where the telencephalon becomes 
morphologically distinct from the diencephalon. Unlike Pax6, Barhl2 is not confined 
to the dorsal neuroepithelium and its expression can be detected in ventral regions, 
extending as far as the floorplate (Fig. 3.2.1F-H). 
By E9.5 (Fig. 3.2.2) the edges of the neural plate have fused to form the roofplate of 
the prosencephalon and neural tube closure is complete. The telencephalon has 
expanded and become morphologically distinct from the diencephalon to an even 
greater extent than before. The telencephalon can also be seen to be forming into two 
distinct hemispheres and by this stage they are visible as fully-enclosed vesicles 
either side of the third ventricle, though this division into two hemispheres is not 





Fig. 3.2.1: The expression domains of Pax6 and Barhl2 in the wild type diencephalon at E8.5 
as visualised by in situ hybridization performed on adjacent coronal sections. The arrows in 
A mark the edges of the neural plate, which have yet to fuse to form the roofplate. K: 
Schematic illustrating the approximate plane of each section. Abbreviations: Tel- 
telencephalon; Di- diencephalon; Mes- mesencephalon; Rh- rhombencephalon; SC- spinal 
cord; FP- floorplate; AP- alar plate; BP- basal plate. 
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At E9.5 Pax6 continues to be expressed along the rostrocaudal extent of the 
prosencephalon while remaining absent from the basal plate. Its expression in the 
telencephalon now clearly corresponds with the position of the developing pallium 
(3.2.2D-E). 
Barhl2 remains absent from the telencephalon and while it is still expressed within 
the diencephalon its domain appears to span a smaller proportion of the diencephalon 
as a whole (3.2.F-H). In more caudal sections two smaller domains of Barhl2 can be 
seen either side of the third ventricle, caudal to the broader diencephalic domain of 
Barhl2, but it is not clear which diencephalic structures they correspond with, if any 
(arrows, Fig. 3.2.2F). These may be visible as a consequence of the plane of section 
in which the tissue was cut, and could possibly represent the caudal extent of the 
thalamic Barhl2 domain visible in Fig. 3.2.2G. 
At E10.5 (Fig. 3.2.3) the dorsal telencephalon begins to fold inwards along the dorsal 
midline and the two telencephalic hemispheres become distinct from each other 
along the entire rostrocaudal extent of the telencephalon. The lumen of the 
diencephalon narrows as it becomes elongated along the dorsoventral axis. Many 
more molecular changes become apparent at this stage, possibly as a consequence of 
the ZLI being established around this time (Shimamura et al 1995). The eyes can 
also be seen ventral to the diencephalic hemispheres, marked by strong Pax6 staining 
in the developing retina (arrows, Fig. 3.2.3C). 
In caudal and medial sections the Barhl2 domain becomes fragmented into two 
separate domains separated by a narrow strip of Barhl2-negative neuroepithelium 
(arrows, Fig. 3.2.3F). The more ventral of the two domains is visible as a wedge-
shaped region of expression in the centre of the diencephalon, tapering as it extends 
from the ventricular surface towards the lateral extent of the diencephalic 
neuroepithelium, and corresponding with the shape and the position of the ZLI. 
Dorsal to this domain and the Barhl2- negative region is an area of strong Barhl2 
expression corresponding with the developing thalamus and pretectum. Within this 
more dorsal expression domain Barhl2 now appears to be expressed in a ventral-to-
dorsal gradient, in contrast to its apparently uniform expression throughout the 




Fig. 3.2.2: The expression domains of Pax6 and Barhl2 in the wild-type diencephalon at E9.5 
as visualised by in situ hybridization performed on adjacent coronal sections. Arrows in F: 
Two small Barhl2 domains, possibly the most caudal region of the broader Barhl2 domain 
visible in G. K: Schematic illustrating the approximate plane of each section. Abbreviations: 
Tel- telencephalon; Di- diencephalon; Mes- mesencephalon; Rh- rhombencephalon; SC- 
spinal cord; RP- roofplate; FP- floorplate; AP- alar plate; BP- basal plate. 
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In more rostral sections a third domain of Barhl2 can be seen forming in a region of 
the diencephalon ventral to the ZLI (arrows, Fig. 3.2.3I). This domain is separated 
from the domain of Barhl2 within the ZLI by a relatively broad region of Barhl2-free 
neuroepithelium. It is not clear whether this domain segregates from the solid Barhl2 
domain visible at earlier developmental stages or it arises independently of this 
domain with the onset of its expression in the ventral diencephalon induced by 
another factor. 
Pax6 continues to be strongly expressed throughout the dorsal regions of the 
telencephalic neuroepithelium and its expression appears to be stronger in the caudal 
telencephalon as the caudal-to-rostral gradient of Pax6 is established. The pallial-
subpallial boundary (PSB) also becomes apparent as the ventral limit of the 
telencephalic Pax6 domain (arrows, Fig. 3.2.3E). 
Within the diencephalon the previously solid and continuous Pax6 domain also 
begins to  fragment into two discrete domains separated by a region free of Pax6 
expression (arrows, Fig. 3.2.3A). The more dorsal of these domains runs from the 
dorsal midline towards the ZLI and corresponds with the developing pretectum and 
thalamus. Within this domain Pax6 appears to be expressed in a dorsal-to-ventral 
gradient, running counter to the gradient of Barhl2 expression in the same region. 
Ventral to the ZLI, Pax6 is strongly expressed in a domain corresponding with the 
position of the prethalamus. There is an apparent gap in its expression corresponding 
with the small Barhl2 domain in this region (arrows, Fig. 3.2.3D) and the expression 
of the two genes may be complementary in this region, with little to no overlap as 
observed in the thalamus, in which the two domains with their countergradients 
appear to overlap to some extent. 
At E11.5 (Fig. 3.2.4) the telencephalon continues to expand rapidly and envelops the 
diencephalon to a greater extent, with the vesicles of the telencephalon visible on 
either side of the diencephalic lumen even in more caudal sections. As neurogenesis 
continues the wall of the diencephalon can be seen to thicken. 
Pax6 continues to be strongly expressed within the dorsal telencephalon and at this 
stage a ventral-to-dorsal gradient becomes apparent (Fig. 3.2.3A-B). With Pax6 
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expression becoming particularly strong in the more ventral regions of the pallium 
the PSB becomes even more apparent as a sharp border at the rostral extent of the 
telencephalic Pax6 domain (compare arrows, Fig. 3.2.4E, with arrows, Fig.3.3.4J).  
Barhl2 begins to be expressed within the ventral telencephalon and its expression 
domains appear to complement the domains of Pax6 within the telencephalon, 
ending sharply at the region where a spike of Pax6 expression can be seen extending 
from the PSB towards the floorplate (arrows, Fig. 3.2.4J). 
Within the dorsal diencephalon the dorsal-to-ventral gradient of Pax6 also becomes 
more apparent (Fig. 3.2.4A-B). Its expression appears stronger in the pTh-C, and it 
appears that a caudal-to-rostral gradient of Pax6 may also have been established 
within the thalamus and pretectum. Pax6 expression also seems to be largely absent 
from the more lateral regions of the thalamic neuroepithelium and is now confined to 
the more medial regions, in a domain corresponding with the ventricular zone of the 
thalamus (the area marked by the dashed line on the left-hand side, Fig.3.2.4A). 
Thalamic expression of Barhl2 also appears to become confined to the ventricular 
zone at this stage (the area marked by the dashed line on the left-hand side, 
Fig.3.2.4F). The domain of Barhl2 which corresponds with the ZLI can also be 
clearly distinguished (arrows, Fig. 3.2.4H). It has become even further separated 
from the thalamic Barhl2 domain by the Barhl2-negative pTh-R, which continues to 
expand along the dorsoventral axis. 
In regions of neuroepithelium ventral to the ZLI the expression domains of Pax6 and 
Barhl2 can be seen to be developing with a high degree of complementarity. In more 
rostral sections, a Pax6-negative region corresponding with the position of the 
eminentia thalami can be seen, and it is surrounded by a region of strong Pax6 
expression (Fig. 3.2.4D). In adjacent sections apparently complementary expression 
of Barhl2 can be observed, with strong expression within the eminentia thalami itself 





Fig. 3.2.3: The expression domains of Pax6 and Barhl2 in the wild-type diencephalon at 
E10.5 as visualised by in situ hybridization performed on adjacent coronal sections. Arrows 
in A and B: the developing pTh-R. Arrows in C: Strong Pax6 expression within the eye. 
Arrows in E and J: Complementary expression of Pax6 and Barhl2 in and around the 
eminentia thalami. K: Schematic illustrating the approximate plane of each section. 
Abbreviations: Tel- telencephalon; Di- diencephalon; Mes- mesencephalon; Rh- 
rhombencephalon; SC- spinal cord; PT- pretectum; Th- thalamus; pTh- prethalamus; Pal- 
pallium; SubPal- subpallium; PSB- pallial-subpallial boundary. 
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At this stage a new domain of strong Barhl2 expression becomes visible at the 
ventral midline of the caudal diencephalon, corresponding with the position of the 
developing hypothalamus (Fig. 3.2.4F). 
By E12.5 (Fig. 3.2.5) the forebrain has greatly increased in size and the 
neuroepithelium has thickened throughout. At this stage the pretectum, thalamus and 
prethalamus can be clearly visualised. 
Within the thalamus the expression of Pax6 remains confined to the ventricular zone 
(the area marked by the dashed line on the left-hand side, Fig. 3.2.5A) as does that of 
Barhl2 (the area marked by the dashed line on the left-hand side, Fig. 3.2.5F). As 
neurogenesis proceeds and neurons exit the cell cycle the thalamic ventricular zone- 
the site of the majority of thalamic neurogenesis- occupies an increasingly smaller 
proportion of the diencephalon. The thalamic expression domains of both Pax6 and 
Barhl2 correspond with the position of this region and both domains also begin to 
extend across a smaller proportion of the diencephalic tissue along the mediolateral 
axis (Fig. 3.2.4A-C and F-H). This may be a consequence of neurogenesis and the 
reduction in size of the ventricular zone in comparison to that of the thalamus as a 
whole. 
As with earlier developmental stages, at this stage Pax6 expression appears to be 
much stronger than Barhl2 expression within the more caudal regions of thalamic 
neuroepithelium and the opposite applies in more rostral regions, with thalamic 
Barhl2 expression appearing to be much stronger than that of Pax6 (Fig. 3.2.5C and 
H). This suggests that by this stage a gradient of Pax6 expression may run from 
caudal to rostral while a countergradient of Barhl2 expression may run from rostral 
to caudal. 
These apparent countergradients may be present in addition to countergradients 
running along the dorsoventral axis of the thalamus At E12.5 Pax6 is strongly 
expressed at the dorsal midline of the diencephalon and throughout the pretectum but 
appears to be less strongly expressed within the thalamus itself (Fig. 3.2.5C), while 
Barhl2 expression remains strong in the more ventral regions of the thalamus and  




Fig. 3.2.4: The expression domains of Pax6 and Barhl2 in the wild-type diencephalon at 
E11.5 as visualised by in situ hybridization performed on adjacent coronal sections. K: 
Schematic illustrating the approximate plane of each section. Outlined areas in A and B: The 
thalamic domains of Pax6 and Barhl2 are confined to the ventricular zone of the pTh-C. 
Arrows in H: Barhl2 expression within the ZLI. Arrows in E and J: the PSB, the point at which 
the telencephalic domains of Pax6 and Barhl2 meet. Abbreviations: Tel- telencephalon; Di- 
diencephalon; Mes- mesencephalon; Rh- rhombencephalon; SC- spinal cord; PT- pretectum; 
Th- thalamus; pTh- prethalamus; VZ- ventricular zone; Ctx- cortex; CP- choroid plexus; PSB- 
pallial-subpallial boundary; LGE- lateral ganglionic eminence; MGE- medial ganglionic 
eminence; Hyp- hypothalamus; ET- eminentia thalami; ZLI- zona limitans intrathalamica. 
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not as apparent here as it is at E11.5 (Fig. 3.25H). The gradient of thalamic Pax6 
expression may therefore run from dorsal to ventral and from caudal to rostral, while 
the gradient of thalamic Barhl2 may run counter to this, from ventral to dorsal and 
from rostral to caudal. 
Within the region of neuroepithelium rostral to the ZLI, the prethalamus has 
increased in size and expresses Pax6 more strongly than before (Fig. 3.2.5C). In 
more rostral sections the complementary expression domains of Pax6 and Barhl2 are 
apparent, with Pax6 being absent from the eminentia thalami but strongly expressed 
in the regions surrounding it (Fig. 3.2.5D) and Barhl2 being strongly expressed in the 
Pax6-negative region corresponding with the eminentia thalami Fig. 3.2.5I) 
Within the telencephalon the dorsal-to-ventral gradient of Pax6 expression can be 
clearly seen, along with a narrow strip of Pax6 expression extending from the PSB 
into the lateral ganglionic eminence (arrows, Fig. 3.2.5E). As with the ventral 
telencephalon at E11.5, at this stage complementary expression domains of Barhl2 
can be seen within the regions flanked by Pax6 expression (arrows, Fig. 3.2.5J). 
Barhl2 expression within the hypothalamus remains strong (Fig. 3.2.5F and G) and it 
continues to be expressed within the ZLI (arrows, Fig. 3.2.5H) while being absent 
from the pTh-R. 
Between E12.5 and E13.5 the forebrain undergoes a substantial increase in size. In 
order to obtain adequately detailed image data from sections of embryos treated at 
E13.5 these sections were imaged at a greater magnification than those treated at 
E10.5, E11.5 and E12.5. In order to show the expression domains of Pax6 and 
Barhl2 in adequate detail the image data are presented here across two separate 
figures, the first of which details the expression of Pax6 and Barhl2 in the dorsal 
diencephalon (Fig. 3.2.6) and the second of which details the gene expression data 
for a more ventral region of the diencephalon (Fig. 3.2.7). 
At E13.5 the neuroepithelium continues to thicken and the ventricular zone continues 





Fig. 3.2.5: The expression domains of Pax6 and Barhl2 in the wild-type diencephalon at 
E12.5 as visualised by in situ hybridization performed on adjacent coronal sections. K: 
Schematic illustrating the approximate plane of each section. Arrows in E and J: the PSB, 
the point at which the telencephalic domains of Pax6 and Barhl2 meet.  Abbreviations: Tel- 
telencephalon; Di- diencephalon; Mes- mesencephalon; Rh- rhombencephalon; SC- spinal 
cord; PT- pretectum; Th- thalamus; pTh- prethalamus; VZ- ventricular zone; Ctx- cortex; CP- 
choroid plexus; PSB- pallial-subpallial boundary; LGE- lateral ganglionic eminence; MGE- 




proceeds. Thalamic Pax6 expression remains confined to the ventricular zone of the 
thalamus (Fig. 3.2.6A-D), as does the thalamic expression of Barhl2 (Fig 3.2.6F-I). 
Pax6 expression is still at its strongest in the more rostral regions of the thalamus 
while the opposite is still true of Barhl2, suggesting that the expression 
countergradients are still present along the rostrocaudal axis. 
The presence of Pax6 and Barhl2 expression countergradients along the dorsoventral 
axis of the thalamus is not apparent at this stage. While Pax6 expression is still 
strong in the pretectum and appears to weaken towards the more ventral regions of 
the thalamus, expression of Barhl2 seems to be more solid and appears to be slightly 
stronger in the pretectum (Fig. 3.2.6G-I). 
The ZLI changes shape at this stage becomes narrower and more curved in shape 
prior to the stage at which it no longer appears to be maintained (Visel et al 2004) 
but it can still be seen to express Barhl2 (arrows, Fig. 3.2.7G) and this domain 
remains distinct from the thalamic domain dorsal to the Barhl2-negative pTh-R. 
Ventral to the ZLI the prethalamus continues to express Pax6 very strongly and the 
prethalamic domain remains complementary to the domain of Barhl2 in this area, 
though Barhl2 expression appears to be much weaker by this stage (Fig. 3.2.7C-E 
and H-J). 
In more dorsal sections of the ventral diencephalon Barhl2 expression also appears 
weaker than before, with the exception of the hypothalamus in which it appears to be 






Fig. 3.2.6: The expression domains of Pax6 and Barhl2 in the wild-type diencephalon at 
E13.5 as visualised by in situ hybridization performed on adjacent coronal sections- detail of 
the pretectum and thalamus K: Schematic illustrating the approximate plane of each section. 
Arrows in H: Barhl2 expression in the ZLI. Abbreviations: Tel- telencephalon; Di- 
diencephalon; Mes- mesencephalon; Rh- rhombencephalon; SC- spinal cord; PT- pretectum; 
Th- thalamus; pTh- prethalamus; VZ- ventricular zone; Ctx- cortex; CP- choroid plexus; LGE- 
lateral ganglionic eminence; MGE- medial ganglionic eminence; Hyp- hypothalamus; ET- 




Fig. 3.2.7: The expression domains of Pax6 and Barhl2 in the wild-type diencephalon at 
E13.5 as visualised by in situ hybridization performed on adjacent coronal sections- detail of 
the rostral thalamus, ZLI, prethalamus, eminentia thalami and hypothalamus. K: Schematic 
illustrating the approximate plane of each section. Arrows in G: Barhl2 expression in the ZLI.  
Abbreviations: Tel- telencephalon; Di- diencephalon; Mes- mesencephalon; Rh- 
rhombencephalon; SC- spinal cord; PT- pretectum; Th- thalamus; pTh- prethalamus; VZ- 
ventricular zone; CP- choroid plexus. LGE- lateral ganglionic eminence; MGE- medial 




3.3 Qualitative analysis: Investigating complementarity and co-expression of 
Pax6 and Barhl2 in the wild-type diencephalon 
3.3.1 Introduction 
In order to confirm the complementarity of the Pax6 and Barhl2 domains outside the 
thalamus, the co-expression of the two genes within individual cells of the thalamus, 
and the presence of two expression gradients running counter to each other, it was 
necessary to employ fluorescence techniques to visualise the expression of both 
genes within the same tissue section. 
Unfortunately it was not possible to perform double in situ hybridization for Pax6 
and Barhl2 because repeated attempts to produce effective 2, 4-dinitrophenyl (DNP)-
labelled probes for both genes were unsuccessful. In experiments using the DNP-
labelled Pax6 probes the signal was unacceptably weak even when the probes were 
diluted by a factor as low as 1:100, while use of the DNP-labelled Barhl2 probes 
resulted in a very high degree of background fluorescence even at the relatively high 
dilution of 1:30,000. It was also not possible to perform immunohistochemistry for 
both genes as an effective antibody against Barhl2 which was suited to 
immunohistochemical applications could not be sourced. 
As a compromise, and because an effective and suitable antibody against Pax6 was 
available, immunohistochemistry for Pax6 protein was performed along with in situ 
hybridization for Barhl2 mRNA. The protocol was performed on 16µm cryosections 
cut in the coronal plane and repeated for 16µm sections cut in the sagittal plane. 
Treated sections were imaged with confocal microscopy. 
3.3.2 Results 
The chromogenic in situ data for Pax6 and Barhl2 suggest that the domains of Pax6 
and Barhl2 are complementary to each other in all forebrain regions with the 
exception of the thalamus (Fig. 3.2.1-Fig.3.2.7). The fluorescence in situ data for 
Barhl2 and the fluorescence immunohistochemistry data for Pax6 protein appear to 
confirm this (Fig. 3.3.1 and Fig. 3.3.2). 
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In a sagittal section from an embryo harvested at E9.5 a narrow spike of Barhl2 
expression can be seen within the broader domain of Pax6, spanning the dorsoventral 
extent of the diencephalon from the floorplate to the roofplate (arrow, Fig. 3.3.1B). It 
appears that the genes are co-expressed within this area of neuroepithelium at this 
developmental stage. 
At E10.5 a gap in the Pax6 expression domain can be seen, apparently corresponding 
with the rostral extent of the thalamus and possibly with the position of the 
developing pTh-R (arrow, Fig. 3.3.1D). At this stage the thalamic Barhl2 domain 
expands along the rostrocaudal axis, within the gap in the Pax6 domain. 
As with the chromogenic in situ hybridization data, a second discrete domain of 
Barhl2 can be seen rostral and ventral to the thalamic domain, corresponding with 
the position of the developing ZLI, and separated from the thalamic domain by a 
narrow strip of neuroepithelium which does not express Barhl2 (arrow, Fig. 3.3.1E). 
The ZLI continues to develop and express Barhl2 at E11.5 (Fig. 3.3.1H), by E12.5 a 
spike-shaped domain of Barhl2 which corresponds with the shape and position of the 
ZLI can be clearly discerned (arrow, Fig. 3.3.1K) and by E13.5 it can still be seen but 
appears to have narrowed (arrow, Fig. 3.3.1N). 
The image data from the treated sagittal sections suggest that within the thalamus a 
gradient of Pax6 may run from caudal to rostral and from dorsal to ventral, while a 
countergradient of Barhl2 may run from rostral to caudal and from ventral to dorsal, 
and that these gradients may have been established by E11.5 (3.3.1G-H). 
The data from the imaging of treated coronal sections also appeared to show a gap in 
the thalamic Pax6 domain (arrows, 3.3.2A) developing as Barhl2 expression 
becomes stronger in this region. 
In the embryo treated at E10.5 and sectioned in the coronal plane, the Barhl2 domain 
corresponding with the ZLI could not be clearly discerned (arrows, Fig. 3.3.2B). This 
could be due to the embryo appearing to be E10.5 when staged according to external 
morphology (Theiler 1989) while still being at a developmental stage prior to ZLI 
development due to the molecular changes within the neuroepithelium not 




Fig.3.3.1: A-P: Sagittal sections of the wild-type diencephalon at embryonic stages from 
E10.5 to E13.5 (rostral to right) treated with immunohistochemistry for Pax6 protein and in 
situ hybridization for Barhl2 mRNA. Each respective scale bar refers to the set of three 
images   presented for each developmental stage. P. Schematic of an embryonic brain 
viewed from the dorsal surface to illustrate the approximate plane of each section. Arrow in 
B: Barhl2 appears to be co-expressed with Pax6 in the dorsal diencephalon at E9.5. Arrow in 
D: Lower levels of Pax6 expression in the presumptive ZLI and pTh-R. Abbreviations: Ctx- 
cortex; Di- diencephalon; PT- pretectum; Th- thalamus; pTh- prethalamus; Mes- 
mesencephalon; Tel- telencephalon; ZLI- zona limitans intrathalamica; CP- choroid plexus. 
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By E11.5 the Barhl2 domain corresponding with the ZLI can be clearly discerned 
(arrows, 3.3.2F) and by E13.5 the ZLI appears narrowed and in the section shown 
here it can only be clearly seen on the right-hand side of the diencephalon (arrow, 
Fig. 3.3.2L) as could be expected at a stage when the disappearance of the ZLI may 
be in progress (Visel et al 2004). 
The results suggested the presence of opposing gradients of Pax6 and Barhl2 
expression within the thalamus, but also that these gradients opposed each other 
more strongly at some developmental stages than they did at others. At E12.5 high 
magnification confocal images of the thalamus appeared to show weaker expression 
of Barhl2 in regions where Pax6 expression was strong. Pax6 expression was strong 
in the pretectum and more dorsal regions of the thalamus while Barhl2 expression in 
this region was relatively weak. The opposite applied in more ventral regions of the 
thalamus, where strong Barhl2 expression and weak expression of Pax6 was 
observed (Fig. 3.3.2H and I). Together these observations suggest the existence of an 
inversely proportional relationship between the two genes’ expression. 
The results also appeared to confirm the high complementarity of the Pax6 and 
Barhl2 domains in regions of neuroepithelium outside the thalamus. In some sections 
a high degree of complementarity was apparent even at low magnification (arrows, 
3.3.2J) and when the boundaries between the Pax6 and Barhl2 domains were imaged 
at high magnification little to no co-expression was observed within the cells located 
at the borders of the Pax6 and Barhl2 domains (Fig. 3.3.4B). 
In addition to this, a narrow and elongated region free of DAPI was observed within 
the eminentia thalami, flanked by a region of strong Barhl2 expression (3.3.4A). 
This region corresponds with the axon tract along which the thalamocortical axons 
project from the thalamus to the cortex, and the corticothalamic axons project from 
the cortex to the thalamus. 
When imaged at high magnification it was possible to observe the nature of Pax6 and 
Barhl2 expression within individual cells. (Fig. 3.3.5). In the majority of cells Pax6 
protein appeared to be evenly distributed throughout the nucleus and cytoplasm. In 




Fig. 3.3.2: Coronal sections of the wild-type diencephalon at embryonic stages from E10.5 to 
E13.5 treated with immunohistochemistry for Pax6 protein and in situ hybridization for Barhl2 
mRNA. Arrows in A and B: Levels of Pax6 protein are reduced in the presumptive ZLI at 
E10.5, while Barhl2 expression becomes stronger at this stage. Arrows in F and I: Barhl2 
expression within the ZLI. Arrows in G: Expression of Pax6 protein and Barhl2 mRNA is 
highly complementary in regions rostral to the ZLI. Abbreviations: PT- pretectum; Th- 




Fig. 3.3.3: A. A coronal section of the wild type diencephalon at E12.5 at high magnification, 
with detail of the neuroepithelium showing co-expression of Pax6 protein and Barhl2 mRNA 
by individual cells in B: the pretectum, C: a dorsal region of the thalamus and D: a more 
ventral region of the thalamus. From dorsal to ventral the expression of Pax6 protein 
appears to become progressively weaker while that of Barhl2 mRNA appears to become 
stronger. Abbreviations: PT- pretectum; Th- thalamus; pTh- prethalamus. 
with DAPI staining, Pax6 protein could not be seen within the nucleus and was seen 
to translocate to the cytoplasm. (Fig. 3.3.5B). In all cells Barhl2 expression appeared 
to be highly punctate, and Barhl2 mRNA was observed in discrete clusters, 




Fig. 3.3.4: Detail of the neuroepithelium at the border of the prethalamic Pax6 domain and 
the Barhl2 domain within the eminentia thalami showing little to no co-expression of Pax6 
protein and Barhl2 mRNA. B. Detail of the area outlined in A imaged at high magnification, 
illustrating the developing axon tracts flanked by regions of Barhl2 mRNA expression. 







Fig. 3.3.5: A. Detail of the prethalamus and pretectum of a coronal section of the wild type 
diencephalon at E12.5, treated with immunohistochemistry for Pax6 protein and in situ 
hybridization for Barhl2 mRNA. B. Detail of the area outlined in A imaged at high 
magnification, showing the translocation of Pax6 protein from the nucleus into the cytoplasm 
within dividing cells. C. Detail of the area outlined in A at high magnification showing Barhl2 
mRNA forming clusters within the cytoplasm of individual cells. Abbreviations: pTh- 
prethalamus; ET- eminentia thalami. 
3.4 Quantitative analysis: spatiotemporal dynamics of Pax6 and Barhl2 within 
the thalamus 
3.4.1 Introduction 
In order to confirm the presence of opposing gradients of Pax6 and Barhl2 within the 
thalamus it was necessary to quantify the changes in their expression across the 
thalamic neuroepithelium. 
The immunohistochemistry for Pax6 protein and in situ hybridization for Barhl2 
mRNA was repeated on tissue sections from two further embryos harvested at each 
developmental stage from E10.5 to E13.5. Confocal image data was recorded for a 
series of 16µm coronal sections from each embryo. One image of each series was 
chosen to be analysed, with the three images chosen for each developmental stage 
cut from a similar position on the rostrocaudal axis, determined by the morphological 
features visible, in order to ensure that the three sections were comparable. 
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Fiji (Schindelin et al 2012) was used to analyse confocal image data. The change in 
the intensity of the fluorescence was measured along a line drawn along the 
ventricular surface of the diencephalon, extending from the diencephalic midline to 
the dorsal extent of the ZLI. The numerical values were entered into an Excel 
spreadsheet and binned into groups of five. The mean values for each bin were 
plotted against distance from the dorsal midline to produce a line graph illustrating 
the changes in the relative intensity of the fluorescence signal across the 
neuroepithelium. A linear regression trend line was calculated for each plot and the 
gradient of this was taken as the steepness of the expression gradient. This was 
repeated for the Pax6 and Barhl2 fluorescence signals. In order to account for the 
possibility of sections not being perfectly symmetrical, this was first carried out 
using data from the left-hand side of each embryo, then using data from the right-
hand side of each embryo. In order to calculate the mean gradient of Pax6 and 
Barhl2 expression at each developmental stage, binned relative intensity data from 
points at the same distance from the dorsal midline on the left and right-hand sides of 
the embryo were used. The mean for the two values recorded at each different 
distance from the dorsal midline was calculated. These means were then plotted 
against distance from the dorsal midline, a linear regression trendline was plotted and 
the gradient of this was recorded. This was carried out for both the Pax6 
immunostaining signal and the Barhl2 in situ hybridization signal in each of the three 
embryos analysed at each developmental stage. The means of the gradients for Pax6 
and Barhl2 at each developmental stage were then recorded and these values were 
plotted on a bar chart. 
3.4.2 Results 
As with the previous in situ hybridization data presented here, the data from these 
experiments appeared to confirm the high complementarity of the Pax6 and Barhl2 
expression domains in regions of neuroepithelium outside the thalamus. 
Quantification of the expression gradients suggested that countergradients of Pax6 
and Barhl2 expression are present in the developing thalamus but that they are not 
present at every stage of development, and that they only strongly oppose each other 
at particular developmental stages. 
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At E10.5 there appeared to be a great deal of variability between the data recorded 
for the three different embryos analysed. Strong countergradients of Pax6 and Barhl2 
were found to be present in the first of the three embryos analysed (Fig. 3.4.1) and 
the data for this embryo suggested that the relationship between Pax6 and Barhl2 
expression could be inversely proportional. Quantification of the expression 
gradients in the second embryo (Fig. 3.4.2) suggested that the Pax6 and Barhl2 
gradients did not run counter to each other. In the third embryo (Fig. 3.4.3) 
countergradients could be seen in left-hand side of the thalamus but not in the right-
hand side, and on the left-hand side the relationship between Pax6 and Barhl2 
expression did not appear to be inversely proportional as it did in the first embryo. 
By E11.5 countergradients of Pax6 and Barhl2 expression were apparent on both 
sides of the second of the three embryos analysed (Fig. 3.4.5) but only on the left 
hand side of the first embryo (Fig. 3.4.4) and in the third embryo countergradients 
were not apparent at all. Quantification of the gradients of Pax6 and Barhl2 in the 
third embryo suggested that both genes were expressed along a gradient running 
from dorsal to ventral, though that of Barhl2 was much less steep than that of Pax6. 
The countergradients of Pax6 and Barhl2 were the most strongly opposed at E12.5 
(Fig. 3.4.7-3.4.9) and this was observed in all three of the embryos analysed. 
By E13.5 (Fig. 3.4.10-Fig. 3.4.12) the expression gradients of both Pax6 and Barhl2 
appeared to become much less steep. Analysis of the data suggested that by this stage 
the gradients no longer run counter to each other, and that for both genes expression 





Fig. 3.4.1: Data from the analysis of the first of the three embryos harvested at E10.5. 
Presented here are Immunostaining data for Pax6 protein and in situ hybridization data for 
Barhl2 mRNA, with line plots of relative intensity across the length of the ventricular surface. 
The asterisk indicates the position of the dorsal midline as the point from which data were 
recorded, while the arrows indicate the end of the plot for the left and right sides of the 





Fig. 3.4.2: Data from the analysis of the second of the three embryos harvested at E10.5.  
Presented here are immunostaining data for Pax6 protein and in situ hybridization data for 
Barhl2 mRNA, with line plots of relative intensity across the length of the ventricular surface. 
The asterisk indicates the position of the dorsal midline as the point from which data were 
recorded, while the arrows indicate the end of the plot for the left and right sides of the 





Fig. 3.4.3: Data from the analysis of the third of the three WT embryos harvested at E10.5. 
Presented here are immunostaining data for Pax6 protein and in situ hybridization data for 
Barhl2 mRNA, with line plots of relative intensity across the length of the ventricular surface. 
The asterisk indicates the position of the dorsal midline as the point from which data were 
recorded, while the arrows indicate the end of the plot for the left and right sides of the 





Fig. 3.4.4: Data from the analysis of the first of the three WT embryos harvested at E11.5. 
Presented here are immunostaining data for Pax6 protein and in situ hybridization data for 
Barhl2 mRNA, with line plots of relative intensity across the length of the ventricular surface. 
The asterisk indicates the position of the dorsal midline as the point from which data were 
recorded, while the arrows indicate the end of the plot for the left and right sides of the 





Fig. 3.4.5: Data from the analysis of the second of the three WT embryos harvested at 
E11.5.  Presented here are immunostaining data for Pax6 protein and in situ hybridization 
data for Barhl2 mRNA, with line plots of relative intensity across the length of the ventricular 
surface. The asterisk indicates the position of the dorsal midline as the point from which data 
were recorded, while the arrows indicate the end of the plot for the left and right sides of the 





Fig. 3.4.6: Data from the analysis of the third of the three WT embryos harvested at E11.5.  
Presented here are immunostaining data for Pax6 protein and in situ hybridization data for 
Barhl2 mRNA, with line plots of relative intensity across the length of the ventricular surface. 
The asterisk indicates the position of the dorsal midline as the point from which data were 
recorded, while the arrows indicate the end of the plot for the left and right sides of the 





 Fig. 3.4.7: Data from the analysis of the first of the three WT embryos harvested at E12.5.  
Presented here are immunostaining data for Pax6 protein and in situ hybridization data for 
Barhl2 mRNA, with line plots of relative intensity across the length of the ventricular surface. 
The asterisk indicates the position of the dorsal midline as the point from which data were 
recorded, while the arrows indicate the end of the plot for the left and right sides of the 





 Fig. 3.4.8: Data from the analysis of the second of the three WT embryos harvested at 
E12.5.  Presented here are immunostaining data for Pax6 protein and in situ hybridization 
data for Barhl2 mRNA, with line plots of relative intensity across the length of the ventricular 
surface. The asterisk indicates the position of the dorsal midline as the point from which data 
were recorded, while the arrows indicate the end of the plot for the left and right sides of the 





Fig. 3.4.9: Data from the analysis of the third of the three WT embryos harvested at E12.5.  
Presented here are immunostaining data for Pax6 protein and in situ hybridization data for 
Barhl2 mRNA, with line plots of relative intensity across the length of the ventricular surface. 
The asterisk indicates the position of the dorsal midline as the point from which data were 
recorded, while the arrows indicate the end of the plot for the left and right sides of the 





Fig. 3.4.10: Data from the analysis of the first of the three WT embryos harvested at E13.5.  
Presented here are immunostaining data for Pax6 protein and in situ hybridization data for 
Barhl2 mRNA, with line plots of relative intensity across the length of the ventricular surface. 
The asterisk indicates the position of the dorsal midline as the point from which data were 
recorded, while the arrows indicate the end of the plot for the left and right sides of the 





Fig. 3.4.11: Data from the analysis of the second of the three WT embryos harvested at 
E13.5.  Presented here are immunostaining data for Pax6 protein and in situ hybridization 
data for Barhl2 mRNA, with line plots of relative intensity across the length of the ventricular 
surface. The asterisk indicates the position of the dorsal midline as the point from which data 
were recorded, while the arrows indicate the end of the plot for the left and right sides of the 





Fig. 3.4.12: Data from the analysis of the third of the three WT embryos harvested at E13.5.  
Presented here are immunostaining data for Pax6 protein and in situ hybridization data for 
Barhl2 mRNA, with line plots of relative intensity across the length of the ventricular surface. 
The asterisk indicates the position of the dorsal midline as the point from which data were 
recorded, while the arrows indicate the end of the plot for the left and right sides of the 





Fig. 3.4.13: The means of the slopes of the gradients for the three embryos analysed at each 
developmental stage, calculated by using the means of relative intensity values recorded at 
points the same distance from the dorsal midline on the left and right-hand sides of the 
embryo. 
3.5 Discussion 
The expression of Pax6 within the wild type murine diencephalon has been extensive 
mapped and described in detail across a wide range of developmental stages 
(Walther and Gruss 1991, Mastick et al 1997, Gray et al 2004, Yokoyama 2009). 
While a relatively small number of previous studies have aimed to characterise the 
expression of Barhl2 and its homologues in the developing CNS, these analyses have 
been carried out on a number of different animal models, ranging from extensive 
studies in Drosophila (Higashijima et al 1992, Sato et al 1999, Lim and Choi 2003) 
to a number of more recent studies in vertebrates such as Xenopus (Juraver-Geslin et 
al 2011, 2014), and zebrafish (Colombo et al 2006, Staudt and Houart 2008). The 
first Barhl2-null mutant mouse was generated relatively recently (Ding et al 2009) 
and studies of Barhl2 expression in the mouse embryo have so far focused mainly on 
the retina (Ding et al 2009, Jin et al 2010) and spinal cord (Ding et al 2012, Duval et 
al 2014). The expression of Barhl2 within the embryonic murine diencephalon has 
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not previously been described in a level of detail comparable to that with which 
diencephalic Pax6 expression has been described in the mouse embryo. 
The chromogenic in situ hybridization data for Pax6 and Barhl2 (Figs. 3.2.1-3.2.7) 
strongly suggested that the genes’ respective expression domains complement each 
other in regions outside the thalamus and pretectum. This complementarity was 
confirmed with the results of the fluorescence in situ hybridization and fluorescence 
immunohistochemistry experiments (Figs. 3.3.1-3.3.3), which showed that the Pax6 
and Barhl2 expression domains meet at sharp boundaries and that little to no co-
expression of Pax6 and Barhl2 can be detected in cells located at these boundaries. 
The high degree of complementarity observed strongly suggests the existence of a 
mutually repressive relationship between Pax6 and Barhl2. 
Mutual transcriptional repression is known to play a role in the establishment of 
tissue boundaries early in the formation of lineage restriction compartments (Kiecker 
and Lumsden 2005). In the Drosophila retina BarH2 inhibits the activity of bHLH 
transcription factors (Lim and Choi 2003) and in the mouse spinal cord and 
midbrain-hindbrain boundary a comparable mechanism has been shown to induce 
boundary formation, involving the inhibition of the bHLH transcription factor Ascl1 
by Hairy and enhancer of split 1 (Hes1) (Baek et al 2006). Mutual repression 
between Pax6 and Barhl2 may serve to induce the formation of boundaries, 
potentially via the inhibition of bHLH transcription factor activity in the 
diencephalon. 
The relationship between Pax6 and Barhl2 within the thalamus and pretectum 
appears to be different and this may be a consequence of the different molecular 
character of the neuroepithelium caudal to the ZLI (Kiecker and Lumsden 2004). The 
chromogenic in situ hybridization data show that both Pax6 and Barhl2 are 
expressed within this region of the diencephalon (Figs. 3.2.1-3.2.7). The results of 
experiments employing fluorescence techniques on sections from E12.5 embryos 
confirmed that Pax6 protein and Barhl2 RNA are co-expressed by individual cells of 
the thalamus and pretectum but suggested that levels of Pax6 expression may be high 
in regions of the neuroepithelium in which levels of Barhl2 expression are low, and 
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vice versa (Fig. 3.3.3). These data suggest the possibility of incomplete mutual 
repression between the two genes within the thalamus and pretectum. 
In the Drosophila retina BarH2 exerts an antiproneural effect via the inhibition of 
bHLH transcription factor activity. This serves to inhibit ectopic neurogenesis and 
modulate the rate of neurogenic activity during the early patterning of the retina (Lim 
and Choi 2003). If Barhl2 plays a comparable role in mammalian neural tissue it may 
be possible that Barhl2 is required to prevent ectopic neurogenesis within regions of 
the mammalian diencephalon. Conversely, repression of Barhl2 expression by Pax6 
may be required in order for neurogenesis to proceed. Previous studies have shown 
that Pax6 induces neurogenesis (Estivill-Torrus et al 2002, Heins et al 2002) and that 
the level of Pax6 expression needs to be regulated in order to prevent premature 
neurogenesis (Sansom et al 2009). It may be possible that the levels of both Pax6 
and Barhl2 need to be regulated in order for neurogenesis to process correctly, and 
that mutual transcriptional repression serves to modulate thalamic neurogenesis. 
This possibility is supported by evidence that the ventricular zone of the thalamus 
strongly expresses a number of bHLH transcription factors, including Neurogenin1 
(Ngn1) (Vue et al 2007) and Neurogenin2 (Ngn2) (Gradwohl et al 1996, Osório et al 
2010, Suzuki-Hirano et al 2011) in domains of a shape comparable to that of the 
Barhl2 expression domain. 
Investigation of the co-expression of Pax6 protein and Barhl2 mRNA within the 
thalamus and pretectum over a series of developmental stages (Fig. 3.3.1 and 3.3.2) 
made it possible to visualise the changing shapes of the Pax6 and Barhl2 expression 
domains over time. As development proceeds the Pax6 expression domain appears to 
occupy an increasingly smaller area of the thalamus and pretectum, becoming 
increasingly restricted to the more dorsal regions of the diencephalon, and by E13.5 
its expression is largely confined to the pretectum. By contrast the Barhl2 domain 
expands along the dorsoventral axis, apparently at the expense of the Pax6 domain, 
and by E13.5 the domain of Barhl2 spans the entire dorsoventral extent of the 
pretectum and thalamus, with the exception of the pTh-R. 
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If Barhl2 represses the proneural activity of bHLH transcription factors in mouse, it 
may be necessary to suppress Barhl2 expression in order for neurogenesis to 
proceed. Pax6 may inhibit Barhl2 expression in specific regions of neuroepithelium 
at specific points in development, allowing neurogenesis to proceed in a precise and 
controlled fashion. Likewise, Barhl2 may be required to restrict the proneural and 
proliferative activity of Pax6 protein (Walcher et al 2013) and prevent ectopic and 
premature neurogenesis. Overall, mutual repression between Pax6 and Barhl2 could 
serve to control the rate of neurogenesis within the thalamus and specify the precise 
locations and times at which neuronal differentiation can occur. 
While the Barhl2 domain expands along the dorsoventral axis over time, it narrows 
along the mediolateral axis. At E8.5 its domain spans the entire thickness of the 
diencephalic neuroepithelium, but by E10.5 its expression begins to become 
restricted to the ventricular zone of the thalamus and a narrower region of the 
pretectum, and by E13.5 its domain in this region of the diencephalon has narrowed 
to an even greater extent. The narrowing of the Barhl2 domain along the 
mediolateral axis could also serve to allow a wave of thalamic neurogenesis to 
proceed from lateral to medial. Because Pax6 is not strongly expressed in more 
ventral regions of the thalamus at E13.5 this narrowing of the Barhl2 domain is 
likely to be induced by a factor other than transcriptional repression by Pax6. 
The quantification of the expression gradients of Pax6 protein and Barhl2 mRNA 
showed that strong expression countergradients were only present in the tissue 
sections analysed at E12.5 (Figs. 3.4.7-3.4.9), and in some of those analysed at E11.5 
(Figs. 3.4.4-3.4.6). The majority of thalamic neurogenesis occurs between E10.5 and 
E12.5 (Bluske et al 2009, Suzuki-Hirano et al 2011) and the presence of 
countergradients at these stages may further support the hypothesis that incomplete 
mutual repression between Pax6 and Barhl2 serves to modulate thalamic 
neurogenesis. The results of the quantitative analysis strongly suggested the presence 
of a dorsal-to-ventral gradient of Pax6 expression at all stages analysed. While the 
results also suggested the presence of a ventral-to dorsal gradient of Barhl2 at some 
stages, the gradient only appeared to be strong at E12.5, at stages prior to this it 
appeared to be much less steep, while it ran from dorsal-to-ventral at E13.5. The data 
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from this analysis more strongly suggest the presence of a Pax6 expression gradient, 
and the evidence for a countergradient of Barhl2 expression is less convincing.  
The results for the quantitative analysis were not as consistent between the different 
embryos analysed at E10.5 and E13.5 respectively. Strong countergradients of Pax6 
and Barhl2 expression were only observed on both sides of the thalamus in one of 
the three embryos analysed at E10.5, while in the second embryo countergradients 
were only present on one side of the thalamus, and in the third they were not present 
at all. At E13.5 the gradients did not run counter to each other, and at these stages 
there was a high degree of variability between different embryos analysed at the 
same developmental stage. 
This variability observed at E10.5 (Figs. 3.4.1-3.4.3) may be due to the ZLI being 
established at this time (Shimamura et al 1995). Embryos were staged according to 
gross external morphology and while the embryos used in these experiments all 
appeared to be E10.5 as defined by the Theiler staging criteria (Theiler 1989) but it is 
possible that changes in external morphological characteristics do not correspond 
exactly with changes in gene expression within the neuroepithelium. In the embryos 
analysed at E10.5 the ZLI could be distinguished more easily in some embryos than 
in others (Figs. 3.4.1-3.4.3) and it is possible that ZLI development was at a more 
advanced stage in the embryos in which it was easier to distinguish. In the embryos 
analysed at E13.5 the ZLI was more easy to distinguish in some tissue sections than 
in others, The variability observed at E13.5 (Figs. 3.4.10-3.4.12) may have been due 
to the disappearance of the ZLI possibly occurring around this time (Lim and Golden 
2007, Visel et al 2004). ZLI development, ZLI disappearance, and the related 
changes in gene expression within the diencephalon occur over a relatively short 
period of time and this may make it more challenging to obtain sections from three 
different embryos at the same point in development, at least by using external 
morphology to stage embryos. In order to overcome this problem in future 
experiments it would be necessary to harvest and cryosection a greater number of 
embryos at E10.5 and E13.5, carry out immunohistochemistry and in situ 
hybridization as before, and compare treated tissue sections in order to identify and 
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collate a set of sections in which the neuroepithelium appears to be at the same 
developmental stage. 
Barhl2 also appears to be strongly expressed within the ZLI itself. A number of 
bHLH transcription factors are expressed within the ZLI, including Ngn2 and Ascl1 
(Vue et al 2007). It may be possible that the expression of Barhl2 within the ZLI 
serves to inhibit neurogenesis and maintain the non-neural character of the ZLI for 
the duration of its existence, allowing it to function as organizer region. 
The spatiotemporal dynamics of Barhl2 expression exhibit a strong correlation with 
the developmental dynamics of the thalamus and ZLI. Fate mapping studies in 
zebrafish have used Barhl2 as a marker of the presumptive thalamus (Scholpp et al 
2007) but in mouse at least its expression does not appear to be confined to the 
thalamic anlage and between E8.5 and E9.5 it may also extend to the anlage of the 
ZLI. 
In mouse the ZLI begins to develop at approximately E10.5 (Shimamura et al 1995). 
In the image data presented here the domain of Barhl2 within the ZLI can be 
distinguished at E10.5, separated from the thalamic Barhl2 domain by a Barhl2-
negative domain corresponding with the position of the p-ThR. Experiments on 
embryos at the 3-5 somite stage have suggested that the ZLI may be specified much 
earlier than this, as early as the 3-5 somite stage (Shimamura and Rubenstein1997), 
or approximately E7.5-8.5 (Theiler 1989). The earliest published expression data for 
Barhl2 in the mouse showed that it is expressed at E9.5 (Yokoyama et al 2009). The 
chromogenic in situ hybridization data presented here show that Barhl2 is expressed 
in the mouse diencephalon as early as E8.5, and while further experiments would be 
needed to determine the onset of Barhl2 expression, these data show that Barhl2 is 
expressed in the mouse diencephalon the ZLI develops, and suggest that prior to this 
it may be expressed in the region fated to become the ZLI. These findings are 
consistent with evidence that Barhl2 is required for ZLI specification and 
development in Xenopus (Juraver-Geslin et al 2014). It may also be possible that the 
degree to which the thalamic Pax6 and Barhl2 expression gradients counter each 
other may be directly proportional to the level of neurogenic activity occurring 
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within the developing thalamus, but further experiments would be needed to 
investigate this possibility. 
The precise developmental stage at which the disappearance of the ZLI begins has 
yet to be determined (Lim and Golden 2007) but in mouse the ZLI can no longer be 
visualised with in situ hybridization for Shh mRNA at E14.5 (Visel et al 2004) 
suggesting that the disappearance of the ZLI may have occurred by this stage. The 
data presented here show that the domain of Barhl2 within the ZLI becomes 
narrower at E13.5 and that Barhl2 expression also becomes weaker throughout the 
entire diencephalon at this stage. These observations support the hypothesis that 
Barhl2 is required to maintain the ZLI in its non-neural state. 
In tissue sections treated using fluorescence techniques observation of the tissue at 
high magnification suggested that both Pax6 protein and Barhl2 mRNA may be able 
to translocate within individual cells (Fig. 3.3.5). Pax6 protein appeared to 
translocate from the nucleus to the cytoplasm of dividing cells, while Barhl2 mRNA 
was detected in small clusters within cells, rather than being distributed more evenly 
throughout the nucleus and cytoplasm. These observations suggest that the 
expression of both genes may be oscillatory. The possibility that Pax6 expression 
may be oscillatory has been considered in one study of its expression in the mouse 
cerebral cortex (Sansom et al 2009) and oscillatory Pax6 expression has also been 
suggested as a component of a model for the regulation of vertebrate neurogenesis, in 
which it interacts with the transcription factors Oligodendrocyte transcription factor 
2 (Olig2) and Nkx2-2 (Panovska-Griffiths et al 2012). 
The punctate expression of Barhl2 has not been described previously. Further 
experiments would be needed in order to further investigate the possibility that 
Barhl2 expression is oscillatory, or that Barhl2 mRNA can translocate and form 
aggregates within individual cells. 
DAPI staining of chromatin within the cells of the diencephalon at E12.5 revealed a 
narrow region free of cell nuclei, extending from the more ventral regions of the 
thalamus, through the eminentia thalami and into the telencephalon (Fig. 3.3.4).  This 
region passes through the Barhl2 domain within the eminentia thalami and is flanked 
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by two expression domains of Pax6- the domain within the prethalamus, and a 
second, more lateral domain within the telencephalic neuroepithelium. This area free 
of cell nuclei corresponds with the position of the axon tract along which the 
thalamocortical axons project from the thalamus to the cortex, and the 
corticothalamic axons project from the cortex to the thalamus (Molnár et al 2012, 
Price et al 2012) and it is possible that it may serve as a physical scaffold along 
which axons can extend and migrate. The antiproneural action of Barhl2 (Lim and 
Choi 2003) may serve to inhibit the differentiation of neurons along the presumptive 
axon tract, allowing the scaffold to form before the thalamocortical and 
corticothalamic axons begin to extend along it. 
In addition to this, Barhl2 is known to be required for the subtype specification of 
dl1 interneurons in the developing mouse spinal cord, and the loss of Barhl2 causes 
neurons which project contralaterally to be specified at the expense of those which 
project ipsilaterally. (Ding et al 2011). This observation suggests the possibility that 
Barhl2 may be indirectly involved in the control of spinal cord axon guidance. It may 
be possible that Barhl2 acts upstream of genes which encode transmembrane 
receptors for secreted axon guidance molecules, thereby conferring them with the 
ability to respond to these molecular cues. The Barhl2-null mutant mouse exhibits an 
increased number of axons which cross the midline of the embryo, and this suggests 
that the defect may be a consequence of disruption to the Slit/Roundabout (Robo) cell 
signalling pathway, which regulates the midline crossing of axons during 
neurogenesis (Dickson and Gilestro 2006). In this pathway, secreted signalling 
proteins of the Slit family bind to transmembrane receptor proteins of the Robo 
family where they are expressed by target cells. In many contexts Slits act as 
repulsive guidance cues and serve to inhibit midline crossing in Robo-expressing 
axons of target neurons (Nguyen-Ba-Charvet and Alain Chédotal, 2001) 
 It has been suggested that Barhl2 may modulate the expression of Roundabout 3 
(Robo3) in the developing mouse spinal cord, acting in a context-dependent manner 
(Ding et al 2011) but further work remains to be carried out in order to characterise 
the relationship between Barhl2 and Robo3. Further work would also be required to 
confirm or refute the existence of a comparable relationship between Barhl2 and the 
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expression of Robo family in the mammalian diencephalon, and in the guidance of 
thalamocortical and corticothalamic axons. 
The reasons for the apparent punctate expression of Barhl2 observed within 
individual cells at high magnification is not clear. The translocation of protein and 
mRNA within the can occur as part of the process of distributing the cell’s contents 
prior to cell division, and the distribution of those contents then determines whether 
the cell’s division is a symmetric, proliferative division, or an asymmetric division 
which leads to the differentiation of one postmitotic daughter cell (Morrison and 
Kimble 2006). Bar family genes have been shown to inhibit neuronal differentiation 
in the Drosophila retina (Lim and Choi 2003) and it may be possible that the 
translocation of Barhl2 mRNA within undifferentiated cells may have an influence 
on whether a dividing cell undergoes symmetric or asymmetric cleavage. In order to 
investigate this possibility further it would be necessary to quantify and characterise 
the distribution of Barhl2 protein or Barhl2 mRNA or protein within individual cells. 
If such an investigation suggested an asymmetric distribution of Barhl2 within cells, 
the nature of the divisions those cells then undergo could then be investigated in 
order to determine whether or not the translocation of Barhl2 has an influence over 
this process. 
Analysis of the gradients on the left-hand and right-hand side of the embryos 
revealed some variation in the steepness of gradients between embryos and between 
the left and right-hand sides, in particular in younger embryos. It may be possible 
that not all sections were adequately close to being symmetrical, or that in smaller 
embryos, where sectioning of the diencephalon yielded a smaller number of sections, 
the variation between these sections was greater than in larger embryos, in which a 
larger number of sections could be cut from the medial diencephalon. The variation 
in the steepness of gradients may also have been due to natural variation between 
embryos, and the gene expression between embryos not being entirely symmetrical. 
Data for the left-hand side of the embryos were analysed, followed by data from the 
right-hand side. The data from the right-hand side was broadly comparable to that 
from the left-hand side. The only exception was the embryos analysed at E10.5, for 
which the analysis of data from the right-hand side of embryo 2 and embryo 3 
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suggested the presence of a dorsal-to-ventral gradient of Barhl2 expression while the 
data for the left hand side suggested that the gradient ran from ventral to dorsal. 
Again, this variation could be due to the ZLI developing around E10.5 and a number 






















4. Barhl2 and the ZLI 
4.1 Introduction 
While the relationship between Pax6 and Shh in vertebrate development has been 
studied extensively (Ekker et al 1995, MacDonald et al 1995, Kiecker and Lumsden 
2004, Vieira et al 2005), comparatively little is known about the relationship 
between Shh and Barhl2 in vertebrates. It is known that during the early development 
of the Drosophila retina the morphogen Hedgehog (Hh) is required to induce 
expression of both BarH1 and BarH2 (Lim and Choi, 2004). On the basis of this 
finding it could be expected that vertebrate Hh homologues act upstream of the 
vertebrate homologues of the two Drosophila Bar genes, but in Xenopus it appears 
that Barhl2 acts upstream of Shh, at least in the process of ZLI development, which 
has been shown to require Barhl2, and that it is expressed in the vertebrate 
diencephalon prior to the onset of Shh expression within the ZLI (Juraver-Geslin et 
al 2014). 
Fate-mapping studies in zebrafish have used Barhl2 as a marker of the presumptive 
diencephalon (Staudt and Houart 2008) but the results of the experiments described 
in the previous chapter suggest that it may only be a marker of regions fated to 
become specific diencephalic structures rather than a marker of the presumptive 
diencephalon as a whole. In particular it seems to be strongly expressed in the 
neuroepithelium of the presumptive ZLI, and then at developmental stages prior to 
and during its development. 
The spatiotemporal dynamics of Barhl2 expression in the mouse diencephalon as 
described in the previous chapter suggest roles for the gene in the specification of the 
ZLI. Prior to ZLI formation Barhl2 is expressed in the region of neuroepithelium in 
which the ZLI later develops. Its expression domain in this region assumes a 
characteristic spike shape extending from the floorplate and narrowing as it 
approaches the roofplate. The shape of the Barhl2 domain is therefore comparable 
with that of the ZLI itself, as marked by Shh expression. 
The previous chapter described a domain of Barhl2 expression which appears to 
strongly correspond with the position of the ZLI following its induction at around 
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E10.5. In order to confirm this it would be necessary to investigate its expression in 
relation to known markers of the ZLI. 
In order to investigate the possibility that the onset of Barhl2 expression in mouse 
does not require Shh, in situ hybridization was performed in order to visualise Barhl2 
expression in the Shh-null mutant mouse (Chiang et al 1996). E12.5 Shh-null mouse 
embryos and wild-type littermates which had been stored in 100% methanol at 4°C 
were rehydrated in a series of ascending methanol washes before being fixed in 4% 
PFA in PBS and then mounted in OCT. Embryos were sectioned in the sagittal plane 
to give 10µm cryosections which were then treated with chromogenic in situ 
hybridization for Barhl2 mRNA. Embryos were sectioned in the sagittal plane in 
order to divide the embryo into a relatively small number of sections, thereby 
allowing in situ hybridization to be carried out on the entire embryo more easily. By 
investigating Barhl2 expression throughout the entire embryo regions of the nervous 
system where Barhl2 is expressed outside the telencephalon, such as the spinal cord, 
could also be analysed, and it would be possible to speculate on the possibility that 
any changes in Barhl2 expression were region-specific. 
In order to determine potential roles for Barhl2 in the induction and development of 
the ZLI, it was necessary to visualise the diencephalic Barhl2 expression domain in a 
greater level of detail than in the experiments of the previous chapter. It was decided 
that performing chromogenic in situ hybridization on whole embryos would be a 
suitable means of achieving this aim, and that treated embryos would then be 
hemisecting along the midline to make it possible to observe the shape and extent of 
the expression domain over the ventricular surface of the diencephalon. 
Pax6+/Sey males were crossed with Pax6+/Sey females to generate litters consisting of 
embryos of the genotypes Pax6+/+, Pax6+/Sey and Pax6Sey/Sey. Embryos were harvested 
at E9.5 and genotyped by PCR. Chromogenic in situ hybridization for Pax6 and 
Barhl2 mRNA was performed on Pax6+/+ embryos. In situ hybridization for Barhl2 
mRNA was also performed on Pax6Sey/Sey embryos in order to visualise any changes 
in its expression which may have occurred as a consequence of the loss of functional 
Pax6. Treated embryos were hemisected and the flat mounts of the dissected tissue 
were prepared for bright-field imaging. 
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Finally, the expression of Barhl2 within the ZLI following its induction was 
investigated with the use of double fluorescent in situ hybridization to visualise the 
potential co-expression of Barhl2 with known markers of the ZLI. Shh was chosen as 
a marker of the ZLI itself (Kiecker and Lumsden 2004) while Ngn2 was chosen as a 
marker of the more caudal compartment of the ZLI alone (Caballero et al 2014). 
16µm cryosections cut in the coronal plane were treated with double in situ 
hybridization for Barhl2 and Shh, or for Barhl2 and Ngn2 and imaged using 
fluorescence microscopy. 
4.2 Results 
4.2.1 Barhl2 in the Shh-null mutant mouse 
Barhl2 mRNA was detected in both the Shh-null mutant mouse embryo and the wild 
type littermate. In the wild type littermate expression was detected in the midbrain, 
thalamus, ZLI, eminentia thalami and lateral ganglionic eminence (Fig.4.1A). It was 
also detected within the spinal cord (arrow, Fig. 4.1B). 
The morphology of the Shh-null mutant mouse differs greatly from that of the wild 
type mouse, with features including a single eye at the ventral midline, situated 
beneath an abnormally elongated craniofacial structure known as the proboscis  
(Chiang et al 1996) (Fig. 4.1C). While these differences in morphology made it 
difficult to identify the regions in which Barhl2 expression was observed, it was 
possible to identify a region of Barhl2 expression within the head of the embryo, 
caudal to the proboscis (dagger, Fig. 4.1C) and in an long and narrow domain 
running along the dorsal midline of the trunk, corresponding with the position of the 
spinal cord (arrow, Fig. 4.1D). It was also detected in a region situated ventral to the 





Fig.4.1: Expression of Barhl2 in sagittal sections of a Shh-null mutant embryo and a wild type 
littermate control, rostral to the right. A: Barhl2 expression in the head of the wild type 
embryo. B: Barhl2 expression in the wild type spinal cord (arrow). C: Expression of Barhl2 in 
the head of a Shh-null mutant (asterisk), with a region which appears to correspond with the 
position of the single eye (arrow). D: Expression of Barhl2 in the Shh-null mutant spinal cord 
(arrow). Abbreviations: Mes- mesencephalon; PT- pretectum; Th- thalamus; ZLI- zona 
limitans intrathalamica; pTh- prethalamus; Hyp- hypothalamus; ET- eminentia thalami; Tel- 
telencephalon; SC- spinal cord 
.4.2.2 Barhl2 expression prior to ZLI formation 
Within the Pax6+/+ embryo at E9.5 (Fig. 4.2) Barhl2 was found to be expressed in an 
approximately oval-shaped region of the diencephalon, corresponding with the 
position of the developing prethalamus (Fig. 4.2B). It was also found to be expressed 





Fig. 4.2: A. Whole mount embryos at E9.5, rostral to right. A. Wild type embryo treated with 
in situ hybridization for Pax6. A region where the expression level of Pax6 is lower can be 
seen at the border between the thalamus and pretectum (arrow). B. Wild type embryo 
treated with in situ hybridization for Barhl2. The shape of part of the expression domain 
resembles the shape of the ZLI (arrow). C. Pax6-null mutant embryo treated with in situ 
hybridization for Barhl2, exhibiting an apparent expansion of the ZLI (arrow). Abbreviations: 




Barhl2 expression could be seen in a region of neuroepithelium with a broad, 
bulbous shape corresponding with the position of the presumptive ZLI (Fig. 4.2B), 
and narrowing as it approached the prethalamus, into a spike shape comparable to 
that of the ZLI (arrow, Fig. 4.2B). These two differently-shaped regions of 
expression did not appear to be two separate and discrete domains and instead 
appeared to make up one single domain of a complex shape. At the same 
developmental stage expression of Pax6 was detected throughout the pretectum and 
thalamus but in a narrow region of neuroepithelium corresponding with the position 
of the border between these two structures its expression appeared to be weaker 
(arrow, Fig. 4.2A). 
Within the Pax6Sey/Sey diencephalon the shape of the Barhl2 domain also appeared to 
have been altered from that of the wild type embryo. While the region of strong 
Barhl2 expression corresponding with the position of the prethalamus could still be 
seen (Fig. 4.2C) it was smaller than that observed in the wild type embryo. The more 
ventral region of the Barhl2 expression domain corresponding with the position of 
the presumptive ZLI (, Fig. 4.2C) appeared to have broadened along the rostrocaudal 
axis, but the expression of Barhl2 within it also appeared more diffuse, and this 
region of the expression domain did not narrow as sharply along the dorsoventral 
axis (arrow, Fig. 4.2C) as the corresponding region of Barhl2 expression had in the 
ventral region of the wild type embryo. 
4.2.3 Barhl2 expression within the mature ZLI 
Double in situ hybridization for Barhl2 and Shh confirmed that Barhl2 is expressed 
within the ZLI itself (Fig. 4.3A-D) but not throughout the entire region of 
neuroepithelium within the ZLI (Fig. 4.3C). Expression of Barhl2 was confined to a 
narrow region of the ZLI with its caudal extent corresponding with the caudal extent 
of the ZLI itself, and its rostral extent located in the medial ZLI (arrow, Fig. 5.4B). A 
previous study has shown that the ZLI consists of two molecularly distinct 
subregions- a rostral region which expresses Developing brain homeobox 1 (Dbx1), 
and a more caudal region marked by the expression of Ngn2 (Caballero et al 2014). 





Fig. 4.3: A: Double in situ hybridization for Barhl2 and Shh. B-C: The region of 
neuroepithelium in outlined area A’ imaged at high magnification. E: Double in situ 
hybridization for Barhl2 and Ngn2. F-H: The region of neuroepithelium in outlined area E’ 
imaged at high magnification. I: Schematic to illustrate the approximate plane of section and 
key to the anatomical features visible in this plane of section. Arrow in B: Barhl2 expression 
in only the most caudal region of the ZLI. Arrow in C: Shh expression throughout the entire 
ZLI. Yellow outlined area in H: The expression domain of Barhl2 situated within the broader 
expression domain of Ngn2 (area outlined in pink). Abbreviations: PT- pretectum; Th- 
thalamus; pTh- prethalamus; ZLI- zona limitans intrathalamica; Tel- telencephalon; Di- 
diencephalon; Mes- mesencephalon; Rh- rhombencephalon; SC- spinal cord; ET- eminentia 
thalami; PSB- pallial-subpallial boundary; LGE- lateral ganglionic eminence; MGE- medial 
ganglionic eminence; VZ- ventricular zone; Ctx- cortex; CP- choroid plexus. 
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was used to confirm that Barhl2 was expressed in the more caudal of these regions 
(arrow, Fig. 4.3F), in a domain corresponding with that of Ngn2 (arrow, Fig.4.3G). 
It was also noted that while Barhl2 and Ngn2 were both expressed within the pTh-C 
and the caudal region of the ZLI, the domain of Ngn2 within the pTh-C was 
noticeably broader than that of Barhl2 in the same region (Barhl2 domain marked by 
the outlined area, Fig. 4.2H) and that where the two domains overlapped, the 
expression of Barhl2 and Ngn2 appeared to be complementary, with Ngn2-positive 
regions of neuroepithelium within the Barhl2 domain appearing to be Barhl2-
negative (arrows, Fig. 4.2H). Following a repeat of the experiment, with double in 
situ hybridization for Barhl2 and Ngn2 being performed on sections from embryos 
harvested at E11.5 and E12.5, it was observed that at E11.5 the Barhl2 and Ngn2 
domains within the pTh-C appeared to extend to approximately the same distance 
from the ventricular surface (arrows, Fig. 4.4A and B) and the Ngn2 domain only 
appeared to be broader than that of Barhl2 by E12.5 (arrows, Fig. 4.4D and E). In the 
data from this experiment, it was also possible to see a region of weaker Ngn2 
expression within the more medial regions of the pTh-C, corresponding with the 





Fig. 4.4: Cryosections from wild type embryos treated with double in situ hybridization for 
Barhl2 and Ngn2. A-C: Sections treated at E11.5. D-F: Sections treated at E12.5. G: 
Schematic to illustrate the approximate plane of section. Arrows in A and D: The lateral 
extent of the Barhl2 domain. Arrows in B and E: The lateral extent of the Ngn2 domain. 
Asterisks in F: The areas at which the domain of Ngn2 extends laterally, beyond the extent 
of the Barhl2 domain. Abbreviations: PT- pretectum; pTh- prethalamus; ZLI- zona limitans 
intrathalamica; ET- eminentia thalami; Tel- telencephalon; Di- diencephalon; VZ- ventricular 
zone; Th- thalamus; Mes- mesencephalon; Rh- rhombencephalon; SC- spinal cord. 
4.3 Discussion 
In situ hybridization for Barhl2 showed that it can be expressed in the complete 
absence of Shh and that Shh is therefore not required for the induction of Barhl2 
expression in the mouse embryo. While Hh is required to induce BarH2 (Lim and 
Choi 2004) in Drosophila, this does not appear to be the case with Shh and Barhl2 in 
mouse. The findings presented here are consistent with earlier reports that Barhl2 
acts upstream of Shh in the development of the ZLI in Xenopus (Juraver-Geslin et al 
2014) and together these findings suggest that the relationship between vertebrate 
Shh and Barhl2 may differ from that which exists between Hh and BarH2 in the 
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Drosophila retina. They also suggest that in vertebrates Barhl2 expression is induced 
independently of Shh and that another factor is required for its induction. 
In situ hybridization for Barhl2 has previously been performed on whole embryos at 
E10.5, and its expression in the presumptive ZLI and thalamus at this stage has been 
described (Suzuki-Hirano et al 2011). E10.5 is the stage at which development of the 
ZLI begins (Shimamura et al 1995). The data presented here show that the 
expression domain of Barhl2 is of a comparable shape at E9.5, prior to ZLI 
development. This suggests the involvement of Barhl2 in a prepattern which is 
established prior to the induction of the ZLI, rather than the expression of Barhl2 in 
this region being induced by Shh from the newly-established ZLI. This finding is 
also consistent with published data showing that Barhl2 acts upstream of Shh in the 
establishment of the ZLI (Juraver-Geslin et al 2014). It may also be possible that the 
ZLI and thalamus share a common anlage, of which Barhl2 expression is a marker. 
Double in situ hybridization for Barhl2 and Shh confirmed that Barhl2 continues to 
be expressed in the mature ZLI, but only within the caudal region marked by the 
expression of Ngn2. The antiproneural action of Drosophila BarH2 has been 
documented in the Drosophila retina (Higashijima et al 1992) and potential 
antiproneural action of vertebrate Barhl2 has been speculated on elsewhere on the 
basis of a FIL domain being present within the Barhl2 protein (Smith and Jaynes 
1996, Muhr et al 2001, Bae et al 2003). It may be possible that expression of Barhl2 
within the ZLI serves to maintain the neuroepithelium in a non-neural state for the 
duration of its activity as a signalling centre, but at E12.5 at least this would only be 
the case in the caudal region of the ZLI, and another factor- potentially Dbx1. 
Another member of the Dbx family, Developing brain homeobox 2 (Dbx2), like 
Barhl2, may also possess the capability to repress neurogenesis (Ma et al 2011, 
Lovrics et al 2014) via interactions with Groucho (Muhr et al 2001). If Dbx1 shares 
this property of Dbx2 is may be possible that it could play a role in maintaining the 
rostral region of the ZLI. Mapping the expression of Ngn2, Dbx1 and Barhl2 by 
performing double in situ hybridization for each gene with Shh at developmental 
stages between E10.5-E13.5 may be a useful approach to investigating the 
development of the ZLI and its molecularly distinct subdivisions. 
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The potential antiproneural activity of vertebrate Barhl2 could also be considered as 
a factor controlling the expression of bHLH transcription factors such as Ngn2 (Saito 
et al 1998) in the modulation of thalamic neurogenesis. The apparent complementary 
expression of Barhl2 and Ngn2 within the developing thalamus was only investigated 
briefly in the experiments described here. Further investigations would be required to 
confirm the complementarity of the two genes’ expression and could potentially 
provide additional evidence to suggest that Barhl2 is an antiproneural factor which 
acts to suppress the transcription of proneural bHLH transcription factors in the 
vertebrate thalamus. 
The apparent change in the degree of overlap between the Barhl2 and Ngn2 may 
suggest the possibility that a wave of thalamic neurogenesis patterns the developing 
thalamus, modulated by the repression of Ngn2 expression by Barhl2. Such a 
mechanism would be comparable to that observed in Drosophila, in which BarH2 
serves to modulate the patterning of the retina, suppressing neurogenesis via the 
inhibition of ato expression (Lim and Choi 2003). In order to investigate this 
possibility further it would be necessary to map the expression of Barhl2 in relation 
to that of Ngn2 over a series of developmental stages over the course of thalamic 
development. 
While Shh is the most extensively studied of all the morphogens secreted by the ZLI, 
the ZLI is also known to secrete the Wnt family morphogen Wnt8b (Garda et al 
2002). Barhl2 has been shown to indirectly inhibit the activity of β-catenin, a 
component of the canonical Wnt signalling pathway, and in turn the proliferative cell 
division normally induced by canonical Wnt signalling. This mechanism has been 
demonstrated in the Xenopus neural plate as a means of inhibiting neural plate 
expansion (Juraver-Geslin et al 2011) but it is not known if a comparable interaction 
exists between Barhl2 in the diencephalon and Wnt8b protein secreted by the ZLI, or 






5. Barhl2 expression in the Pax6Sey/Sey and Pax6Sey/+ forebrain 
5.1 Introduction 
In order to investigate the possibility of interactions between Pax6 and Barhl2, a 
Pax6 loss-of-function approach was taken. In situ hybridization was used to visualise 
the expression of Barhl2 in the forebrain of a Pax6-null mouse mutant strain and the 
Barhl2 expression data were compared with the data for its expression in the wild 
type mouse forebrain. In situ hybridization for Barhl2 mRNA was also performed on 
cryosections from an E12.5 Pax6+/Sey forebrain. Image data for treated sections were 
compared with image data for the expression of Barhl2 in the E12.5 Pax6+/+ 
forebrain of a wild type CD-1® embryo in a qualitative analysis. 
Pax6-null mice used were of a Small-eye (Sey) strain maintained on a CD-1® 
(Charles River Laboratories, Inc.2011) background. The mice carry a mutant Pax6 
allele named SeyEd which arose from a spontaneous mutation causing a single base 
pair change. The mutation led to the addition of a second stop codon at a point before 
the region which encodes to homeobox. This allele encodes a truncated, non-
functioning form of the Pax6 protein (Hill et al 1991). Mice carrying two wild-type 
Pax6 alleles are termed Pax6+/+, homozygous Sey mutants are referred to as 
Pax6Sey/Sey while heterozygous mutants are known as Pax6+/Sey. 
Pax6+/Sey males were crossed with Pax6+/Sey females in order to generate litters 
consisting of Pax6+/+, Pax6+/Sey and Pax6Sey/Sey embryos. Litters were harvested at 
E8.5, E9.5, E10.5, E11.5, E12.5 and E13.5. Embryos harvested at E10.5 or earlier 
were genotyped by PCR while Pax6Sey/Sey embryos harvested at E11.5 and later 
identified by the absence of eyes. The genotype of the E12.5 Pax6+/Sey embryo was 
also determined via PCR. Embryos were fixed and cryosectioned in the coronal 
plane. Tissue sections were treated with chromogenic in situ hybridization with the 







5.2.1 Barhl2 expression in the Pax6Sey/Sey forebrain 
The morphology of the Pax6Sey/Sey mouse embryo is markedly different from that of 
the Pax6+/+ mouse embryo and for this reason it can be difficult to make valid 
comparisons between sections from embryos of each of these genotypes. The figures 
in this chapter each feature an image of a section cut from a Pax6+/+ embryo 
presented alongside an image of a section from the Pax6Sey/Sey forebrain in which 
comparable features can be identified. Each figure also includes a key with a 
schematic of the wild type embryonic forebrain on which the approximate plane of 
section is detailed. 
Deletion of Pax6 results in a number of changes in forebrain morphology, including 
a marked reduction in the size of the forebrain overall (Quinn et al 2007) and a 
reduction in the thickness of the neuroepithelium (Jones et al 2002, Quinn et al 
2007). The data presented here show that these features are apparent in all 
developmental stages analysed and manifest as early as E8.5 (Fig. 5.1) The lumen of 
the diencephalon is also broader in the Pax6-null mouse mutant (Schmahl et al 1993) 
and in the data presented here this broadening is evident from E11.5 (Fig. 5.4F-H). 
At E.8.5 (Fig. 5.1) the Pax6Sey/Sey embryo is smaller than that of the wild type embryo 
and the neuroepithelium is thinner but in all other respects the morphology of the 
Pax6Sey/Sey embryo at E8.5 broadly resembles that of the wild-type embryo at the 
same developmental stage. The edges of the neural plate have yet to fuse along the 
entire length of the neural tube and the neural tube remains open along the 
rostrocaudal extent of the forebrain (arrows, Fig. 5.1A). In the Pax6-null mutant the 
neural tube also appears to be open at its ventral extent (asterisk, Fig. 5.1G) but this 
could be a result of damage to the tissue. In coronal sections cut from the wild type 
embryo at this stage the telencephalon is visible as two vesicles lateral to the 
diencephalon (Fig. 5.1C) and this also appears to be the case with the Pax6Sey/Sey 
mutant embryo (Fig. 5.1H). 
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Barhl2 expression appeared to be absent from the telencephalon in both the wild type 
and the mutant (Fig. 5.1E and J) but was detected in all of the more caudal sections 
analysed (Fig. 5.1A-D and F-I). 
At this stage Barhl2 expression only appeared to be noticeably altered in more caudal 
sections of the diencephalon. In the more caudal sections from the wild type embryo 
Barhl2 was found to be expressed throughout the majority of the neuroepithelium 
(Fig. 5.1A and B), with the exception of the floorplate in which little to no 
expression detected in the floorplate (Fig. 5.1A and B). In the mutant the Barhl2 
domain appeared to have narrowed along the dorsoventral axis (arrows, Fig. 5.1F and 
G). In more rostral sections the Barhl2 domain appeared to extend along a similar 
proportion of the neuroepithelium along its dorsoventral extent in both the mutant 
and the wild type diencephalon (Fig. 5.1 C-D and H-I). 
At E9.5 (Fig. 5.2) the reduction in forebrain size is apparent in the Pax6Sey/Sey embryo 
but appears as an overall narrowing of the forebrain along the mediolateral axis. 
Notably the lumen of the diencephalon does not appear to have undergone an 
expansion at this stage and the Pax6Sey/Sey diencephalon appears to be narrower than 
that of the wild type diencephalon (Fig. 5.2F-H). The neuroepithelium also does not 
appear to be noticeably thinner in the mutant at this stage. As with the wild-type 
embryo, neural tube closure in the mutant is complete by this stage and the edges of 
the neural plate have fused to form the roofplate (Fig. 5.2A and F) while in the 
mutant embryo the floorplate is continuous and unbroken (Fig. 5.2F). As at E8.5, 
Barhl2 expression could not be detected within the telencephalon at this stage (Fig. 
5.2E and I-J) 
At this stage the Barhl2 domain appears to extend along a similar proportion of the 
rostrocaudal axis, with Barhl2 expression detected in more caudal sections (Fig. 5.2 
A-C and F-H) but not within the telencephalon (Fig. 5.1E and J). In more caudal 
sections of the diencephalon Barhl2 expression was detected in discrete domains 
with clearly defined borders (arrows, Fig. 5.2A-C). In the mutant Barhl2 expression 
appeared to be more diffuse. In the mutant diencephalon strong expression of Barhl2 





Fig. 5.1: A-J. In situ hubridization data for Barhl2 mRNA in the Pax6+/+ and Pax6Sey/Sey 
forebrain at E8.5. K. Schematic to illustrate the approximate plane of each section. Arrows in 
A: The edges of the neural plate, which have yet to fuse to form the roofplate. Asterisk in G: 
The dorsal neural tube also remains open in the Pax6Sey/Sey embryo. Arrows in F and G: The 
Barhl2 domain appears to have narrowed along the dorsoventral axis in the Pax6Sey/Sey 
diencephalon. Abbreviations: Tel- telencephalon; Di- diencephalon; Mes- mesencephalon; 
Rh- rhombencephalon; SC- spinal cord; FP- floorplate; AP- alar plate; BP- basal plate. 
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in the the wild type diencephalon, but these regions of Barhl2 expression appeared to 
span a greater proportion of the diencephalic neuroepithelium along the dorsoventral 
axis and their borders were not as well defined  (arrows, Fig. 5.1F-H). 
At E10.5 (Fig. 5.3) the neuroepithelium appeared thinner in the mutant than in the 
wild type and the telencephalic vesicles were greatly reduced in size (asterisks, Fig. 
5.3B and G). The lumen of the diencephalon had broadened along the mediolateral 
axis but the morphology in this particular embryo resembled that of hydrocephalic 
embryos and in this case the expansion of the lumen may not have been caused by 
the loss of Pax6. 
In the Pax6+/+ embryo at E10.5 the domains of Barhl2 within the ZLI were 
apparent, separated from the domain within the pTh-C and pretectum by the Barhl2-
negative pTh-R (arrows, Fig. 5.3A) but a comparable expression pattern could not be 
seen in the Pax6Sey/Sey embryo. In the mutant Barhl2 was found to be expressed in a 
continuous domain within the neuroepithelium of the dorsal diencephalon (asterisks, 
Fig. 5.1G-H). 
Barhl2 expression in the mutant appeared to be confined to a smaller area of 
neuroepithelium than in the wild-type, in a domain corresponding with the position 
of the pretectum and a more dorsal region of the thalamus (asterisk, Fig. 5.3G), 
rather than with the position of the pretectum and the entire pTh-C (asterisk, Fig. 
5.3B). 
In the wild type embryo Barhl2 expression was detected in two domains rostral to 
the developing ZLI (arrows, Fig. 5.3D) while in the mutant Barhl2 expression was 
restricted to more dorsal regions of the diencephalon and no expression was detected 
in rostral regions of the diencephalic neuroepithelium (Fig. 5.3A-J). 
As with earlier developmental stages, no Barhl2 expression could be detected in the 
telencephalon of both the wild type and the mutant (Fig. 5.3E and J). 
In the Pax6Sey/Sey mutant at E11.5 (Fig. 5.4F-J) the neuroepithelium appeared to be 





Fig. 5.2: A-J. In situ hubridization data for Barhl2 mRNA in the Pax6+/+ and Pax6Sey/Sey 
forebrain at E9.5. K. Schematic to illustrate the approximate plane of each section. Arrows in 
A and F: The caudal extent of the Barhl2 domains. Arrows in B, C, G and H: The rostral 
extent of the Barhl2 domain in these sections. Abbreviations: Tel- telencephalon; Di- 




the wild type forebrain (Fig. 5.4A-E). The reduction in overall forebrain size was 
also apparent, with the telencephalic vesicles being affected to a particularly great 
extent (asterisks, Fig. 5.4C and H). The lumen of the diencephalon was also 
noticeably broader along the mediolateral axis than that of the wild type 
diencephalon (asterisks, Fig. 5.4A and F). The medial ganglionic eminence (MGE) 
and lateral ganglionic eminence (LGE) could be seen to be developing in the wild 
type telencephalon (asterisks, Fig.5.4E) but could not be clearly distinguished in the 
mutant telencephalon (asterisks, Fig. 5.5J). 
By this stage the Barhl2-positive region of the ZLI could be visualised in both the 
wild type and mutant embryos. In the wild-type it appeared as a narrow wedge-
shaped region (arrows, Fig. 5.4A). An expansion of the ZLI has previously been 
described in the Pax6-null mutant (Grindley et al 1997, Pratt et al 2000a) and in the 
embryo analysed here a region of strong Barhl2 expression of a shape and position 
comparable to that of the expanded ZLI could be visualised in more caudal sections 
of the diencephalon (Fig. 5.4F). This expression domain was distinct from a more 
dorsal domain of Barhl2 expression which could be seen to span almost the 
dorsoventral extent of the thalamus, corresponding with the position of the pTh-C 
(Fig. 5.4F). This region appeared to occupy a smaller proportion of the diencephalic 
neuroepithelium in the mutant, with the pTh-C domain in the wild type embryo 
extending further along the dorsoventral axis (Fig. 5.4C and H). A Barhl2-negative 
region between the two domains appeared to correspond with the position of the 
pTh-R (arrows, Fig. 5.4F) although the borders of this Barhl2-negative region were 
irregular and not as clearly defined as the borders of the pTh-R in the wild type 
diencephalon (Fig. 5.4C).  
In more rostral sections a region of strong Barhl2 expression could also be seen in a 
region corresponding with the position of the expanded ZLI, along with a region of 
slightly weaker expression spanning the dorsoventral extent of the thalamus, but 
these regions with differing levels of Barhl2 expression were not as distinct as they 
appeared in more caudal sections and were not separated from each other by a 
Barhl2-negative region of neuroepithelium corresponding with the position of the 




Fig. 5.3: A-J. In situ hubridization data for Barhl2 mRNA in the Pax6+/+ and Pax6Sey/Sey 
forebrain at E10.5. K. Schematic to illustrate the approximate plane of each section. Arrows 
in A: The Pax6-negative pTh-R. Asterisks in B and G: The neuroepithelium is reduced in 
thickness in the Pax6Sey/Sey embryo. Arrows in D: The Pax6-negative eminentia thalami. 
Asterisks in B and C: The neuroepithelium could be seen to be reduced in thickness in the 
mutant at this stage. Abbreviations: Tel- telencephalon; Di- diencephalon; Mes- 




In the Pax6+/+ diencephalon the domain of Barhl2 within the pTh-C was restricted to 
the ventricular zone (outlined area, Fig. 5.4C) while in the Pax6Sey/Sey mutant the 
thalamic Barhl2 domain appeared to have expanded laterally and spanned the 
mediolateral extent of the thalamic neuroepithelium (outlined area, Fig. 5.4H). 
In regions of forebrain neuroepithelium rostral to the ZLI, loss of Pax6 appeared to 
have led to a downregulation of Barhl2 expression. While Barhl2 expression could 
be detected in the eminentia thalami of the wild type diencephalon (Fig. 5.4D), no 
expression of Barhl2 could be detected rostral to the ZLI in the mutant diencephalon 
(asterisks, Fig. 5.4I). Within the telencephalon the Barhl2 domain within the 
subpallium of the mutant appeared to be greatly reduced in size (arrows, Fig. 5.4J) 
compared with the subpallial Barhl2 domain in the wild type embryo (arrows, Fig 
5.4E). In the mutant this domain was also greatly altered in shape and instead of 
extending towards the PSB (Fig. 5.4E) the Barhl2 domain in the mutant appeared to 
have adopted a narrow crescent shape at a position immediately adjacent to the pial 
surface of the subpallium (Fig. 5.4J). 
At E12.5 (Fig. 5.5) the forebrain of the mutant appeared to be considerably smaller in 
size overall (Fig. 5.4 F-J) than that of the wild type (Fig. 5.4 A-E).  The 
telencephalon of the mutant (Fig. 5.5 H) was considerably smaller than that of the 
wild type forebrain (Fig. 5.5C) and by this stage the subpallium appeared to be 
markedly underdeveloped, and while the LGE and MGE of the mutant could be 
distinguished as discrete structures (Fig. 5.5J) they appeared to be less distinct and 
smaller in size compared to the same structures in the wild type subpallium (Fig. 
5.5E). The lateral expansion of the diencephalic lumen was particularly noticeable in 
more rostral sections (asterisk, Fig. 5.5G) while at this stage the ventricular surfaces 
of the wild type diencephalon were in contact at most points along their dorsoventral 
extents and the lumen of the diencephalon was almost completely closed (asterisk, 
Fig. 5.5B). 
In more caudal sections of the Pax6-null mutant diencephalon Barhl2 expression 
appeared to have been upregulated. Barhl2 expression appeared to be relatively weak 





Fig. 5.4: A-J. In situ hubridization data for Barhl2 mRNA in the Pax6+/+ and Pax6Sey/Sey 
forebrain at E11.5. K. Schematic to illustrate the approximate plane of each section. 
Asterisks in A and B: The lumen of the diencehaphalon, which expands laterally in the 
Pax6Sey/Sey mutant. Asterisks in C and H: The telencephalic vesicles are greatly reduced in 
size in the Pax6Sey/Sey mutant. Outlined areas in C and H: The domain of Barhl2 expands 
beyond the ventricular zone of the pTh-C in the Pax6Sey/Sey mutant. Arrows in C and H: The 
domain of Barhl2 within the ZLi is greatly expanded in the Pax6Sey/Sey mutant. Asterisks in E 
and J: The ganglionic eminences are smaller and less clearly defined in the Pax6Sey/Sey 
mutant. Arrows in G: The pTh-R is narrower and less well defined. Abbreviations: Tel- 
telencephalon; Di- diencephalon; Mes- mesencephalon; Rh- rhombencephalon; SC- spinal 
cord; PT- pretectum; Th- thalamus; pTh- prethalamus; VZ- ventricular zone; Pal- pallium; 
SubPal- subpallium; PSB- pallial-subpallial boundary; LGE- lateral ganglionic eminence; 




stronger expression of Barhl2 was detected in both the thalamus and hypothalamus 
(Fig. 5.5F). While Barhl2 expression was detected within the pretectum of the 
mutant, a small, circular Barhl2-negative region was also observed close to the 
dorsal midline (Fig. 5.5F) and this was also present in the wild-type pretectum 
although the weaker Barhl2 expression in the surrounding areas of the pretectum 
made this more difficult to distinguish (Fig. 5.5A). 
In the mutant diencephalon at E11.5 the domain of Barhl2 within the pTh-R 
appeared to have expanded laterally, beyond the thalamic ventricular zone (outlined 
area, Fig. 5.4H). This expansion was even more pronounced in the mutant at E12.5, 
with the Barhl2 domain appearing to span the entire mediolateral extent of the 
neuroepithelium (outlined area, Fig. 5.5G) while in the wild type diencephalon 
Barhl2 expression was restricted to a narrow area immediately adjacent to the 
ventricular surface, with its lateral extent corresponding with the border of the 
ventricular zone (outlined area, Fig. 5.5B). As at earlier stages, the pTh-C of the 
mutant did not extend across as great a proportion of the dorsoventral axis less far as 
the same structure did in the wild type diencephalon (outlined areas, Fig. 5.5B and 
C). 
As in the Pax6Sey/Sey diencephalon at E11.5, strong Barhl2 expression was detected in 
a region corresponding with the position of the expanded ZLI (Fig. 5.5G). By this 
stage it appeared to be more distinct from the Barhl2 domain within the pTh-C and 
the pTh-R was more easily distinguished as a region of Barhl2-negative 
neuroepithelium (Fig. 5.5H-I) although this was still more irregular in shape and with 
less clearly defined borders than that of the wild type pTh-R (Fig. 5.5C). 
As at E11.5, this Barhl2-negative region immediately adjacent to the caudal extent of 
the ZLI was more easily distinguished in more rostral sections (arrows, Fig. 5.5H and 
I) while it could not be distinguished in more caudal sections (arrows, Fig. 5.5G) In 
these more caudal sections the domain of Barhl2 within the thalamus appeared to be 
immediately adjacent to that within the ZLI, although the ZLI could be distinguished 





Fig. 5.5: A-J. In situ hubridization data for Barhl2 mRNA in the Pax6+/+ and Pax6Sey/Sey 
forebrain at E12.5. K. Schematic to illustrate the approximate plane of each section. 
Asterisks in B and G: The lumen was seen to have expanded in the mutant diencephalon. 
Arrows in I: Altered Barhl2 expression in the neuroepithelium lateral to the eminentia thalami. 
Arrows in E and J: Altered Barhl2 expression in the subpallium. Abbreviations: Tel- 
telencephalon; Di- diencephalon; Mes- mesencephalon; Rh- rhombencephalon; SC- spinal 
cord; PT- pretectum; Th- thalamus; pTh- prethalamus; VZ- ventricular zone; Pal- pallium; 
SubPal- subpallium; PSB- pallial-subpallial boundary; LGE- lateral ganglionic eminence; 




Where the pTh-R could be visualised by the absence of Barhl2 expression in the 
mutant, it appeared to have expanded along with the ZLI (Fig. 5.5H and I) and the 
pTh-R also spanned a greater proportion of the neuroepithelium than the relatively 
narrow pThR of the wild type diencephalon (Fig. 5.5C). 
Rostral to the ZLI, the domain of Barhl2 within the eminentia thalami was observed 
in the wild type diencephalon (Fig. 5.5D) but no Barhl2 expression was observed in 
this region of the mutant diencephalon and instead a smaller domain of Barhl2 could 
be seen close to the pial surface of the diencephalon, and lateral to the region where 
the eminentia thalami could be expected to be seen (arrows, Fig. 5.5I).  
Within the telencephalon of the Pax6Sey/Sey mutant Barhl2 expression was detected 
within the subpallium but, as in the mutant at E11.5 (arrows, Fig.5.4J) its size and 
shape were altered and it could be seen as a narrow crescent shape immediately 
adjacent to the pial surface (arrow, Fig.5.5J) rather than as a region of Barhl2 
expression located more medially and extending dorsally towards the PSB (arrow, 
Fig. 5.5E). 
Between E12.5 and E13.5 a period of rapid growth occurs and the wild type mouse 
embryo greatly increases in size, and by E13.5 (Fig. 5.6) the Pax6+/+ forebrain as a 
whole is much greater in size than that of the Pax6Sey/Sey embryo. The data for each 
section from the wild type embryo is presented as two images- one image detailing 
the pretectum and more dorsal regions of the diencephalon (Fig. 5.6A-E) and a 
second image detailing the more ventral regions of the diencephalon, including more 
ventral regions of the pTh-C, the pTh-R, the ZLI and the prethalamus (Fig. 5.6F-J). 
The smaller size of the mutant embryo allowed for image data to be presented as a 
single image for each section (Fig. 5.6K-O). 
At E13.5 the lumen of the diencephalon still appeared to be broader in the mutant 
(asterisk, Fig. 5.6N) thank in the wild type (asterisk, Fig. 5.6N), in which the 
ventricular surfaces of the left and right-hand sides of the diencephalon were in 




At E13.5 Barhl2 continued to be expressed throughout the pTh-C of the wild type 
thalamus (Fig. 5.6A-E) and was restricted to an area corresponding with the thalamic 
ventricular zone (outlined area, Fig. 5.6A). In the mutant at E13.5 this expression 
domain was found to have expanded laterally and spanned the mediolateral extent of 
the diencephalic neuroepithelium (outlined area, Fig. 5.6K). The pTh-C of the mutant 
also appeared to occupy a smaller proportion of the diencephalic neuroepithelium in 
the mutant than it did in the wild type embryo (Fig. 5.6A and K). 
Within the pretectum of both the Pax6+/+ embryo and the Pax6Sey/Sey embryo a small, 
circular Barhl2-negative region was observed within the pretectum (Fig. 5.6A and 
K), similar in shape and position to the Barhl2-negative region observed in embryos 
of both genotypes at E12.5 (Fig. 5.5A). 
While the Barhl2 domain of the mutant pTh-C could be seen to have expanded along 
the mediolateral axis, expression of Barhl2 in this region also appeared to be more 
diffuse and weaker than at previous stages (Fig. 5.6 M), and in comparison with the 
expression of Barhl2 in the pTh-C of the wild type embryo (Fig. 5.6C). 
In the wild type embryo at E13.5 the ZLI appeared narrower than it had at stages 
E10.5-E11.5 (Fig. 5.6G) while expression of Barhl2 within the ZLI remained visible 
as a relatively broad expression domain (Fig. 5.6M) separated from the pTh-C by the 
Barhl2-negative pTh-R (Fig. 5.6M-O). In comparison with the expression of Barhl2 
in the mutant ZLI at earlier developmental stages, expression of Barhl2 within the 
ZLI of the mutant at E13.5 seemed relatively weak (Fig. 5.6M). 
At E13.5 low levels of Barhl2 expression could still be detected within the eminentia 
thalami of the wild type embryo (Fig. 5.6H) but none could be visualised within the 






Fig. 5.6: A-O. In situ hubridization data for Barhl2 mRNA in the Pax6+/+ and Pax6Sey/Sey 
forebrain at E13.5. P. Schematic to illustrate the approximate plane of each section. Outlined 
areas in A and K: The Barhl2 domains expands laterally in the thalamus of the mutant. 
Asterisks in I and N: A lateral expansion of the diencephalic lumen was observed in the 
mutant forebrain. Arrows in M: Altered expression of Barhl2 in the neuroepithelium lateral to 
the eminentia thalami. Abbreviations: Tel- telencephalon; Di- diencephalon; Mes- 
mesencephalon; Rh- rhombencephalon; SC- spinal cord; PT- pretectum; Th- thalamus; pTh- 
prethalamus; VZ- ventricular zone; Pal- pallium; SubPal- subpallium; PSB- pallial-subpallial 
boundary; LGE- lateral ganglionic eminence; MGE- medial ganglionic eminence; Hyp- 
hypothalamus; ET- eminentia thalami; ZLI- zona limitans intrathalamica. 
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5.2.2 Barhl2 expression in the Pax6+/Sey forebrain 
As in the E12.5 Pax6+/+ forebrain (Fig. 3.2.5), expression of Barhl2 mRNA in the 
E12.5 Pax6+/Sey forebrain was found to be strong in the hypothalamus (Fig. 5.7A and 
F), eminentia thalami (Fig. 5.7D and I), the ZLI (Fig. 5.7C and H) the pretectum and 
ventricular zone of the pTh-C (Fig. 5.7B and G) and a region of the ventral 
telencephalon extending ventrally from the subpallium towards to pallial-subpallial 
boundary (Fig. 5.7E and J). In embryos of both genotypes Barhl2 expression could 
not be detected in the pTh-R (Fig. 5.7C and H), prethalamus (Fig. 5.7D and I), dorsal 
telencephalon (Fig. 5.7E and J), and lateral to the ventricular zone of the pTh-C (Fig. 
5.7C and H). 
The expression of Barhl2 mRNA in the Pax6+/+ and Pax6+/Sey forebrains appeared to 








Fig. 5.7: Cryosections from Pax6+/+ and Pax6+/Sey embryos at E12.5 treated with in situ 
hybridization for Barhl2. A-E: Treated sections from a Pax6+/+ embryo. F-J: Treated sections 
from a Pax6+/Sey embryo. K: Schematic to illustrate the approximate plane of each section. 
Abbreviations: Di- diencephalon; PT- pretectum; Th- thalamus; pTh- prethalamus; VZ- 
ventricular zone; Tel- telencephalon; Pal- pallium; SubPal- subpallium; PSB- pallial-subpallial 
boundary; Tel- telencephalon; Di- diencephalon; Mes- mesencephalon; Rh- 




While gene expression in the Pax6Sey/Sey mutant and other Pax6-null mutants has 
been studied extensively (Hill et al 1991, Grindley et al 1997, Mastick et al 1997, 
Pratt et al 2000a, Manuel and Price 2005, Stoykova et al 2006, Manuel et al 2008, 
Georgala et al 2011), the expression of Barhl2 in the Pax6-null mutant forebrain has 
not previously been described. The data presented here suggest that interactions may 
exist between Pax6 and Barhl2, and in particular an inhibition of Barhl2 expression 
by Pax6. 
The changes in Barhl2 expression which were found to occur as a result of the loss 
of functional Pax6 were found to be context-dependent, varying according to the 
position of the neuroepithelium in relation to the position of the ZLI. This 
observation is consistent with those described in chapter 4. 
Caudal to the ZLI Barhl2 appeared to be upregulated, while rostral to the ZLI 
expression of Barhl2 appeared to be downregulated. This would be consistent with 
evidence that Shh signalling from the ZLI acts in an asymmetric manner in order to 
induce different patterning events in the tissues immediately rostral and caudal to its 
position within the diencephalon (Kiecker and Lumsden 2004). 
Within the pTh-C of the mutant the Barhl2 domain was found to have expanded 
along the mediolateral axis, instead of being confined to the thalamic ventricular 
zone as it was in the wild type diencephalon. From the data presented here it is not 
possible to confirm that Barhl2 expression was upregulated in the pTh-C or if the 
Barhl2 domain had merely expanded without any alteration in the overall level of 
Barhl2 expression. At E13.5 in particular the expression of Barhl2 in the thalamus of 
the mutant appeared to be more diffuse than it did in the thalamus of the wild-type 
embryo. In order to confirm or refute an upregulation of Barhl2 it would be 
necessary to employ a quantitative approach such as quantitative PCR (qPCR) to 
determine the levels of Barhl2 mRNA, or Western blotting to quantify the levels of 
Barhl2 protein expression within the thalamus. 
Suggested functions of Barhl2 in neural development include the modulation of 
neuronal differentiation via the inhibition of proneural bHLH transcription factor 
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expression (Reig et al 2007). Increased expression of Barhl2 could therefore be 
indicative of an increased inhibition of neuronal differentiation within the thalamus. 
A broadening of the Barhl2 domain along the mediolateral axis without an increase 
in the overall level of Barhl2 mRNA could indicative of ectopic inhibition of 
neuronal differentiation in regions of neuroepithelium outside the ventricular zone of 
the pTh-C. 
The mediolateral expansion of the thalamic Barhl2 domain suggests that Pax6 may 
be required to restrict the thalamic expression of Barhl2 to a region of 
neuroepithelium within the ventricular zone. If Pax6 does act to inhibit the 
transcription of Barhl2, this transcriptional inhibition could serve to restrict the area 
of neuroepithelium in which Barhl2 is able to inhibit neuronal differentiation, 
thereby ensuring that neurogenesis proceeds correctly. It is also possible that Pax6 
may act to modulate the rate of neurogenesis by controlling the levels of Barhl2 
protein expression. The changes in shape of the thalamic Pax6 and Barhl2 domains 
over time, as described in Chapter 3, could also play a role in modulating the time 
and place at which neuronal differentiation can occur during thalamic development.  
Alternatively increased levels of Barhl2 mRNA could be indicative of changes in 
neuronal subtype specification. Loss of Barhl2 in the murine retina leads to the 
misspecification of amacrine interneurons, with the differentiation of cholinergic 
neurons occurring at the expense of GABAergic and glycinergic neurons (Ding et al 
2009). Loss of Barhl2 also leads to the misspecification of interneurons within the 
murine spinal cord and subsequent defects in axon guidance (Ding et al 2012). It is 
not yet known if Barhl2 is required for neuronal subtype specification within the 
thalamus, or if the consequences of any misspecification of thalamic neurons would 
lead to axon guidance defects, but defects in thalamocortical and corticothalamic 
axon guidance have been observed in Pax6-null mutants. If a mutually repressive 
relationship exists between Pax6 and Barhl2 this may act to directly control neuronal 
subtype specification, and indirectly serve to modulate axon guidance following 
neuronal differentiation. 
The expansion of the ZLI in the Pax6-null mutant has been described previously 
(Grindley et al 1997, Pratt et al 2000a). It is known that Barhl2 is required for the 
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induction of the ZLI and that the ZLI develops within a Barhl2-positive region of the 
neural tube (Juraver-Geslin et al 2014). If Pax6 exerts an inhibitory effect on the 
expression of Barhl2 it may be possible that Pax6 is required to inhibit the expansion 
of the Barhl2-positive region of neuroepithelium which is competent to develop into 
the ZLI. The loss of functional Pax6 may therefore lead to an expansion of the ZLI 
as a result of an expansion of the Barhl2 expression domain. 
The expansion of the pTh-R in the Pax6Sey/Sey mouse has also been described 
previously, along with the possibility that this may be directly linked to the 
expansion of the ZLI and the resulting increase in the levels of Shh protein 
(Caballero et al 2014). An inhibition of Pax6 expression by Shh has been shown to 
be required for the development of the pTh-R (Robertshaw et al 2013). Increased 
levels of Shh protein within the neuroepithelium of the thalamus may lead to 
increased inhibition of Pax6 expression and, as a consequence, an increase in the size 
of the area which can then develop into the pTh-R. 
Within the diencephalon of the Pax6-null mutant the domain of Barhl2 within the 
pTh-C appeared to extend along a smaller proportion of the diencephalic 
neuroepithelium as a whole, with the thalamic Barhl2 domain extending a greater 
distance from the dorsal midline and into more ventral regions of the 
neuroepithelium. It is known that part of the pTh-C is misspecified as pTh-R in 
Pax6-null mutants (Grindley et al 1997) and the expansion of the ZLI and pTh-R 
may occur at the expense of pTh-C.  
Rostral to the ZLI the loss of functional Pax6 protein appeared to cause a 
downregulation of Barhl2, and in particular the loss of its expression within the 
eminentia thalami. It may be possible that the loss of functional Pax6 leads to a loss 
or misspecification of the eminentia thalami, or that the gene expression profile of 
the eminentia thalami is simply altered in the absence of functional Pax6 protein. In 
order to investigate these possibilities further it would be necessary to investigate the 
expression of other known markers of the eminentia thalami, such as ISL LIM 
homeobox 1 (Islet1) and the Dlx family of transcription factors (Fotaki et al 2006), 
within the diencephalon of the Pax6-null mutant. 
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In the Pax6+/Sey embryo no major changes in Barhl2 mRNA expression appeared to 
have been induced by the loss of one copy of the functional Pax6 allele. This may be 
due to the levels of Pax6 protein not differing greatly between the Pax6+/+ 
diencephalon and the Pax6+/Sey diencephalon (Pinson 2005), possibly as a 
consequence of the ability of Pax6 protein to regulate the levels of its own expression 




















6. The effects of the inhibition of Shh signalling on the expression of Pax6 and 
Barhl2 in the diencephalon 
6.1 Introduction 
In order to investigate the relationship between the expression of Pax6 and Barhl2 
and signalling by the morphogen Shh, a Shh loss-of-function approach was taken via 
the use of drug treatment to inhibit Shh signalling. 
In the adult brain Shh signalling plays roles in the regulation of stem cell 
maintenance and renewal (Álvarez-Buylla and Ihrie 2014). While transient Shh 
activity induces the renewal of adult stem cells, more sustained activation of Shh 
signalling has been linked to the development of malignant tumours (Taipale and 
Beachy 2001, Beachy et al 2004) and elevated levels of Shh have been observed in 
some cancers, such as basal cell carcinoma (Oro et al 1997), gastric cancer (Katoh 
and Katoh 2005) and prostate cancer (Peng and Joyner 2015). Evidence that Shh can 
induce the development of carcinomas from stem cells has led to components of the 
Shh pathway being considered as targets for chemotherapeutic agents (Bijlsma and 
Roelink 2010, Gupta et al 2010).  
Elevated levels of Shh activity have been implicated in the development of basal cell 
carcinoma, a form of skin cancer (Epstein 2008, Athar et al 2014). One 
chemotherapeutic agent currently used to treat basal cell carcinoma is the relatively 
novel Shh antagonist vismodegib (Berrada et al 2014, Basset-Seguin et al 2015). 
Vismodegib is able to bind to the Shh receptor Smo and suppress Shh signalling by 
acting as a competitive inhibitor of endogenous Shh (Yauch et al 2008). Its action is 
comparable to that of the Shh antagonist cyclopamine (Taipale et al 2000), which 
had also been considered as a potential treatment for carcinomas in which Shh 
signalling is implicated (Miller et al 2002) and then used in the treatment of 
medulloblastoma (Yauch et al 2009) but the potency of vismodegib has been found 
to be much greater than that of cyclopamine and vismodegib has also been found to 
cause fewer adverse effects in humans (Yun et al 2012). 
While cyclopamine has been used to suppress Shh signalling in the study of 
embryonic brain development in mouse (Lipinski et al 2010), studies in mouse have 
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shown that its potency is relatively low compared to that of vismodegib, and that the 
solubility and chemical stability of vismodegib in aqueous solution are also greater 
(Robarge et al 2009). For these reasons it was decided that vismodegib would be 
used in the experiments described in this chapter. 
Loss of Shh or inhibition of Shh expression leads to a very severe embryonic lethal 
phenotype with affected embryos exhibiting morphology which is greatly altered 
from that of untreated wild type embryos (Chang et al 1996, Roessler et al 1996). 
These differences in morphology can make it difficult to make useful comparisons 
between the Shh-null embryo and the wild type embryo. For this reason it can be 
preferable to use drug treatment to suppress Shh signalling at a stage at which the 
structure being investigated has been established. Delaying the administration of the 
drug to a point at which particular structures have already been specified can ensure 
that the morphology of the treated embryo will not differ too greatly from that of the 
untreated control embryo and make it easier to interpret changes in gene expression. 
In the experiments described here, vismodegib was administered at E9.5, a point at 
which the neural tube has closed, the murine prosencephalon has differentiated into 
the telencephalon and the diencephalon, and the segmentation of the diencephalon is 
taking place. 
Pax6+/Sey males were crossed with Pax6+/Sey females in order to generate litters 
comprising Pax6+/+, Pax6+/Sey and Pax6Sey/Sey embryos. The effective dose of 
vismodegib had been determined to be 4mg previously (Caballero et al 2014). At 
E9.5 pregnant females were administered with 4mg of vismodegib in a 
methylcellulose vehicle solution, or the vehicle solution alone as a control, by oral 
gavage. Embryos were harvested at E12.5 before being fixed and cryosectioned. 
Pax6Sey/Sey embryos were identified by their lack of eyes and altered craniofacial 
morphology. 
In situ hybridization for Pax6 mRNA was performed on sections from control 
embryos of the genotypes Pax6+/+ or Pax6+/Sey, while in situ hybridization for Barhl2 
mRNA was performed on Pax6+/+, Pax6+/Sey and Pax6Sey/Sey embryos. Each 
experiment was repeated three times on tissue from three different embryos. 
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While the expression of Pax6 protein in the Pax6+/Sey forebrain has been investigated 
and described previously (Pinson 2005) the expression of Barhl2 mRNA and Barhl2 
protein in the Pax6+/Sey forebrain have yet to be described. An antibody for Barhl2 
protein which was suitable for immunohistochemical applications was not available, 
and for this reason the expression of Barhl2 mRNA rather than that of Barhl2 protein 
was investigated.  
For the experiments described here a limited quantity of vismodegib was available. 
Material from embryos treated with vismodegib was therefore scarce. For this reason 
it was decided that while ideally Pax6+/+ embryos only would be used as controls, it 
would be necessary to perform some experiments using Pax6+/Sey embryos in 
addition to these. 
The phenotype of the Pax6Sey/+ mouse is less severe than of the Pax6Sey/Sey mouse. 
Pax6Sey/+ mice exhibit gross morphology that is similar to that the wild-type mouse, 
with the exception of the eyes, which are reduced in size (Hill et al 1991), while the 
forebrain morphology is also similar in mice of both genotypes (Mastick et al 1997). 
Quantification of the expression levels of Pax6 protein have shown that they are 
broadly similar in the Pax6+/+ and Pax6+/Sey mouse forebrain (Pinson 2005), possibly 
as a consequence of the ability of Pax6 to autoregulate its expression within the 
forebrain (Aota et al 2003, Pinson 2005, Pinson et al 2005, Manuel et al 2007). The 
Pax6+/Sey forebrain exhibits a mild axon pathfinding defect in the postoptic 
commissure but appears normal in other respects (Mastick et al 1997). In addition to 
these earlier published findings, the data presented in chapter 5 suggest that the 
expression pattern of Barhl2 in the Pax6+/Sey forebrain does not differ greatly from 
that observed in the Pax6+/+ forebrain (Fig. 5.7). For these reasons Pax6Sey/+ embryos 
were considered acceptable to use as control embryos in this study, and were used to 
compensate for the scarcity of treated Pax6+/+ embryos. 
6.2 Results 
In control embryos which had been exposed to the methylcellulose control vehicle 
alone (Fig. 6.1) Pax6 appeared to be expressed in domains of a similar size and 
position to those observed in the untreated Pax6+/+ embryo (Fig. 3.2.5A-E) and 
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appeared to have been unaltered by the experimental procedure. In the diencephalon 
strong Pax6 expression was observed in the pretectum (asterisk, Fig. 6.1A) and 
prethalamus (asterisks, Fig. 6.1B) and the dorsal-to-ventral gradient of Pax6 
expression was visible within the ventricular zone of the pTh-C (Fig. 6.1F), while in 
the telencephalon Pax6 expression was strong within the ventricular zone of the 
cortex (asterisks, Fig. 6.1D) and its expression gradient ended at a sharp border 
coinciding with the position of the pallial-subpallial boundary (arrows, Fig. 6.1D-E). 
Strong Pax6 expression could also be seen in the retina of the eye (6.1J). 
Barhl2 expression in control embryos which had been exposed to the methylcellulose 
control vehicle alone (Fig. 6.2) also appeared to have been unaltered by the 
experimental procedure and in these embryos the Barhl2 expression domains 
appeared to be of a similar size and position to those observed in the untreated 
control embryo (Fig. 3.2.5F-J). Within the diencephalon Barhl2 expression could be 
seen within the ventricular zone of the pTh-C in an expression gradient running from 
ventral to dorsal (Fig. 6.2F) and within the ZLI (Fig. 6.2L) in a domain distinct from 
the domain within the pTh-C and separated from it by a narrow Barhl2-negative 
domain corresponding with the position of the pTh-R (Fig. 6.2G). Rostral to the ZLI 
Barhl2 expression could be seen within the eminentia thalami (asterisks, Fig. 6.2N) 
and within the telencephalon Barhl2 was observed in a domain within the subpallium 
which extended dorsally and ended at the pallial-subpallial boundary (arrows, Fig. 
6.2D). 
In control embryos which had been exposed to 4mg of vismodegib the morphology 
was altered (Figs. 6.3 and 6.4) from that of the control embryos treated with the 
vehicle control alone (Figs. 6.1 and 6.2). The telencephalic vesicles were enlarged 
and the diencephalic neuroepithelium was seen to have thickened along the 
mediolateral axis. 
Of the three wild type embryos which had been exposed to 4mg of vismodegib (Fig. 
6.3 and 6.4) the first appeared to be slightly larger in size (Figs. 6.3A-E and 6.4A-E) 
than the second (Fig. 6.3F-J and Fig. 6.4F-J) and third (Figs. 6.3K-O and 6.4K-O). 
The first embryo may have reached a slightly later developmental stage than the 
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others but the morphology and expression domains appeared to be similar enough to 
allow useful comparisons to be made between the three embryos. 
In the control embryos analysed, exposure to 4mg of vismodegib appeared to have 
altered the expression of Pax6 (Fig. 6.3) and within several regions of 
neuroepithelium it differed from that observed in the embryos which had been 
treated with the control vehicle alone (Fig. 6.1). Pax6 expression within the 
pretectum remained as strong as it had been in the pretectum of the control embryos 
exposed to the vehicle only (Fig. 6.3B) while in the thalamus Pax6 expression it 
appeared to be stronger overall (Fig. 6.3H) Expression of Pax6 in the ventricular 
zone of the pTh-C appeared to extend into a more ventral region of the 
neuroepithelium (arrows, Fig. 6.3D) than it had in the embryo treated with the 
methylcellulose control vehicle alone (Fig. 6.1). Pax6 expression also appeared to be 
stronger within the ventricular zone of the cortex and the ventral-to-dorsal expression 
gradient of Pax6 appeared to be less steep, with stronger expression of Pax6 detected 
in more dorsal regions of the pallium (Fig. 6.3E). Expression of Pax6 within the 
vismodegib-treated prethalamus appeared to be of a similar strength to that observed 
in the prethalamus of the embryo treated with the vehicle control and the prethalamic 
expression domain also appeared to be of a similar shape and position in both caudal 
sections (Fig. 6.3F) and rostral sections (Fig. 6.3C). 
In control embryos which had been exposed to 4mg of vismodegib the expression of 
Barhl2 did not appear to have been affected to as great an extent as the expression of 
Pax6 within treated embryos (Fig. 6.4). Within the ventricular zone of the pTh-C 
strong Barhl2 expression could still be observed and it still seemed to  
be confined to the ventricular zone (asterisks, Fig. 6.4G) but a ventral-to-dorsal 
gradient of expression was not apparent (Fig. 6.4L) as it had been in some sections 




Fig. 6.1: A-O: In situ hybridization for Pax6 mRNA in sections from three control embryos 
exposed to with the methylcellulose control vehicle alone. P: Schematic to illustrate the 
approximate plane of section. Asterisks: A: Strong Pax6 expression in the pretectum. B: 
Strong Pax6 expression in the prethalamus D: Dorsoventral gradients of Pax6 expression in 
the pallium. Arrows in E: The boundary of the Pax6 domain at the pallial-subpallial boundary. 
Abbreviations: Di- diencephalon; PT- pretectum; Th- thalamus; pTh- prethalamus; VZ- 
ventricular zone; Tel- telencephalon; Mes- mesencephalon; Rh- rhombencephalon; SC- 




Fig. 6.2: A-O In situ hybridization for Barhl2 mRNA in sections from three control embryos 
exposed to the methylcellulose control vehicle alone. P: Schematic to illustrate the 
approximate plane of section. Asterisks: B: Absence of Barhl2 expression in the 
prethalamus. Arrows in D: The PSB. Abbreviations: Di- diencephalon; PT- pretectum; Th- 
thalamus; pTh- prethalamus; VZ- ventricular zone; Tel- telencephalon; Mes- 
mesencephalon; Rh- rhombencephalon; SC- spinal cord Pal- pallium; SubPal- subpallium; 
PSB- pallial-subpallial boundary; Ctx- cortex. 
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Barhl2 could also still be detected within the ZLI but this Barhl2 domain appeared to 
have broadened slightly along the dorsoventral axis (Figs. 6.4B, H and I) and this 
domain was also not as sharply defined as the domain of Barhl2 within the ZLI of 
the control embryo which had been exposed to the vehicle control only (Fig. 6.4L) 
The Barhl2-negative pTh-R appeared also appeared narrower and harder to 
distinguish (Fig. 6.4G) than the pTh-R of embryos exposed to the vehicle control 
alone (Fig. 6.4G). 
Within more caudal sections Barhl2 expression was detected (asterisks, Fig. 6.4F) in 
a domain of a shape comparable to that of the hypothalamic domain observed in 
untreated CD-1® embryos (Fig.3.2.5F). No expression of Barhl2 within the ventral 
diencephalon had been observed in sections cut from a comparable point along the 
rostrocaudal axis in the embryos treated with the vehicle control alone (Fig. 6.4A, F 
and K). 
The expression of Barhl2 within the eminentia thalami (Fig. 6.4I) was of a 
comparable size and shape to that observed within the eminentia thalami of the 
embryo exposed to the vehicle control (Fig. 6.4N). Within the telencephalon the 
subpallial Barhl2 domain appeared to have broadened slightly along the mediolateral 
axis but the overall shape did not seem to have been altered (Fig. 6.4J). 
The morphology of the Pax6Sey/Sey mutant embryos exposed to the control vehicle 
(Fig. 6.5) was apparently unaltered from that of the untreated Pax6Sey/Sey mutant 
embryo (Fig. 5.5F-J). and the overall reduction in forebrain size, with the 
telencephalic vesicles being most severely affected (Fig. 6.5G), the reduced thickness 
of the neuroepithelium (asterisks, Fig. 6.5I and J) and broader diencephalic lumen 
(asterisk, Fig. 6.5H) as described in Chapter 3 were all apparent, and within the 
telencephalon the lateral ganglionice eminence and medial ganglionic eminence 







Fig. 6.3: A-O In situ hybridization for Pax6 mRNA in sections from three control embryos 
exposed to 4mg of vismodegib. P: Schematic to illustrate the approximate plane of section. 
Arrows in D: Thalamic Pax6 extending more dorsally than in the control embryo treated with 
the vehicle alone. Abbreviations: Di- diencephalon; PT- pretectum; Th- thalamus; pTh- 
prethalamus; VZ- ventricular zone; Tel- telencephalon; Mes- mesencephalon; Rh- 
rhombencephalon; SC- spinal cord Pal- pallium; SubPal- subpallium; PSB- pallial-subpallial 




Fig. 6.4: A-O: In situ hybridization for Barhl2 mRNA in sections from three control embryos 
exposed to 4mg of vismodegib. P: Schematic to illustrate the approximate plane of section. 
Abbreviations: Di- diencephalon; PT- pretectum; Th- thalamus; pTh- prethalamus; VZ- 
ventricular zone; Tel- telencephalon; Pal- pallium; SubPal- subpallium; PSB- pallial-subpallial 
boundary; Tel- telencephalon; Di- diencephalon; Mes- mesencephalon; Rh- 
rhombencephalon; SC- spinal cord; Ctx- cortex. 
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The expression of the Barhl2 also appeared to have been unaffected by the 
administration of the vehicle control. As in the untreated Pax6Sey/Sey mutant embryo 
at the same stage (Fig. 5.5 F-J) the Barhl2 expression domain within the pTh-C was 
seen to have expanded laterally (outlined area, Fig. 6.5D) while the broadened 
Barhl2 domain within the expanded ZLI (Fig. 6.5D) could be seen ventral to the 
pTh-C, separated from it by the Barhl2-negative pTh-R which was also broader than 
the pTh-R of the treated control embryo (Fig. 6.4G) and less sharply defined.  
Within the telencephalon the Barhl2 expression domain could be visualised within 
the subpallium (arrows, Fig. 6.5E), reduced in size and in a more lateral position than 
in the control embryo (arrows Fig. 6.4D). 
In the Pax6Sey/Sey mutant embryo which had been exposed to 4mg of vismodegib 
(Fig. 6.6) the morphology appeared different from that of the mutant embryo which 
had been exposed to the control vehicle alone (Fig. 6.5). The expanded diencephalic 
lumen (double asterisk, Fig. 6.6I) was visible as it was in the mutant exposed to the 
vehicle control alone (asterisk, Fig. 6.5H) but in the mutant treated with vismodegib 
the overall size of the forebrain was greater and the neuroepithelium of the 
diencephalon was thicker (asterisk, Fig. 6.6B). While the neuroepithelium of the 
telencephalon did not appear to have increased in thickness to the same extent 
(asterisk, Fig. 6.6O) the telencephalic vesicles, while still smaller than those of the 
control embryo treated with the vehicle control (asterisks, Fig. 6.2D) or with 4mg of 
vismodegib (asterisk, Fig. 6.4E), appeared to be larger than those of the untreated 
mutant embryo (Fig. 6.5G). Within the diencephalon vesicle-like structures could be 
seen to have formed close to the lateral extent of the neuroepithelium (single 
asterisks, Figs. 6.6D, H and N), adjacent to the choroid plexus in more rostral 
sections (Fig. 6.6I and J) Within the telencephalon the lateral ganglionic eminence 
and medial ganglionic eminence (asterisks, Fig. 6.6J) were relatively large (asterisks, 
Fig. 6.6J) and more distinct from one another than the same structures in the mutant 





Fig. 6.5: A-O: In situ hybridization for Barhl2 mRNA in sections from three Pax6Sey/Sey 
embryos exposed to the vehicle control only. P: Schematic to illustrate the approximate 
plane of section. Asterisks: E: The LGE and MGE cannot be distinguished. H: The expanded 
diencephalic lumen. I and J: The neuroepithelium is reduced in thickness in both the 
telencephalon and diencephalon. Arrows in E: Barhl2 expression in the subpallium is 
comparable to that observed in the untreated mutant subpallium. Outlined area in D: The 
laterally expanded thalamic Barhl2 domain. Abbreviations: Di- diencephalon; PT- pretectum; 
Th- thalamus; Mes- mesencephalon; Rh- rhombencephalon; SC- spinal cord; pTh- 
prethalamus; VZ- ventricular zone; Tel- telencephalon; Pal- pallium; SubPal- subpallium; 




Fig. 6.6: A-O: In situ hybridization for Barhl2 mRNA in sections from three Pax6Sey/Sey 
embryos exposed to 4mg of vismodegib. P: Schematic to illustrate the approximate plane of 
section. Arrows in B and G: The apparent loss of the Barhl2-negative pTh-R. Single 
asterisks: Vesicle-like structures at the position of the choroid plexus. Double asterisk in I: 
The expanded diencephalic lumen. Arrows in I: A lateral expansion of the Barhl2 domain into 
the telencephalic neuroepithelium. Outlined area in F: The laterally expanded thalamic 
Barhl2 domain. Arrows in E: Reduced Barhl2 expression in the subpallium. Abbreviations: 
Di- diencephalon; PT- pretectum; Th- thalamus; pTh- prethalamus; VZ- ventricular zone; Tel- 
telencephalon; Pal- pallium; SubPal- subpallium; PSB- pallial-subpallial boundary, LGE- 
lateral ganglionic eminence; MGE- medial ganglionic eminence. Mes- mesencephalon; Rh- 
rhombencephalon; SC- spinal cord 
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The expression of Barhl2 also appeared to have been altered by the treatment with 
vismodegib. Within the thalamus the Barhl2 domain was seen to have expanded 
laterally (outlined area, Fig. 6.6F) as it had in the mutant embryo treated with the 
control vehicle (outlined area, Fig. 6.5D), but in the mutant treated with vismodegib 
the pTh-C, pTh-R and ZLI could not be distinguished by Barhl2 expression. Barhl2 
appeared to be expressed in a continuous domain extending along the dorsoventral 
axis from the dorsal midline of the pretectum to a point corresponding with the 
position of the ZLI’s dorsal extent (outlined area, Fig. 6.6B and F). Within this 
expression domain the strength of Barhl2 expression appeared to be uniform along 
the dorsoventral extent, with no apparent gradient of expression. No region of 
stronger Barhl2 expression corresponding with the position of the expanded ZLI was 
seen, as it had been in the mutant exposed to the control vehicle alone (Fig. 6.5D), 
and the Barhl2-negative region corresponding with the position of the pTh-R was 
also absent (arrows, Fig. 6.6B and G). In the second of the three embryos analysed 
the ventral Barhl2 domain was seen to extend laterally into the telencephalic 
neuroepithelium (arrows, Fig. 6.6I). 
Within the telencephalon a domain of Barhl2 could be seen close to the pial surface 
of the subpallium (arrows, Fig. 6.6E) but this domain appeared smaller than the 
subpallial Barhl2 domain observed in the mutant treated with the vehicle control 
(arrows, Fig. 6.5E) and the expression in the mutant subpallium was also found to be 
much weaker. 
6.4 Discussion 
The suppression of Pax6 expression by Shh signalling has been described in detail in 
previous studies using vertebrate models (, Ericson et al 1997, Goulding et al 2003, 
Kiecker and Lumsden 2004, Vieira et al 2005, Robertshaw et al 2013, Caballero et al 
2014) but the effects of Shh signalling on Barhl2 expression has not previously been 
described in vertebrates. Drosophila Hh is known to be required to initiate the 
expression of Drosophila BarH2 (Lim and Choi 2004) but the data presented here in 
Chapter 4 (Fig. 4.1C and D) show that in mouse Shh is not required for the 
expression of Barhl2. The relationship between Shh and Barhl2 in mouse is clearly 
different from that which exists between Hh and BarH2 in Drosophila. The 
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experiments described here were performed in an attempt to characterise the 
relationship between Shh signalling and Barhl2 expression within the murine 
diencephalon. The observation of changes in gene expression described here build on 
the findings from previous investigations in mouse which focused on the effects of 
vismodegib on a number of other genes expressed within the murine thalamus 
(Caballero et al 2014). 
In addition to this the effects of suppressing Shh signalling on Barhl2 expression 
were studied alongside the effects on the expression of Pax6 in an attempt to gain 
some insight into the potential for relationships existing between Pax6 and Barhl2. If 
a mutually repressive relationship exists between the two genes, the suppression of 
one gene’s expression should in theory lead to an upregulation in the expression of 
the other. This was not observed with Pax6 and Barhl2, as the apparent upregulation 
of Pax6 did not appear to correlate with a downregulation of Barhl2, and this finding 
was not consistent with the hypothesis of a mutually repressive relationship existing 
between the two genes. 
Vismodegib is a relatively novel drug and its effects on embryonic brain 
development have yet to be described comprehensively. Some effects of vismodegib 
on the development of the rat embryo (Rattus norvegicus) have been characterised 
(Morinello et al 2014) and its severe effects on the gross morphology of the murine 
telencephalon (Heyne et al 2015) have been described but its more subtle effects on 
the morphology of the murine diencephalon have yet to be described in detail. The 
data presented here represent an attempt to characterise some of the morphological 
changes which occur as a result of exposure to vismodegib as well as the changes in 
gene expression induced by its effects on the Shh signalling pathway. 
While vismodegib is more soluble and more potent than cyclopamine (Robarge et al 
2009) it has yet to be used as widely as cyclopamine and its action and effects have 
yet to be characterised as comprehensively. Administration of vismodegib could 
prove to be preferable means of suppressing Shh signalling in some contexts and 
findings related to its effects on embryonic development may also have implications 




Within the control embryos exposed to the vehicle control alone (Figs. 6.2 and 6.3), 
the morphology of the forebrain and the expression of both Pax6 and Barhl2 did not 
appear to have been altered. This suggested that the vehicle control and the oral 
gavage method by which it was administered did not exert any biological effects on 
the embryo, and that any changes observed in the embryos exposed to vismodegib 
were therefore induced by the drug itself. 
In control embryos treated with vismodegib the expression of Pax6 appeared to be 
stronger in the pretectum, thalamus and pallium. It is known that Shh signalling can 
inhibit the expression of Pax6 in some contexts (Ericson et al 1997, Goulding et al 
2003, Kiecker and Lumsden 2004, Vieira et al 2005, Robertshaw et al 2013, 
Caballero et al 2014) and that ectopic expression of Shh can downregulate Pax6 
expression in the thalamus (Kiecker and Lumsden 2004; Vieira et al., 2005). It may 
be possible that vismodegib treatment causes an upregulation of Pax6 expression via 
the suppression of Shh signalling and this would be consistent with these earlier 
published findings, but it would be necessary to quantify Pax6 levels in order to 
confirm this. 
In the prethalamus no upregulation of Pax6 was apparent (asterisks, Fig. 6.4C and F). 
This could be because Pax6 expression within the prethalamus is very strong within 
the control embryo even in the absence of vismodegib (Fig. 6.2B) and any increase 
in the strength of its expression may therefore be subtle and hard to confirm without 
the use of quantitative methods. This could also be due to the differential competence 
to respond to the Shh signal in the regions of neuroepithelium rostral and caudal to 
the ZLI (Bulfone et al 1993, Hirata et al 2006, Kiecker and Lumsden 2004, 
Robertshaw et al 2013). The prethalamic neuroepithelium may not be competent to 
respond to the Shh signal, or it may not respond to the signal with a downregulation 
of Pax6, and if this is the case an inhibition of the Shh signal would not lead to an 
increase in Pax6 levels. 
Drug treatment with vismodegib did not appear to have a great effect on the 
expression of Barhl2 in the forebrain of the control embryo (Fig. 6.5) and the shape 
and position of its expression domains appeared unaltered from those of the 
expression domains in the untreated control embryo (Fig. 6.3). Notably the domains 
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of Barhl2 within the pTh-C and ZLI remained distinct from one another and 
separated by a Barhl2-negative region corresponding with the position of the pTh-R, 
although the borders of the pTh-R were harder to distinguish than in the control 
embryo exposed to the vehicle alone. Previous studies have shown that the loss of 
Shh results in a total failure of the pTh-R to develop (Szabó et al 2009, Vue et al 
2009) so the observation that the pTh-R was still present, albeit harder to distinguish, 
is perhaps surprising. The inhibition of Shh with vismodegib may therefore have 
exerted a minor effect on pTh-R development. 
The observation of pTh-R development in vismodegib-treated embryos may also be a 
consequence of the inhibition of Shh signalling by the drug being incomplete. While 
vismodegib has been shown to be more a more potent inhibitor of Shh signalling than 
cyclopamine (Robarge et al 2009) and attempts to determine the dose of vismodegib 
required to inhibit Shh signalling in mouse have found a 4mg dose to be effective 
(Caballero et al 2014) it may still be possible that this dose is not sufficient to cause a 
total inhibition of Shh signalling, although it may be reasonable to expect this dose of 
vismodegib to exert a greater effect on the size of the pTh-R. 
The pTh-R could also be distinguished in Pax6Sey/Sey embryos which had been 
exposed to the control vehicle alone and only appeared to have been lost in 
vismodegib-treated Pax6Sey/Sey embryos. One previous study has suggested that while 
the inhibition of Pax6 by Shh signalling is required for the development of the pTh-
R, it is not sufficient to induce pTh-R development and that another function of Shh 
may play a role in pTh-R induction (Robertshaw et al 2013). The observation that the 
pTh-R is present in the control embryo treated with vismodegib and the mutant 
embryo exposed to the control vehicle, but absent in the vismodegib-treated 
Pax6Sey/Sey mutant embryo (arrows, Fig. 6.6G), is consistent with this hypothesis. 
In Pax6Sey/Sey embryos the ZLI undergoes a great expansion (Grindley et al 1997, 
Pratt et al 2000a), as does the domain of Barhl2 within it as described in Chapter 3.  
This Barhl2 domain can ordinarily be visualised as a region of expression stronger 
than that within the pTh-C and separated from it by the Barhl2-negative pTh-R. This 
domain of strong Barhl2 expression was visible in the mutant embryo which had 
been exposed to the control vehicle alone, but it could not be distinguished in mutant 
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embryos which had been exposed to vismodegib. Within the caudal diencephalon of 
these embryos Barhl2 appeared to be expressed in one continuous domain extending 
from the pretectum to a region corresponding with the rostral extent of the expanded 
ZLI. The strength of Barhl2 expression within this domain also appeared to be 
uniform along its entire extent, with no regions of stronger expression corresponding 
with the positions of the pTh-C and expanded ZLI, and no region of weaker 
expression corresponding with the position of the pTh-R. This suggests that the loss 
of functional Pax6 combined with the suppression of Shh signalling led to a 
disruption in the specification of these structures. Observation of vismodegib-treated 
control embryos showed that the inhibition of Shh signalling alone did not affect the 
development of the ZLI to as great an extent. Together these findings suggest a role 
for Pax6 in the normal development of the ZLI. 
A lateral expansion of the Barhl2 domain within the pTh-C was observed in 
Pax6Sey/Sey mutants whether they had been exposed to vismodegib (outlined area, Fig. 
6.6F) or to the vehicle control alone (Fig.6.5D). While Pax6 is known to repress the 
expression of Shh (Caballero et al 2014), this finding suggests that the altered 
expression of Barhl2 in the Pax6Sey/Sey mutant is independent of the interactions 
between Pax6 and Shh signalling and is more likely to be a direct effect of the loss of 
functional Pax6. Further experiments would be required to determine whether or not 
there is a direct relationship between the expression of Pax6 and that of Barhl2. 
A number of the changes in morphology caused by the loss of functional Pax6 were 
not observed in Pax6Sey/Sey embryos which had been exposed to vismodegib.  While 
the mutant embryos which had been exposed to the control vehicle alone exhibited a 
reduction in the size of the telencephalic vesicles (asterisks, Fig. 6.5G) and an 
underdevelopment of the lateral and medial ganglionic eminences (asterisks, 6.5E) 
the telencephalic vesicles of the mutant treated with vismodegib appeared to be 
larger (asterisks, Fig.6.6L), and the ganglionic eminences were larger and more 
distinct from one another (asterisks, Fig. 6.6J). In addition to this the reduction in the 
thickness of the diencephalic neuroepithelium observed in the mutant exposed to the 
control vehicle alone (outlined area, Fig.6.5D) was not observed in the mutant treated 
with vismodegib (outlined area, Fig. 6.6F). Following early investigations into the 
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possibility of a mutually repressive relationship existing between Pax6 and Shh in 
the CNS (Goulding et al 1993, Ericson et al 1997) it was shown that the loss of Pax6 
was sufficient to rescue the loss of ventral telencephalic structures in the Shh-null 
mutant mouse (Fuccillo et al 2006). The apparent rescue of defects of the Pax6-null 
mutant telencephalon by the suppression signalling of Shh is consistent with these 
findings. 
Previous studies of the Pax6Sey/Sey diencephalon have shown that the loss of the 
habenula and a number of specification defects of the mutant diencephalon can be 
rescued via the suppression of Shh signalling (Chatterjee et al 2014). The findings 
described here suggest that the inhibition of Shh activity may also be able to rescue 
the reduced thickness of the diencephalic neuroepithelium in the Pax6Sey/Sey mutant 
mouse. Further experiments focused on specific defects may be able to confirm 
which defects are related to interactions between Pax6 and Shh and the extent to 
which the Pax6-null phenotype can be rescued via the suppression of Shh signalling. 
The fact that the rescue of the Pax6Sey/Sey phenotype was more complete in the 
telencephalon than it was in the diencephalon suggests that the relationship between 
Pax6 and Shh in the diencephalon is more complex than the apparent mutually 
repressive relationship which exists between them in the telencephalon. This 
possibility would be consistent with findings which suggest that suppression of Shh 
signalling is not sufficient to rescue some defects of the Pax6Sey/Sey diencephalon 
(Caballero et al 2014). 
It is not clear why the development of vesicle-like structures was observed within the 
diencephalic neuroepithelium of the Pax6Sey/Sey embryos treated with vismodegib 
(asterisks, Fig. 6.6H, D and N). These structures developed in a region adjacent to 
the telencephalic choroid plexus and it is possible that they could have developed as 
a result of choroid plexus overgrowth. In mouse embryos in which Shh signalling is 
activated the telencephalic choroid plexus fails to develop, while in embryos in 
which Shh levels are reduced it increases in size, suggesting that the level of Shh  
signalling needs to be carefully regulated in order to ensure the correct development 
of the choroid plexus (Himmelstein et al 2010). The findings presented here also 
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support the hypothesis that choroid plexus growth may have a direct relationship 
with levels of Shh signalling activity. 
The scarcity of material for these experiments presented a number of problems. It 
would have been preferable to use Pax6+/+ embryos as controls rather than using 
both ungenotyped Pax6+/+ and Pax6+/Sey embryos, because the expression of both 
Pax6 and Barhl2 in the Pax6+/+ embryo was described in chapter 3 while the 
expression of both genes in the Pax6+/Sey embryo has not been described as 
comprehensively, here or in the literature. While the expression of Barhl2 in the 
Pax6+/Sey forebrain does not appear to differ greatly from that in the wild type 
forebrain at E12.5 (Fig. 5.7), it may be possible to make more useful comparisons 
between the data from Pax6+/+ embryos described in chapter 3, and Pax6+/+ embryos 
exposed to vismodegib. Ideally a larger quantity of vismodegib would be used, 
allowing more pregnant females to be treated, and a greater number of Pax6+/+ 
embryos to be harvested so Pax6+/Sey embryos would not have to be used. 
Vismodegib has previously been shown to effectively inhibit Shh signalling at the 
dose used in this study (Caballero et al 2014) and in the data presented here, treated 
embryos exhibited altered morphology, suggesting that vismodegib was biologically 
active in treated mouse embryos and that it altered development at the 4mg dose 
which was administered. It may have been preferable to have utilised an observation 
of a change in molecular character rather than a change in morphology, and to have 
chosen a bona fide target of the Shh pathway to act as this marker. Dbx1 is an 
example of a marker which could be used, as its expression has been shown to be 
abolished following the inhibition of Shh signalling by vismodegib (Caballero et al 
2014). If the experiments described in this chapter were to be repeated with a greater 
quantity of material available, it would be preferable to cut a number of sections 
from each embryo and to perform in situ hybridization for Dbx1 in order to confirm 
its absence from the ZLI and the inhibition of Shh signalling by vismodegib. 
In order to make a better comparison between mRNA expression levels in treated 
and untreated embryos, it would have been preferable to carry out the colour reaction 
step of the chromogenic in situ hybridization protocol on all sections being treated 
using the same solution, and allowing the reaction to proceed for the same length of 
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time. If this were done, darker staining would be indicative of stronger mRNA 
expression and not of a longer development time or a more concentrated solution of 
NBT/BCIP, for example. More meaningful data could also be obtained by taking a 
quantitative approach and measuring mRNA or protein levels directly. In order to 
measure levels of Barhl2 protein by Western blotting, for example, a suitable Barhl2 




















7. The effects of Shh pathway activation on the expression of Pax6 and Barhl2 in 
the diencephalon 
7.1 Introduction 
In order to further investigate the interactions between Barhl2, Pax6 and Shh, the 
technique of in utero electroporation was used to activate Shh signalling throughout 
the diencephalic neuroepithelium. The aim of this experiment was to investigate the 
effects of activating Shh signalling in vivo by analysing electroporated embryos to 
observe changes in the expression of Pax6 and Barhl2, and to investigate the 
possibility of Shh signalling exerting context-dependent effects on the expression of 
both transcription factors. 
The plasmids used in the following experiments were cShh pXeX and pTP6. cShh 
pXeX (Agarwala et al 2001) consists of an expression construct for chick (Gallus 
gallus) Shh (cShh) (Riddle et al 1993) inserted into the pXeX Xenopus vector 
(Johnson and Krieg 1994). The pTP6 plasmid encodes a tau-tagged form of green 
fluorescent protein (GFP) (Pratt et al 2000b). 
E12.5 mouse embryos were electroporated in utero with an aqueous solution of the 
DNA plasmids cShh pXeX and pTP6. Control embryos were electroporated with 
pTP6 alone. In order to target different structures along the entire rostrocaudal extent 
of the diencephalon, broad paddle electrodes were used to target a broad region of 
neuroepithelium. Embryos were harvested a minimum of 24 hours post-
electroporation, at E13.5, and dissected in order to isolate whole brains from the 
remaining embryonic tissue. Tissue was observed under fluorescence in order to 
detect GFP expression. The expression of GFP was used as an indicator that the 
electroporation had resulted in cells being transfected successfully and to identify the 
location of the electroporated area. Successfully electroporated embryos were fixed 
and cryosectioned before being treated with in situ hybridization. 
In situ hybridization for cShh mRNA was carried out in order to confirm that the 
cShh construct was being transcribed and to determine the efficiency of the 
electroporation. In situ hybridization for cShh mRNA and immunostaining for GFP 
were carried out in order to determine the efficiency of co-electroporation. Double in 
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situ hybridization for cShh and endogenous mouse Shh (mShh) was carried out to 
determine the specificity of the cShh probe. The findings from these experiments 
were considered in the design of the experiments to investigate changes in gene 
expression induced by the activation of Shh signalling. 
In addition to changes in Pax6 and Barhl2 expression, changes in Ptch1 expression 
were also investigated. Ptch1 is the receptor for Shh and a bona fide target gene 
which is known to be upregulated in response to Shh signalling activity (Marigo et al 
1996) and for these reasons its expression can act as an indicator of Shh pathway 
activity. 
A total of nine embryos electroporated with the cShh pXeX construct were analysed 
to detect changes in gene expression induced by the ectopic expression of cShh. For 
each of these nine embryos three series of cryosections were prepared. These series 
were treated with in situ hybridization for Ptch1, Pax6 and Barhl2 respectively, in 
addition to in situ hybridization for cShh. Two embryos which had been 
electroporated with the pTP6 construct alone served as controls. These embryos were 
also cryosectioned and three series of sections were prepared- these were treated with 
in situ hybridization for Ptch1, Pax6 and Barhl2 respectively, in addition to 
immunostaining for GFP. 
7.2 Results 
7.2.1 Co-electroporation efficiency 
In the technique of in utero electroporation the embryo is often transfected with 
plasmids encoding a fluorescent protein. Treated embryos are then observed under 
fluorescence in order to detect fluorescence as a consequence of ectopic fluorescent 
protein expression. The observation of fluorescence within the treated embryo can 
then be used as confirmation that cells have been successfully transfected, and to 
determine the location of the electroporated area (Momose et al 1999). 
 
The DNA plasmid cShh does not encode a fluorescent protein in addition to cShh. 
For this reason it was necessary to co-electroporate the plasmid with a second 
plasmid encoding a fluorescent protein. The plasmid pTP6 expresses a tau-tagged 
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form of green fluorescent protein (GFP) under the control of a promoter which is 
active in all cells of the CNS (Pratt et al 2000b). The protein binds to microtubules 
and can be visualised throughout the cytoplasm of transfected cells, a property of the 
protein which allows transfected cells to be visualised with ease (Pratt et al 2000b). 
For these reasons pTP6 was selected as the plasmid to be co-electroporated with 
cShh pXeX. 
While the co-electroporation method can be useful as a means of identifying 
successfully electroporated cells, its usefulness is limited because transfected cells 
may not necessarily have been transfected with both plasmids. The efficiency of co-
expression in this experiment was evaluated with the use of in situ hybridization to 
detect the expression of cShh along with immunostaining for GFP in order to identify 
regions of co-expression and regions in which cells had taken up just one of the two 
plasmids. 
Within the electroporated area of neuroepithelium it was found that both cShh 
mRNA and GFP were strongly expressed 24 hours post-electroporation, but while 
both GFP protein and cShh mRNA could be detected in some regions of treated 
neuroepithelium (arrows. Fig. 7.1A and B), many regions were found to strongly 
express GFP protein with little to no cShh mRNA (daggers, Fig. 7.1A and B), and 
regions of neuroepithelium which expressed cShh mRNA but not GFP were also 
observed (asterisks, Fig. 7.1A and B). The area of ectopic cShh expression appeared 
to be broader than the region in which cells expressed GFP (Fig. 7.1C). 
These observations suggested that not all cells were transfected with both plasmids 
during the process of electroporation and that GFP expression, while useful as an 
indicator of a successful electroporation and of the location of the electroporated 
area, may not be a reliable indicator of cells in which transfection of the cShh pXeX 




Fig.7.1: High magnification confocal image of a cryosection from an embryo electroporated 
with cShh pXeX and pTP6 and treated with in situ hybridization for cShh and immunostaining 
for GFP. While some regions of neuroepithelium were successfully transfected with both 
GFP and cShh (arrow), a number of regions which expressed GFP did not express cShh 
mRNA (dagger) and cShh mRNA was in was detected in regions of neuroepithelium where 
GFP was not expressed (asterisk). 
For this reason it was decided that the detection of cShh mRNA via in situ 
hybridization would be a more reliable indicator that cells had been successfully 
transfected with the cShh pXeX plasmid. 
For the remainder of the experiments described in this chapter, the pTP6 tau GFP 
plasmid was co-electroporated with cShh pXeX in order to allow the electroporated 
area to be visualised in harvested forebrain tissue, while experiments carried out to 
analyse electroporated tissue by in situ hybridization employed the cShh riboprobe. 
Electroporation with the pTP6 plasmid alone was used to generate control embryos, 
which were analysed with in situ hybridization for Pax6, Barhl2 or Ptch1 mRNA 
along with immunostaining for GFP to visualise the electroporated area. A total of 
two control embryos were produced and analysed in this manner. 
7.2.2 Electroporation efficiency 
Training in the thalamic transillumination electroporation method was provided by 
the Lab for Molecular Mechanisms of Thalamus Development at The Riken Brain 
Science Institute, Wako-shi, Saitama, Japan. The method was performed as described 
by Matsui et al (2011) on CD-1® embryos at E10.5-E13.5 in accordance with the 
Law for the Humane Treatment and Management of Animals (Japan 2009) (Hau and 
Schapiro 2010). In this method the embryo is illuminated with a cold light source via 
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a fibre optic cable, the end of which is placed in direct contact with the uterine wall, 
and the whelp is manipulated into the optimum position for the injection of plasmid 
DNA and the application of the current. In order to prevent damage to the tissue a 
muscle relaxant drug is administered to prevent the smooth muscle of the uterus 
contracting, ensuring the tissue of the uterus remains pliable and can be manipulated 
without causing damage. The method also involves the use of injectable anaesthesia 
rather than gaseous anaesthesia administered via a facemask, which allows the 
surgeon to change to position of the animal during surgery in order to achieve the 
optimum position, rather than having to manipulate the uterus itself. 
For surgery performed in the UK the use of injectable anaesthesia and muscle 
relaxants are not permitted under the Animals (Scientific Procedures) Act 1986. For 
this reason it was required to develop a modified form of the method. Because of the 
requirement to use gaseous anaesthesia administered via a facemask the position of 
the animal could not be altered during surgery, and because muscle relaxant drugs 
could not be used, the smooth muscle of the uterine wall would contract, becoming 
more rigid and more difficult to manipulate into the optimum position for 
transillumination, the injection of plasmid DNA and the application of the current. 
Attempts to perform the transillumination method at E11.5 and earlier were 
unsuccessful. The small size of embryos at E11.5 and earlier made it difficult to 
distinguish their morphological features without the use of transillumination, but 
attempts to manipulate embryos into the correct position in relation to the fibre optic 
cable, without the ability to change the position of the animal, required the tissue to 
be handled to an unacceptable degree, causing tissue damage and haemorrhaging. 
For embryos at E12.5 and later it was found that, due to the increased size of the 
embryo and the morphological features being easier to distinguish, adequate 
illumination could be provided by a fibre optic light source placed above the embryo, 
rather than via a light source placed in direct contact with the tissue. 
Transillumination of these embryos was therefore not required, and the use of a light 
source placed above the embryo minimised the need to handle the uterine tissue to 
the degree that tissue damage and haemorrhaging could be avoided. 
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In situ hybridization for cShh mRNA was performed on sections from embryos 
which had been electroporated with the cShh pXeX plasmid via the modified method 
described above. These experiments employed a riboprobe for cShh which had been 
synthesised from the cShh pXeX plasmid itself (Agarwala et al 2001). 
Double in situ hybridization for cShh and mShh was carried out on cryosections 
sections from an embryo electroporated with cShh pXeX in order to confirm that the 
cShh riboprobe did not bind to endogenous mShh and could therefore be used as a 
marker of the electroporated area, and an indicator of cells in which cShh was being 
transcribed. Expression of cShh mRNA within the treated embryos also confirmed 
that the ectopic cShh DNA was being transcribed 24 hours following the 
electroporation (Fig. 7.2). 
 
Fig. 7.2: A: A section from an embryo electroporated with cShh pXeX and treated with 
double in situ hybridization for cShh mRNA and mShh mRNA. B-D: Detail of outlined area in 
A. E: Schematic to illustrate the approximate plane of section. The lightning flashes denote 
the electroporated side of the embryo. Abbreviations: Di- diencephalon; PT- pretectum; Th- 
thalamus; pTh- prethalamus; Tel- telencephalon; ZLI- zona limitans intrathalamica; Mes- 
mesencephalon; Rh- rhombencephalon; SC- spinal cord. 
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Following neural tube closure at E9.5 the diencephalic lumen is relatively broad (Fig. 
3.2.2) but over the course of development it becomes progressively narrower, and by  
E12.5 (Fig. 3.3.5) it has narrowed to such an extent that regions of the ventricular 
surfaces on either side of the lumen come into contact with each other at several 
points. When the plasmid DNA solution is injected into the lumen it does not always 
make direct contact with the neuroepithelium in these regions, and for this reason the 
electroporation of some diencephalic regions proved to be more challenging than the 
electroporation of others (Fig. 7.3). 
Structures which are more difficult to electroporate at later developmental stages 
include more rostral regions of the thalamus, in which the diencephalic lumen is 
particularly narrow, while structures closer to broader regions of the lumen, such as 
the prethalamus and pretectum, can be electroporated with relative ease and 
transfection with DNA plasmids is more efficient (arrows, Fig. 7.3G). The limited 
efficiency of electroporation in the rostral thalamus made it necessary to 
electroporate a greater number of embryos in order to ensure that enough samples of 
electroporated thalamic tissue could be obtained. 
For embryos electroporated with both cShh pXeX and pTP6 the position of the 
electroporated area was determined by the expression of cShh as detected by in situ 
hybridization. For embryos electroporated with pTP6 alone electroporated tissue was 
identified by the expression of GFP as detected by immunohistochemistry. The 
structures which were successfully electroporated in each of these embryos are 
summarised in Table 7.1. 
Of the embryos electroporated with both cShh pXeX and pTP6 it was found that the 
pretectum had been successfully electroporated in eight embryos, with particularly 
strong expression of cShh mRNA being detected in cryosections cut from the caudal 
diencephalon- these were the embryos numbered 1, 2, 3, 4, 5, 7, 8 and 9 under “cShh 
pXeX” in Table 7.1. Caudal sections from these embryos were analysed for changes 
in expression of Ptch1, Pax6 and Barhl2 within the pretectum. 
Six of the embryos electroporated with both cShh pXeX and pTP6 were found to 
have been successfully electroporated in a region of the medial diencephalon 
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including the ZLI and the tissues immediately adjacent to it in the thalamus and 
prethalamus- these were the embryos numbered 1, 3, 4, 5, 6 and 9 under “cShh 
pXeX”  in Table 7.1. Medial sections from these embryos were analysed for changes 
in the expression of Ptch1, Pax6 and Barhl2 within the thalamus, ZLI and 
prethalamus. 
 
In the figures which follow, each embryo which was analysed following 
electroporation with both cShh pXeX and pTP6 is referred to as “cShh pXeX” 
followed by the embryo number. 
 
Of the two embryos electroporated with pTP6 alone to serve as experimental 
controls, described under “pTP6” in Table 7.1, only one embryo was found to have 
been electroporated over a region of neuroepithelium broad enough to include a 
substantial area of the pretectum. While the second embryo was also found to have 
been electroporated within the pretectum, the electroporated area was much smaller 
and the immunostaining for GFP performed on sections from this embryo was not 
strong enough to allow for the recording of high quality image data. For these 
reasons, changes in the expression of Ptch1, Pax6 and Barhl2 were investigated in 
caudal sections from the first of the two embryos electroporated with pTP6 alone. 
 
Within the first of the two embryos electroporated with pTP6 alone, a region of the 
medial diencephalon including the ZLI and the regions of the prethalamus and 
pretectum adjacent to it was also found to have been successfully electroporated. 
Medial sections from this embryo were analysed for changes in the expression of 
Ptch1, Pax6 and Barhl2 within the thalamus, ZLI and prethalamus. 
 
In the figures which follow, sections from the embryo electroporated with pTP6 




 Fig. 7.3: A-C: At early developmental stages plasmid DNA solution injected into the 
diencephalic lumen is in contact with most of the neuroepithelium at the ventricular surface 
and cells can be successfully transfected with the plasmids. D-F: At later developmental 
stages cells which are adjacent to the lumen at points where it has narrowed are not 
electroporated as efficiently as those in contact with the plasmid DNA solution. G: Coronal 
cryosection from an embryo electroporated on the right-hand side with cShh pXeX at E12.5 
and treated with in situ hybridization for cShh mRNA at E13.5. The lightning flash denotes 
the electroporated side of the embryo. cShh expression is strongest in the regions of 
neuroepithelium which were immediately adjacent to the open regions of the lumen at E12.5, 





Table 7.1: The regions of neuroepithelium which were successfully electroporated within the 
diencephalon of the nine embryos electroporated with the cShh pXeX construct and pTP6, 
as determined by the expression of cShh mRNA detected via in situ hybridization, and the 
structures which were successfully electroporated within the diencephalon of the two control 
embryos electroporated with pTP6 alone, as determined by the expression of GFP detected 
via immunohistochemistry. 
7.2.3 Analysis of control experiments 
In the pTP6 control embryo, no changes in the expression of Ptch1, Pax6 or Barhl2 
appeared to have been induced. 
Within the electroporated side of the pretectum in a caudal section of the pTP6 
control embryo (lightning flash, Fig. 7.4B) Ptch1 expression did not appear to have 
been induced and it was not detected in either the unelectroporated control side of the 
embryo or the electroporated side (Fig. 7.4C). 
In a medial section from the pTP6 control embryo no changes in Ptch1 expression 
appeared to have been induced on the electroporated side (lightning flash, Fig. 7.5B). 
Expression of Ptch1 appeared to be broadly symmetrical and its expression on the 
electroporated side did not appear to differ from its expression on the 
unelectroporated control side (Fig. 7.5C), suggesting that the electroporation had not 




Expression of Pax6 also appeared to have been unchanged by the electroporation. 
Within the electroporated side of the pretectum (lightning flash, Fig. 7.4E) no 
increase or decrease in the strength of Pax6 was apparent (Fig. 7.4F). Within the 
electroporated side of the diencephalon in a medial section from the control embryo 
(lightning flash, Fig. 7.5E) expression of Pax6 appeared broadly symmetrical and did 
not appear to have been altered within the thalamus, ZLI or  prethalamus (Fig. 7.5F). 
Within the electroporated side of the pretectum in a caudal section from the pTP6 
control (lightning flash, Fig. 7.4H) Barhl2 expression could not be detected and it did 
not appear to have been induced by the electroporation (Fig. 7.4I). Within the 
electroporated side of a medial section from the pTP6 control embryo (lightning 
flash, Fig. 7.5H) the expression of Barhl2 appeared to be broadly symmetrical and no 














Fig. 7.4: Analysis of gene expression within the pretectum of the experimental control 
embryo electroporated with pTP6 alone. A: Schematics to illustrate the approximate plane of 
section and the approximate position of the electroporated area. B-D: Section treated with 
immunohistochemistry for GFP and in situ hybridization for Ptch1 mRNA, in which no Ptch1 
mRNA could be detected in the electroporated area or in the untreated neuroepithelium. E-
G: Section treated with immunohistochemistry for GFP and in situ hybridization for Pax6 
mRNA. H-J: Section treated with immunohistochemistry for GFP and in situ hybridization for 
Barhl2 mRNA, in which no Barhl2 mRNA could be detected in the electroporated area or in 
the untreated neuroepithelium. The lightning flashes denote the electroporated side of the 
embryo. Abbreviations: Tel- telencephalon; Di- diencephalon; PT- pretectum; Th- thalamus; 
pTh- prethalamus; Mes- mesencephalon; Rh- rhombencephalon; SC-spinal cord; VZ- 




Fig. 7.5: Analysis of gene expression within the thalamus, ZLI and prethalamus of the 
experimental control embryo electroporated with pTP6 alone. A: Schematics to illustrate the 
approximate plane of section and the approximate position of the electroporated area. B-D: 
Section treated with immunohistochemistry for GFP and in situ hybridization for Ptch1 
mRNA. E-G: Section treated with immunohistochemistry for GFP and in situ hybridization for 
Pax6 mRNA. H-J: Section treated with immunohistochemistry for GFP and in situ 
hybridization for Ptch1 mRNA. The lightning flashes denote the electroporated side of the 
embryo. Abbreviations: Tel- telencephalon; Di- diencephalon; PT- pretectum; Th- thalamus; 
pTh- prethalamus; Mes- mesencephalon; Rh- rhombencephalon; SC-spinal cord; VZ- 
ventricular zone; ZLI- zona limitans intrathalamica; Hyp- hypothalamus; Ctx- cortex. LGE- 




7.2.4 The effects of ectopic cShh expression on Ptch1 expression 
Following experimental confirmation that the cShh protein is ectopically expressed 
by cells which have been transfected with the cShh pXeX plasmid it was necessary to 
confirm that the translated cShh protein was biologically active in mouse and that 
any effects it exerted on the neuroepithelium of the mouse were  comparable to those 
of endogenous murine Shh. 
For these experiments the expression of Ptch1 was investigated. Ptch1 is a bona fide 
target gene of the Shh signalling pathway and its expression is known to be 
upregulated by Shh (Marigo et al 1996). Upregulation of Ptch1 is therefore an 
indicator of Shh pathway activation and the observation of changes in its expression 
within the electroporated area can be used to determine whether or not the cShh 
construct is biologically active in mouse, and if it is active, the areas of 
neuroepithelium in which it is active, and the range of the cShh signal in those areas. 
A series of cryosections cut from embryos which had been electroporated with cShh 
pXeX were treated with double fluorescence in situ hybridization for Ptch1 and 
cShh. Sections from a total of nine different embryos were treated in this way and 
analysed to observe changes in Ptch1 expression. 
In embryos electroporated with the cShh pXeX plasmid upregulation of Ptch1 was 
observed, confirming that the cShh protein encoded by the plasmid is able to activate 
the Shh signalling pathway in mouse, but this upregulation of Ptch1 was only 
observed within particular diencephalic structures, while in others the ectopic 
expression of cShh had no noticeable effect on Ptch1 expression. 
Eight embryos were found to have been successfully electroporated in a region 
including the pretectum (Table 7.1).  Data for changes in Ptch1 expression was 
successfully obtained from seven of these embryos (Fig. 7.6 and 7.7), while the in 
situ signal in an eighth was found to be of insufficient strength to allow high quality 
image data to be recorded.  
Within the electroporated side of the pretectum in caudal sections (lightning flashes, 
Fig. 7.6B, E, H and K, and Fig. 7.7B, E and H) an upregulation of Ptch1 was 
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observed in all seven embryos for which Ptch1 expression data was obtained (Fig. 
7.6C, F, I and L, and Fig. 7.7C, F and I). This upregulation was observed even in the 
two embryos in which the ectopic expression of cShh was relatively weak on the 
electroporated side (lightning flashes, Fig. 7.6B and K). 
The strength of the Ptch1 upregulation varied greatly. On the electroporated side of 
embryo 8 (lightning flash, Fig. 7.7E), a relatively weak upregulation of Ptch1 was 
observed (Fig. 7.7F), and this may have due to the small size of the electroporated 
area. On the electroporated side of embryo 3 (lightning flash, Fig. 7.6E) a weak 
upregulation of Ptch1 was also observed (Fig. 7.6F) and in this case it may have been 
due to the ectopic expression of cShh being relatively weak. 
On the electroporated side of embryo 1 (lightning flash, Fig. 7.6B) a slightly stronger 
upregulation of Ptch1 was observed. Endogenous Ptch1 mRNA was detected on the 
unelectroporated side, but its expression was noticeably stronger on the 
electroporated side (Fig. 7.6C). A similar increase in the strength of Ptch1 expression 
was noted on the electroporated side of embryo 6 (lightening flash, Fig. 7.6K), with 
the expression of Ptch1 appearing to be stronger than on the unelectroporated side 
(Fig. 7.6L). 
On the electroporated side of embryo 5 (lightning flash, Fig. 7.6H) a strong 
upregulation of Ptch1 was observed, in contrast to the unelectroporated side on 
which little to no Ptch1 mRNA was detected (Fig. 7.6I). Data for this embryo are 
presented at a higher resolution in Fig. 7.8. On the electroporated side (lightning 
flash, Fig. 7.8B) strong expression of cShh mRNA could be detected along the 
majority of the ventricular surface of the pretectum, and the lateral extent of this 
expression was relatively far from the ventricular surface (arrows, Fig. 7.8B). A 
strong upregulation of Ptch1 was observed within this cShh-expressing area (Fig. 
7.8C), with its lateral extent closer to the ventricular surface than that of the region of 
ectopic cShh expression (Fig. 7.8D). 
On the electroporated side of embryo 7 (lightning flash, Fig. 7.7B) a strong 
upregulation of Ptch1 was also observed (Fig. 7.7C). Data for this embryo are 
presented at a higher resolution in Fig. 7.9. On the electroporated side (lightning 
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flash, Fig. 7.9B) expression of ectopic cShh was more diffuse than in embryo 5, and 
did not extend as far dorsally. The upregulation of Ptch1 was confined to this area 
and did not extend beyond the dorsal extent of the region of cShh expression, and 
while some endogenous Ptch1 mRNA was detected on the unelectroporated side of 
the embryo, in the most ventral region of the pretectum, expression of Ptch1 was still 
stronger in this region of the electroporated side (Fig. 7.9C). As in embryo 5, the 
lateral extent of the region of ectopic cShh expression was slightly further away from 
the ventricular surface than the extent of the region of neuroepithelium in which 
Ptch1 was upregulated (Fig. 7.9D). 
On the electroporated side of embryo 9 (lightning flash, Fig. 7.7H) a strong 
upregulation of Ptch1 was also observed (Fig. 7.7I). Data for this embryo are presented at 
a higher resolution in Fig. 7.10. This strong upregulation of Ptch1 (Fig. 7.10C) was 
observed despite the expression of ectopic cShh on the electroporated side (lightning flash, 
Fig. 7.10B) appearing to be weaker than in embryo 5 and embryo 7. In this embryo little to 
no endogenous Ptch1 mRNA was detected on the unelectoporated side (Fig. 7.10C), in 
contrast with the strong expression of Ptch1 expression on the electroporated side. As with 
embryo 5 and embryo 7, the region in which cShh was expressed appeared to slightly 





Fig. 7.6: Analysis of changes in Ptch1 expression in the pretectum of embryos 
electroporated with cShh pXeX by double in situ hybridization for Ptch1 and cShh mRNA. A: 
Schematics to illustrate the approximate plane of section and the approximate position of the 
electroporated area. B-D: Data for embryo 1. E-G: Data for embryo 3. H-J: Data for embryo 
5. K-M: Data for embryo 6. The lightning flashes denote the electroporated side of the 
embryo. Abbreviations: Tel- telencephalon; Di- diencephalon; PT- pretectum; Th- thalamus; 
pTh- prethalamus; Mes- mesencephalon; Rh- rhombencephalon; SC-spinal cord; VZ- 




Fig. 7.7: Analysis of changes in Ptch1 expression in the pretectum of embryos 
electroporated with cShh pXeX by double in situ hybridization for Ptch1 and cShh mRNA. A: 
Schematics to illustrate the approximate plane of section and the approximate position of the 
electroporated area. B-D: Data for embryo 7. E-G: Data for embryo 8. H-J: Data for embryo 
9. The lightning flashes denote the electroporated side of the embryo. Abbreviations: Tel- 
telencephalon; Di- diencephalon; PT- pretectum; Th- thalamus; pTh- prethalamus; Mes- 
mesencephalon; Rh- rhombencephalon; SC-spinal cord; VZ- ventricular zone; ZLI- zona 




Fig. 7.8: Detail of embryo 5, caudal section. A: Schematic to illustrate the position of the 
electroporated area. B: In situ hybridization data for cShh mRNA. The lightening flash 
denotes the electroporated side of the embryo. The arrows indicate areas in which cells were 
transfected. C: In situ hybridization data for Ptch1. D: In situ hybridization data for both cShh 
and Ptch1. Abbreviations: Tel- telencephalon; Di- diencephalon; PT- pretectum; Th- 
thalamus; pTh- prethalamus; Mes- mesencephalon; Rh- rhombencephalon; SC-spinal cord; 




Fig. 7.9: Detail of embryo 7, caudal section. A: Schematic to illustrate the position of the 
electroporated area. B: In situ hybridization data for cShh mRNA. The lightening flash 
denotes the electroporated side of the embryo. The arrows indicate areas in which cells were 
transfected. C: In situ hybridization data for Ptch1. D: In situ hybridization data for both cShh 
and Ptch1. Abbreviations: Tel- telencephalon; Di- diencephalon; PT- pretectum; Th- 
thalamus; pTh- prethalamus; Mes- mesencephalon; Rh- rhombencephalon; SC-spinal cord; 




Fig. 7.10: Detail of embryo 9, caudal section. A: Schematic to illustrate the position of the 
electroporated area. B: In situ hybridization data for cShh mRNA. The lightening flash 
denotes the electroporated side of the embryo. The arrows indicate areas in which cells were 
transfected. C: In situ hybridization data for Ptch1. D: In situ hybridization data for both cShh 
and Ptch1. Abbreviations: Tel- telencephalon; Di- diencephalon; PT- pretectum; Th- 
thalamus; pTh- prethalamus; Mes- mesencephalon; Rh- rhombencephalon; SC-spinal cord; 
VZ- ventricular zone; ZLI- zona limitans intrathalamica; Hyp- hypothalamus; Ctx- cortex. 
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Data for Ptch1 expression was obtained from all six embryos which had been 
successfully electroporated in a region of the medial diencephalon including the 
thalamus, ZLI and pretectum (Fig. 7.11 and 7.12). 
As with the pretectum of treated embryos, upregulation of Ptch1 mRNA was 
observed within the electroporated area of medial sections from the six embryos 
electroporated with cShh pXeX within the thalamus, ZLI and prethalamus (lightning 
flashes, Fig. 7.11 B, E and H, and Fig. 7.12, B, E and H), but not in all regions of the 
neuroepithelium within the electroporated area. 
Ptch1 is not ordinarily expressed within the ZLI (Caballero et al 2014) and it was 
also found to be absent from the ZLI in all six embryos in which the neuroepithelium 
of the ZLI had been electroporated with cShh pXeX (arrows, Fig. 7.11C, F and I, and 
Fig. 7.12 C, F and I). 
On the electroporated side of embryo 3 (lightning flash, Fig. 7.11E) no upregulation 
of Ptch1 was apparent in either the thalamus or pretectum (Fig. 7.11F) and the 
expression domains of Ptch1 in this embryo appeared to be broadly symmetrical. 
This may have been due to the relatively weak expression of ectopic cShh within the 
electroporated area. 
On the electroporated side of embryo 9 (lightning flash, Fig. 7.12H) the expression 
domains of Ptch1 observed in embryo 9 also appeared to be broadly similar, with no 
apparent change in Ptch1 expression levels on the electroporated side (Fig. 7.12I). As 
with embryo 3, the electroporated area of embryo 9 did not strongly express cShh 
and this may be the reason why no change in Ptch1 expression was observed. 
On the electroporated side of embryo 6 (lightning flash, Fig. 7.12E) a slight 
upregulation of Ptch1 was observed in the thalamus, while no change in the level of 
Ptch1 expression was apparent in the prethalamus (Fig. 7.12F), despite the 
expression of cShh being stronger than it appeared to have been in embryo 3 and 
embryo 9. In this embryo a region of the medial ganglionic eminence (MGE) was 




On the electroporated side of embryo 4 (lightning flash, Fig. 7.11H) cShh expression 
was particularly strong within the prethalamus. A slight upregulation of Ptch1 was 
observed in the thalamus, with a stronger upregulation of Ptch1 in the prethalamus 
(Fig. 7.11I). The region of strong Ptch1 upregulation in the prethalamus 
corresponded with the position of the neuroepithelium in which ectopic cShh 
expression was particularly strong (Fig. 7.11J). 
Within the electroporated area of embryo 5 (lightning flash, Fig. 7.12B) a strong 
upregulation of Ptch1 was observed in the thalamus (Fig. 7.12C) Data for this 
embryo are presented at a higher resolution in Fig. 7.13. On the electroporated side 
of this embryo (lightning flash, Fig. 7.13B) cShh was strongly expressed over a 
relatively broad area of neuroepithelium were several regions where cShh expression 
was particularly strong (arrows, 7.13B), but while this electroporated region spanned 
the majority of the thalamic neuroepithelium, it did not extend into the prethalamus. 
A strong upregulation of Ptch1 was observed within the thalamus, with no 
upregulation apparent in the prethalamus (Fig. 7.13C). As in the pretectum, the 
domain of Ptch1 did not extend as far laterally as the extent of the cShh-expressing 
electroporated area (Fig. 7.13D). 
Within the electroporated side of embryo 1 (lightning flash, Fig. 7.11B) a strong 
upregulation of Ptch1 was observed in both the thalamus and pretectum (Fig. 7.11C). 
Data for this embryo are presented at a higher resolution in Fig. 7.14. On the 
electroporated side of this embryo (lightning flash, Fig. 7.14B) strong cShh 
expression could be observed within several discrete regions within the 
electroporated area, and most of these were observed in the neuroepithelium of the 
ZLI and prethalamus (arrows, Fig. 7.14B). The upregulation of Ptch1 was 
particularly strong in the prethalamus but Ptch1 was also found to have been 
upregulated in the thalamus, despite the thalamic neuroepithelium being situated 
further from the electroporated area than the prethalamus (Fig. 7.14C). In this 
embryo some cells situated a considerable distance from the ventricular surface were 
found to be expressing cShh, but little to no upregulation of Ptch1 was detected in or 




Fig. 7.11: Medial sections from embryos treated with double in situ hybridization for Ptch1 
and cShh following electroporation with cShh pXeX. A: Schematics to illustrate the 
approximate plane of section and the position of the electroporated area. B-D: Data for 
embryo 1. E-G: Data for embryo 3. H-J: Data for embryo 4. Lightning flashes denote the 
electroporated side of the embryo. Arrows indicate the approximate position of the ZLI. 
Abbreviations: Tel- telencephalon; Di- diencephalon; PT- pretectum; Th- thalamus; pTh- 
prethalamus; ZLI- zona limitans intrathalamica; MGE- medial ganglionic eminence; LGE- 
lateral ganglionic eminence; ET- eminentia thalami; VZ- ventricular zone; Ctx- cortex; Mes- 




Fig. 7.12: Medial sections from embryos treated with double in situ hybridization for Ptch1 
and cShh following electroporation with cShh pXeX. A: Schematics to illustrate the 
approximate plane of section and the position of the electroporated area. B-D: Data for 
embryo 5. E-G: Data for embryo 6. H-J: Data for embryo 9. Lightning flashes denote the 
electroporated side of the embryo. Arrows indicate the approximate position of the ZLI. 
Abbreviations: Tel- telencephalon; Di- diencephalon; PT- pretectum; Th- thalamus; pTh- 
prethalamus; ZLI- zona limitans intrathalamica; MGE- medial ganglionic eminence; LGE- 
lateral ganglionic eminence; ET- eminentia thalami; VZ- ventricular zone; Ctx- cortex; Mes- 






Fig. 7.13: Detail of embryo 5, medial section. A: Schematic to illustrate the position of the 
electroporated area. B: In situ hybridization data for cShh mRNA. The lightening flash 
denotes the electroporated side of the embryo. The arrows indicate areas in which cells were 
transfected. C: In situ hybridization data for Ptch1. D: In situ hybridization data for both cShh 
and Ptch1. Abbreviations: Tel- telencephalon; Di- diencephalon; PT- pretectum; Th- 
thalamus; pTh- prethalamus; Mes- mesencephalon; Rh- rhombencephalon; SC-spinal cord; 




Fig. 7.14: Detail of embryo 1, medial section. A: Schematic to illustrate the position of the 
electroporated area. B: In situ hybridization data for cShh mRNA. The lightening flash 
denotes the electroporated side of the embryo. The arrows indicate areas in which cells were 
transfected. C: In situ hybridization data for Ptch1. D: In situ hybridization data for both cShh 
and Ptch1. Abbreviations: Tel- telencephalon; Di- diencephalon; PT- pretectum; Th- 
thalamus; pTh- prethalamus; Mes- mesencephalon; Rh- rhombencephalon; SC-spinal cord; 
VZ- ventricular zone; ZLI- zona limitans intrathalamica; Hyp- hypothalamus; Ctx- cortex. 
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7.2.5 The effects of ectopic cShh expression on Pax6 expression 
Following experimental confirmation that the cShh pXeX construct was biologically 
active in mouse and was able to activate the Shh pathway in some areas of 
neuroepithelium, experiments were performed to determine the effect of Shh 
pathway activation by ectopically expressed cShh on the expression of Pax6. 
Cryosections from embryos electroporated with cShh pXeX were treated with double 
fluorescence in situ hybridization for cShh and Pax6 in order to observe changes in 
Pax6 expression induced by the activation of the Shh pathway. Following the 
treatment and analysis of cryosections cut at the level of the caudal diencephalon, 
data for Pax6 expression in the pretectum was successfully obtained from all eight of 
the embryos in which the electroporated area included the pretectum (Figs. 7.15 and 
7.16). 
On the electroporated side of embryo 1 (lightning flash, Fig. 7.15B) ectopic cShh 
expression was relatively weak, no change in Pax6 expression was observed and the 
expression of Pax6 appeared to be equally strong on both the electroporated and 
unelectroporated sides of the embryo (Fig. 7.15C). 
No change in Pax6 expression was observed on the electroporated side of embryo 3 
(lightning flash, Fig. 7.15H). cShh was not strongly expressed within the 
electroporated area and expression of Pax6 appeared to be of equal strength on the 
electroporated and unelectroporated sides of the pretectum in this embryo (Fig. 
7.15I). 
On the electroporated side of embryo 7 (lightning flash, 7.16E) cShh expression was 
of moderate strength, with one discrete region in which it was particularly strong, but 
despite this no changes in Pax6 expression were observed and expression of Pax6 
appeared to be broadly symmetrical in the pretectum of this embryo (Fig. 7.16F). 
On the electroporated side of embryo 8 (lightning flash, Fig. 7.16H) the 
electroporated area was relatively broad, although expression of cShh within this area 
was also diffuse. No change in Pax6 expression was observed and the strength of 
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Pax6 expression appeared to be equally strong on both the electroporated and 
unelectroporated sides of the pretectum (Fig. 7.16I). 
On the electroporated side of embryo 2 (lightning flash, Fig. 7.15E) expression of 
cShh was relatively strong and extended over a relatively broad area of 
neuroepithelium. An apparent downregulation of Pax6 was observed within the 
electroporated area of this embryo (asterisk, Fig. 7.15F). Data for this embryo are 
presented at a higher resolution in Fig. 7.17. On the electroporated side of this 
embryo (lightning flash, Fig. 7.17B) discrete regions of strong cShh expression were 
observed (arrows, Fig. 7.17B). While Pax6 was strongly expressed on the 
unelectoporated side of the pretectum, its expression was markedly weaker within 
the electroporated area (asterisk, Fig. 7.17C). 
On the electroporated side of embryo 6 (lightning flash, Fig. 7.16B) strong 
expression of cShh was observed within a small region of neuroepithelium and an 
apparent downregulation of Pax6 was observed within this region (Fig. 7.16C). Data 
for this embryo are presented at a higher resolution in Fig. 7.18. On the 
electroporated side of this embryo (lightning flash, Fig. 7.18B) expression of cShh 
appeared to be concentrated within one small region of the pretectum (arrows, Fig. 
7.18B) and in this region of the neuroepithelium Pax6 expression appeared to be 
weaker than on the unelectroporated side (asterisk, Fig. 7.18C). The region of 
apparent downregulation corresponded with the position of the electroporated area 
(Fig. 7.18D). 
On the electroporated side of embryo 9 (lightning flash, Fig. 7.16K) a small region of 
strong cShh expression appeared to correspond with a region of apparent Pax6 
downregulation (Fig. 7.16L). Data for this embryo are presented at a higher 
resolution in Fig. 7.19. On the electroporated side of this embryo (lightning flash, 
Fig. 7.19B) expression of cShh was concentrated in a small region of the ventral 
pretectum, close to the ventricular surface (arrows, Fig. 7.19B). An apparent 
downregulation of Pax6 (asterisk, Fig. 7.19C) was also observed in the ventral 
pretectum, with Pax6 expression appearing to be weaker than it appeared on the 
unelectroporated side. This region of apparent Pax6 downregulation corresponded 
with the position of the electroporated area (Fig. 7.19D). 
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On the electroporated side of embryo 5 (lightning flash, Fig. 7.15K) expression of 
cShh was relatively strong and could be observed over a broad area of 
neuroepithelium. Data for this embryo are presented at a higher resolution in Fig. 
7.20. On the electroporated side of this embryo (Fig. 7.20B) expression of cShh was 
particularly strong in the more ventral regions of the pretectum (arrows, Fig. 7.20B). 
Despite this a downregulation of Pax6 expression was not observed within the 
electroporated region (asterisk, Fig. 7.20C).as it had been in embryo 2, embryo 6 and 
embryo 9. The expression domain of Pax6 in embryo 5 appeared to be slightly 
broader on the electroporated side, but this may have been due to the tissue section 
not being entirely symmetrical. The expression of Pax6 appeared to be of equal 




Fig. 7.15: Analysis of changes in Pax6 expression in the pretectum of embryos 
electroporated with cShh pXeX by double in situ hybridization for Pax6 and cShh mRNA. A: 
Schematics to illustrate the approximate plane of section and the approximate position of the 
electroporated area. B-D: Data for in embryo 1. E-G: Data for embryo 2. H-J: Data for 
embryo 3. K-M: Data for embryo 5. The lightning flashes denote the electroporated side of 
the embryo. Asterisks: regions of apparent Pax6 downregulation. Abbreviations: Tel- 
telencephalon; Di- diencephalon; PT- pretectum; Th- thalamus; pTh- prethalamus; Mes- 
mesencephalon; Rh- rhombencephalon; SC-spinal cord; VZ- ventricular zone; ZLI- zona 




Fig. 7.16: Analysis of changes in Pax6 expression in the pretectum of embryos 
electroporated with cShh pXeX by double in situ hybridization for Pax6 and cShh mRNA. A: 
Schematics to illustrate the approximate plane of section and the approximate position of the 
electroporated area. B-D: Data for embryo 6. E-G: Data for embryo 7. H-J: Data for embryo 
8. K-M: Data for embryo 9. The lightning flashes denote the electroporated side of the 
embryo. Asterisks denote regions of apparent Pax6 downregulation. Abbreviations: Tel- 
telencephalon; Di- diencephalon; PT- pretectum; Th- thalamus; pTh- prethalamus; Mes- 
mesencephalon; Rh- rhombencephalon; SC-spinal cord; VZ- ventricular zone; ZLI- zona 




Fig. 7.17: Detail of embryo 2, caudal section. A: Schematic to illustrate the position of the 
electroporated area. B: In situ hybridization data for cShh mRNA. The lightening flash 
denotes the electroporated side of the embryo. The arrows indicate areas in which cells were 
transfected. C: In situ hybridization data for Pax6. The asterisk denotes an apparent 
downregulation.  D: In situ hybridization data for both cShh and Pax6. Abbreviations: Tel- 
telencephalon; Di- diencephalon; PT- pretectum; Th- thalamus; pTh- prethalamus; Mes- 
mesencephalon; Rh- rhombencephalon; SC-spinal cord; VZ- ventricular zone; ZLI- zona 





Fig. 7.18: Detail of embryo 6, caudal section. A: Schematic to illustrate the position of the 
electroporated area. B: In situ hybridization data for cShh mRNA. The lightening flash 
denotes the electroporated side of the embryo. The arrows indicate areas in which cells were 
transfected. C: In situ hybridization data for Pax6. The asterisk denotes an apparent 
downregulation. D: In situ hybridization data for both cShh and Pax6. Abbreviations: Tel- 
telencephalon; Di- diencephalon; PT- pretectum; Th- thalamus; pTh- prethalamus; Mes- 
mesencephalon; Rh- rhombencephalon; SC-spinal cord; VZ- ventricular zone; ZLI- zona 




Fig. 7.19: Detail of embryo 9, caudal section. A: Schematic to illustrate the position of the 
electroporated area. B: In situ hybridization data for cShh mRNA. The lightening flash 
denotes the electroporated side of the embryo. The arrows indicate areas in which cells were 
transfected. C: In situ hybridization data for Pax6. The asterisk denotes an apparent 
downregulation. D: In situ hybridization data for both cShh and Pax6. Abbreviations: Tel- 
telencephalon; Di- diencephalon; PT- pretectum; Th- thalamus; pTh- prethalamus; Mes- 
mesencephalon; Rh- rhombencephalon; SC-spinal cord; VZ- ventricular zone; ZLI- zona 





Fig. 7.20: Detail of embryo 5, caudal section. A: Schematic to illustrate the position of the 
electroporated area. B: In situ hybridization data for cShh mRNA. The lightening flash 
denotes the electroporated side of the embryo. The arrows indicate areas in which cells were 
transfected. C: In situ hybridization data for Pax6. The asterisk denotes a region of no 
apparent downregulation within the electroporated area. D: In situ hybridization data for both 
cShh and Pax6. Abbreviations: Tel- telencephalon; Di- diencephalon; PT- pretectum; Th- 
thalamus; pTh- prethalamus; Mes- mesencephalon; Rh- rhombencephalon; SC-spinal cord; 
VZ- ventricular zone; ZLI- zona limitans intrathalamica; Hyp- hypothalamus; Ctx- cortex. 
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Data for Pax6 expression was obtained from five embryos which were electroporated 
in a medial region of the diencephalon including the thalamus, ZLI and prethalamus 
(Fig. 7.21, Fig. 7.22 and Fig. 7.23). On the electroporated side of embryo 1 (lightning 
flash, Fig. 7.21B) expression of cShh was relatively weak and no changes in Pax6 
expression were observed within the electroporated area (Fig. 7.21C). 
On the electroporated side of embryo 4 (lightning flash, Fig. 7.21E) only weak 
expression of cShh mRNA was detected. The expression domains of Pax6 in this 
embryo were broadly symmetrical and no change in Pax6 expression appeared to 
have been induced (Fig. 7.21F). 
On the electroporated side of embryo 5 (Fig. 7.21 H) cShh expression was relatively 
weak and diffuse. The treated section cut from this embryo was not entirely 
symmetrical, but the strength of Pax6 expression appeared to be the same on both the 
electroporated and unelectoporated sides (Fig. 7.21I). 
Expression of cShh within the electroporated area of embryo 6 was relatively strong. 
Data for this embryo are shown at high resolution in Fig. 7.22. On the electroporated 
side of this embryo (lightning flash, 7.22B) strong cShh expression was observed in a 
region spanning the ventral regions of the thalamic neuroepithelium and the ZLI 
(arrows, Fig. 7.22B). Expression of Pax6 in this region of the thalamus appeared to 
be very slightly weaker than on the unelectroporated side (asterisk, Fig. 7.22C). 
Expression of cShh within the electroporated area of embryo 9 was relatively strong. 
Data for this embryo are presented at high resolution in Fig. 7.23. The lumen of this 
embryo appears wider than the others described in this chapter because of damage to 
the roofplate during the process of tissue fixation, but the section shown here was cut 
at a comparable point along the rostrocaudal axis of the diencephalon. On the 
electroporated side of this embryo (lightning flash, Fig. 7.23B) ectopic cShh 
expression was relatively strong within the thalamus and many areas of particularly 
strong expression could be seen within the electroporated area (arrows, Fig. 7.23B). 
Despite this relatively high strength of expression, no apparent change in the 
expression of Pax6 was noted on the electroporated side of the embryo (Fig. 7.23C) 




Fig. 7.21: Analysis of changes in Pax6 expression in the thalamus, ZLI and prethalamus of 
embryos electroporated with cShh pXeX by double in situ hybridization for Pax6 and cShh 
mRNA. A: Schematics to illustrate the approximate plane of section and the approximate 
position of the electroporated area. B-D: Data for embryo 1. E-G: Data for embryo 4. H-J: 
Data for embryo 5. The lightning flashes denote the electroporated side of the embryo. 
Abbreviations: Tel- telencephalon; Di- diencephalon; PT- pretectum; Th- thalamus; pTh- 
prethalamus; ZLI- zona limitans intrathalamica; MGE- medial ganglionic eminence; LGE- 
lateral ganglionic eminence; ET- eminentia thalami; VZ- ventricular zone; Ctx- cortex; Mes- 






Fig. 7.22: Detail of embryo 6, medial section. A: Schematic to illustrate the position of the 
electroporated area. B: In situ hybridization data for cShh mRNA. The lightening flash 
denotes the electroporated side of the embryo. The arrows indicate areas in which cells were 
transfected. C: In situ hybridization data for Pax6. The asterisk denotes a potential 
downregulation of Pax6. D: In situ hybridization data for both cShh and Pax6. Abbreviations: 
Tel- telencephalon; Di- diencephalon; PT- pretectum; Th- thalamus; pTh- prethalamus; Mes- 
mesencephalon; Rh- rhombencephalon; SC-spinal cord; VZ- ventricular zone; ZLI- zona 




Fig. 7.23: Detail of embryo 9, medial section. A: Schematic to illustrate the position of the 
electroporated area. B: In situ hybridization data for cShh mRNA. The lightening flash 
denotes the electroporated side of the embryo. The arrows indicate areas in which cells were 
transfected. C: In situ hybridization data for Pax6. The asterisk denotes no apparent 
downregulation within the electroporated area. D: In situ hybridization data for both cShh and 
Pax6. Abbreviations: Tel- telencephalon; Di- diencephalon; PT- pretectum; Th- thalamus; 
pTh- prethalamus; Mes- mesencephalon; Rh- rhombencephalon; SC-spinal cord; VZ- 
ventricular zone; ZLI- zona limitans intrathalamica; Hyp- hypothalamus; Ctx- cortex. 
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7.2.6 The effects of ectopic cShh expression on Barhl2 expression 
Experiments were performed to determine the effect of Shh pathway activation by 
the ectopic expression of cShh on the expression of Barhl2. Cryosections from 
embryos electroporated with cShh pXeX were treated with double fluorescence in 
situ hybridization for cShh and Barhl2 in order to observe changes in Barhl2 
expression induced by the activation of the Shh pathway. 
Following the treatment and analysis of cryosections cut at the level of the caudal 
diencephalon, data for Barhl2 expression in the pretectum was successfully obtained 
from all eight of the embryos in which the electroporated area included the pretectum 
(Figs. 7.24 and 7.25).  
An apparent upregulation of Barhl2 was observed in six of the eight embryos which 
were analysed. 
On the electroporated side of embryo 1 (lightning flash, Fig. 7.24B) cShh was 
strongly expressed within a ventral region of the pretectum, close to the ventricular 
surface. Despite this strong expression no change in Barhl2 expression was noted 
and the expression domains of Barhl2 in this embryo appeared to be broadly 
symmetrical (Fig. 7.24C). 
On the electroporated side of embryo 2 (lightning flash, Fig. 7.24E) cShh was also 
strongly expressed within the ventral pretectum, close to the ventricular surface. As 
in embryo 1, this ectopic expression of cShh did not appear to have induced a change 
in Barhl2 expression in embryo 2, and in this embryo the expression domains of 
Barhl2 were broadly symmetrical (Fig. 7.24F). 
On the electroporated side of embryo 6 (lightning flash, Fig. 7.25B) cShh was found 
to be expressed in a broad region of neuroepithelium extending to a point close to the 
dorsal midline. In this embryo Barhl2 expression was upregulated in the dorsal 
pretectum, while it was not expressed in this region on the unelectroporated side 
(Fig. 7.25C). 
On the electroporated side of embryo 8 (lightning flash, Fig. 7.25H) cShh was also 
strongly expressed close to the dorsal midline of the embryo, and as in embryo 6, 
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Barhl2 was upregulated in this region, and the dorsal extent of Barhl2 expression on 
the electroporated side of the embryo was closer to the dorsal midline than that of the 
Barhl2 domain on the unelectroporated side of the embryo (Fig. 7.25I). 
On the electroporated side of embryo 9 (lightning flash, Fig. 7.25K) Barhl2 also 
appeared to have been upregulated (Fig. 7.25L). Data for this embryo are presented 
at higher resolution in Fig. 7.26. On the electroporated side (lightning flash, Fig. 
7.26B) cShh expression was concentrated in a small region of the ventral pretectum 
close to the dorsal midline (arrows, Fig. 7.26B). A lateral expansion of the Barhl2 
domain was observed on the electroporated side (asterisk, Fig. 7.26C) and it 
appeared broader than the Barhl2 domain on the unelectroporated side even in 
regions of neuroepithelium located relatively far from the strongest region of cShh 
expression (Fig. 7.26D). 
On the electroporated side of embryo 7 (lightning flash, Fig. 7.25E) a lateral 
expansion of the Barhl2 domain was also observed (Fig. 7.25F). Data for this 
embryo are presented at higher resolution in Fig. 7.27. On the electroporated side 
(lightning flash, Fig. 7.27B) cShh was strongly expressed and cShh mRNA could be 
detected at a relatively great distance from the ventricular surface (arrows, Fig. 
7.27B). The Barhl2 domain was found to have undergone an expansion around the 
electroporated area (asterisk, Fig. 7.27C) and appeared broader than the Barhl2 
domain on the unelectroporated side. As with embryo 9, the expanded Barhl2 
domain was broader than the region in which cShh was expressed (Fig. 7.27D). 
On the electroporated side of embryo 3 (lightning flash, 7.24H) a lateral expansion of 
the Barhl2 domain was also observed, in addition to an expansion along the 
dorsoventral axis (Fig. 7.24I). Data from this embryo are presented at a higher 
resolution in Fig. 7.28. On the electroporated side (lightning flash, Fig. 7.28B) cShh 
could be detected throughout the majority of the neuroepithelium of the pretectum, 
with the exception of the region closest to the dorsal midline (arrows, Fig. 7.28B). 
Although cShh expression in this embryo was relatively diffuse, it still appeared to 
have induced an upregulation of Barhl2 on the electroporated side of the embryo 
(asterisk, Fig. 7.28C), with the Barhl2 domain appearing to be broader along both the 
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dorsoventral and mediolateral axes in comparison with the Barhl2 domain on the 
unelectroporated side of the embryo. 
On the electroporated side of embryo 5 (lightning flash, Fig. 7.24K) an upregulation 
of Barhl2 was also observed (Fig. 7.24L). Data for this embryo are presented at a 
higher resolution in Fig. 7.29. On the electroporated side of this embryo (lightning 
flash, Fig. 7.29B) cShh mRNA was detected throughout most regions of the 
pretectum, with the exception of the neuroepithelium close to the dorsal midline 
(arrows, Fig. 7.29B). Upregulation of Barhl2 was observed as an expansion of the 
domain along to dorsoventral axis, with Barhl2 mRNA being detected close to the 
dorsal midline on the electroporated side, while the domain of Barhl2 on the 
unelectroporated side did not extend as far dorsally (Fig. 7.29C). A region of 
particularly strong Barhl2 expression was also observed and found to coincide with 






Fig. 7.24: Analysis of changes in Barhl2 expression in the pretectum of embryos 
electroporated with cShh pXeX by double in situ hybridization for Barhl2 and cShh mRNA. A: 
Schematics to illustrate the approximate plane of section and the approximate position of the 
electroporated area. B-D: Data for in embryo 1. E-G: Data for embryo 2. H-J: Data for 
embryo 3. K-M: Data for embryo 5. The lightning flashes denote the electroporated side of 
the embryo. Abbreviations: Tel- telencephalon; Di- diencephalon; PT- pretectum; Th- 
thalamus; pTh- prethalamus; Mes- mesencephalon; Rh- rhombencephalon; SC-spinal cord; 




Fig. 7.25: Analysis of changes in Barhl2 expression in the pretectum of embryos 
electroporated with cShh pXeX by double in situ hybridization for Barhl2 and cShh mRNA. A: 
Schematics to illustrate the approximate plane of section and the approximate position of the 
electroporated area. B-D: Data for embryo 6. E-G: Data for embryo 7. H-J: Data for embryo 
8. K-M: Data for embryo 9. The lightning flashes denote the electroporated side of the 
embryo. Abbreviations: Tel- telencephalon; Di- diencephalon; PT- pretectum; Th- thalamus; 
pTh- prethalamus; Mes- mesencephalon; Rh- rhombencephalon; SC-spinal cord; VZ- 





Fig. 7.26: Detail of embryo 9, caudal section. A: Schematic to illustrate the position of the 
electroporated area. B: In situ hybridization data for cShh mRNA. The lightening flash 
denotes the electroporated side of the embryo. The arrows indicate areas in which cells were 
transfected. C: In situ hybridization data for Barhl2. The asterisk denotes an apparent 
upregulation of Barhl2 and a lateral expansion of the Barhl2 domain. D: In situ hybridization 
data for both cShh and Pax6. Abbreviations: Tel- telencephalon; Di- diencephalon; PT- 
pretectum; Th- thalamus; pTh- prethalamus; Mes- mesencephalon; Rh- rhombencephalon; 





Fig. 7.27: Detail of embryo 7, caudal section. A: Schematic to illustrate the position of the 
electroporated area. B: In situ hybridization data for cShh mRNA. The lightening flash 
denotes the electroporated side of the embryo. The arrows indicate areas in which cells were 
transfected. C: In situ hybridization data for Barhl2. The asterisk denotes an apparent 
upregulation of Barhl2 and a lateral expansion of the Barhl2 domain. D: In situ hybridization 
data for both cShh and Pax6. Abbreviations: Tel- telencephalon; Di- diencephalon; PT- 
pretectum; Th- thalamus; pTh- prethalamus; Mes- mesencephalon; Rh- rhombencephalon; 






Fig. 7.28: Detail of embryo 3, caudal section. A: Schematic to illustrate the position of the 
electroporated area. B: In situ hybridization data for cShh mRNA. The lightening flash 
denotes the electroporated side of the embryo. The arrows indicate areas in which cells were 
transfected. C: In situ hybridization data for Barhl2. The asterisk denotes an apparent 
upregulation of Barhl2 and a lateral expansion of the Barhl2 domain. D: In situ hybridization 
data for both cShh and Pax6. Abbreviations: Tel- telencephalon; Di- diencephalon; PT- 
pretectum; Th- thalamus; pTh- prethalamus; Mes- mesencephalon; Rh- rhombencephalon; 





Fig. 7.29: Detail of embryo 5, caudal section. A: Schematic to illustrate the position of the 
electroporated area. B: In situ hybridization data for cShh mRNA. The lightening flash 
denotes the electroporated side of the embryo. The arrows indicate areas in which cells were 
transfected. C: In situ hybridization data for Barhl2. The asterisk denotes a region of stronger 
Barhl2 expression within the electroporated area. D: In situ hybridization data for both cShh 
and Pax6. Abbreviations: Tel- telencephalon; Di- diencephalon; PT- pretectum; Th- 
thalamus; pTh- prethalamus; Mes- mesencephalon; Rh- rhombencephalon; SC-spinal cord; 
VZ- ventricular zone; ZLI- zona limitans intrathalamica; Hyp- hypothalamus; Ctx- cortex. 
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Data for Barhl2 expression was also obtained from two embryos which had been 
electroporated with cShh in the hypothalamus (Fig. 7.30). On the electroporated side 
of a caudal section cut from embryo 2 (lightning flash, Fig. 7.30B) cShh was found 
to be strongly expressed in a ventral region of the hypothalamus (arrows, Fig. 7.30B) 
and a strong downregulation of Barhl2 was observed in this region of 
neuroepithelium (asterisk, Fig. 7.30C). Embryo 4 was also successfully 
electroporated in a region of neuroepithelium within the hypothalamus, although the 
expression of cShh was less strong than in embryo 2, and on the electroporated side 
of this embryo (Fig. 7.30E) cShh was also found to be expressed in a more ventral 
region of the hypothalamus (arrows, Fig. 7.30E). In this embryo no downregulation 
of Barhl2 was observed within the electroporated region of neuroepithelium 
(asterisk, Fig. 7.30F), although this may be due to the expression of cShh being much 
weaker in the electroporated area. The hypothalamus was only successfully 
electroporated with cShh pXeX in a total of two embryos, and in neither of the two 
embryos electroporated with pTP6 alone (Table 7.1) so data for a control experiment 





Fig. 7.30: Analysis of changes in Barhl2 expression in the hypothalamus of embryos 
electroporated with cShh pXeX by double in situ hybridization for Barhl2 and cShh mRNA. A: 
Schematics to illustrate the approximate plane of section and the approximate position of the 
electroporated area. B-D: Data for embryo 2. E-G: Data for embryo 4. The lightening flashes 
denotes the electroporated side of the embryo. The arrows indicate areas in which cells were 
transfected. Asterisk in C denotes an apparent downregulation of Barhl2. Asterisk in F 
denotes no downregulation of Barhl2 within the electroporated area. Abbreviations: Tel- 
telencephalon; Di- diencephalon; PT- pretectum; Th- thalamus; pTh- prethalamus; Mes- 
mesencephalon; Rh- rhombencephalon; SC-spinal cord; VZ- ventricular zone; ZLI- zona 
limitans intrathalamica; Hyp- hypothalamus; Ctx- cortex. 
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Data for Barhl2 expression was successfully obtained for all six of the embryos 
which had been electroporated with cShh pXeX in a region spanning the ZLI and 
parts of the thalamus and prethalamus (Fig. 7.31 and Fig. 7.32). 
On the electroporated side of embryo 1 (lightning flash, Fig. 7.31B) cShh was not 
strongly expressed. No changes in Barhl2 expression were apparent (Fig. 7.31C). 
This was also the case with embryo 4, where little cShh mRNA was detected on the 
electroporated side (lightning flash, Fig. 7.31E) and Barhl2 expression appeared to 
have been unaffected by the electroporation (Fig. 7.31F). 
On the electroporated side of embryo 6 (lightning flash, Fig. 7.32B) cShh expression 
was only strong in small discrete regions within the more ventral regions of the 
thalamus and the ZLI. The expression domains of Barhl2 in these regions were 
broadly symmetrical (Fig. 7.32C) and the expression of Barhl2 also appeared to have 
been unaffected by the electroporation. 
On the electroporated side of embryo 9 (lightning flash, Fig. 7.32H) cShh expression 
was strong in one small region close to the ventricular surface but was otherwise 
weak and diffuse. The expression domains of Barhl2 in this embryo were broadly 
symmetrical (Fig. 7.32I) and no changes in the levels of Barhl2 expression on the 
electroporated side appeared to have been induced by the electroporation. 
On the electroporated side of embryo 5 (lightning flash, Fig. 7.31H) expression of 
cShh was relatively strong and cShh mRNA was detected over a broad area of 
neuroepithelium. Data for this embryo are presented at a higher resolution in Fig. 
7.33. On the electroporated side of this embryo (lightning flash, Fig. 7.33B) 
expression of cShh was moderately strong and mostly diffuse, with a number of 
discrete regions of strong cShh expression within the electroporated area (arrows, 
Fig. 7.33B). Barhl2 expression within the electroporated area (asterisk, Fig. 7.33C) 
did not appear to have been altered and the domains on both sides were comparable 
in size and the strength of Barhl2 expression within. 
On the electroporated side of embryo 7 (lightning flash, Fig. 7.32E) expression of 
cShh was relatively strong and observed across a broad region of neuroepithelium. 
Data for this embryo are presented at higher resolution in Fig. 7.34. On the 
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electroporated side of this embryo (lightning flash, Fig. 7.34B) diffuse cShh 
expression was detected over a wide area of the neuroepithelium, with small and 
discrete regions of strong cShh expression within (arrows, Fig. 7.34B). Within the 
electroporated area Barhl2 expression did not appear to have been altered (asterisk, 
Fig. 7.34C) and the shape of the Barhl2 domain appeared similar to that of the 
Barhl2 domain on the unelectroporated side. 
Data for Barhl2 expression was successfully obtained for one embryo which had 
been electroporated with cShh pXeX in an area around the ZLI and ventral thalamus 
in the rostral diencephalon, and for the same region of the pTP6 control embryo (Fig. 
7.35). On the electroporated side of a rostral section cut from embryo 3 (lightning 
flash, Fig. 7.35B) several discrete regions of strong cShh expression were observed 
over a small area of neuroepithelium spanning a ventral region of the pTh-C, the p-
Th-R and the ZLI (arrows, Fig. 7.35B). Within the electroporated region an apparent 
downregulation of Barhl2 was observed (asterisk, Fig. 7.35C). On the electroporated 
side of a rostral section cut from the pTP6 control embryo (lightning flash, 7.35E) 
GFP was found to be expressed in a region spanning the ventral pTh-C, the pTh-R 
and the ZLI (arrows, Fig. 7.35E) but no change in Barhl2 expression was observed 




Fig. 7.31: Analysis of changes in Barhl2 expression in the thalamus, ZLI and prethalamus of 
embryos electroporated with cShh pXeX by double in situ hybridization for Barhl2 and cShh 
mRNA. A: Schematics to illustrate the approximate plane of section and the approximate 
position of the electroporated area. B-D: Data for embryo 1. E-G: Data for embryo 3. H-J: 
Data for embryo 4. K-M: Data for embryo 5. The lightning flashes denote the electroporated 
side of the embryo. Single asterisks: The electroporated area of the thalamus. Double 
asterisks: The electroporated area of the prethalamus. Abbreviations: Tel- telencephalon; Di- 
diencephalon; PT- pretectum; Th- thalamus; pTh- prethalamus; ZLI- zona limitans 
intrathalamica; MGE- medial ganglionic eminence; LGE- lateral ganglionic eminence; ET- 
eminentia thalami; VZ- ventricular zone; Ctx- cortex; Mes- mesencephalon; Rh- 




Fig. 7.32: Analysis of changes in Barhl2 expression in the thalamus, ZLI and prethalamus of 
embryos electroporated with cShh pXeX by double in situ hybridization for Barhl2 and cShh 
mRNA. A: Schematics to illustrate the approximate plane of section and the approximate 
position of the electroporated area. B-D: Data for embryo 6. E-G: Data for embryo 7. H-J: 
Data for embryo 9. The lightning flashes denote the electroporated side of the embryo. 
Single asterisks: The electroporated area of the thalamus. Double asterisks: The 
electroporated area of the prethalamus. Abbreviations: Tel- telencephalon; Di- diencephalon; 
PT- pretectum; Th- thalamus; pTh- prethalamus; ZLI- zona limitans intrathalamica; MGE- 
medial ganglionic eminence; LGE- lateral ganglionic eminence; ET- eminentia thalami; VZ- 





Fig. 7.33: Detail of embryo 5, medial section. A: Schematic to illustrate the position of the 
electroporated area. B: In situ hybridization data for cShh mRNA. The lightening flash 
denotes the electroporated side of the embryo. The arrows indicate areas in which cells were 
transfected. C: In situ hybridization data for Barhl2. The asterisk denotes no apparent 
change in Barhl2 expression within the electroporated area. D: In situ hybridization data for 
both cShh and Pax6. Abbreviations: Tel- telencephalon; Di- diencephalon; PT- pretectum; 
Th- thalamus; pTh- prethalamus; Mes- mesencephalon; Rh- rhombencephalon; SC-spinal 





Fig. 7.34: Detail of embryo 7, medial section. A: Schematic to illustrate the position of the 
electroporated area. B: In situ hybridization data for cShh mRNA. The lightening flash 
denotes the electroporated side of the embryo. The arrows indicate areas in which cells were 
transfected. C: In situ hybridization data for Barhl2. The asterisk denotes no apparent 
change in Barhl2 expression within the electroporated area. D: In situ hybridization data for 
both cShh and Pax6. Abbreviations: Tel- telencephalon; Di- diencephalon; PT- pretectum; 
Th- thalamus; pTh- prethalamus; Mes- mesencephalon; Rh- rhombencephalon; SC-spinal 





Fig. 7.35: Detail of embryo 3 and pTP6 control, rostral sections.  A: Schematic to illustrate 
the position of the electroporated area. B: In situ hybridization data for cShh mRNA. C: In 
situ hybridization data for Barhl2. The asterisk denotes a potential downregulation of Barhl2 
expression within the electroporated area. D: In situ hybridization data for both cShh and 
Pax6. E: Immunostaining for GFP. In situ hybridization data for Barhl2 mRNA. F: In situ 
hybridization data for Barhl2 and immunostainign for GFP. The lightening flashes denote the 
electroporated side of the embryo. The arrows indicate areas in which cells were transfected. 
Abbreviations: Tel- telencephalon; Di- diencephalon; PT- pretectum; Th- thalamus; pTh- 
prethalamus; Mes- mesencephalon; Rh- rhombencephalon; SC-spinal cord; VZ- ventricular 
zone; ZLI- zona limitans intrathalamica; Hyp- hypothalamus; Ctx- cortex. 
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7.2.7 Summary of results 
A summary of the results of the experiments described in 7.2.4 - 7.2.6 is presented in 
Table 7.2. 
 
Table 7.2: Summary of the changes in gene expression observed for Ptch1, Pax6, and 
Barhl2 in the regions of the diencephalon which were electroporated with cShh pXeX and 
then analysed with in situ hybridization. 
7.3 Discussion 
Within control embryos electroporated with pTP6 alone no apparent changes in the 
expression of Ptch1, Pax6 and Barhl2 were observed. This suggested that any 
changes in gene expression observed in the embryos electroporated with both pTP6 
and cShh pXeX were induced as a consequence of electroporation with cShh pXeX 
and not by the electroporation technique itself, or by the ectopic expression of tau 
GFP encoded by the pTP6 plasmid. 
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Investigation of the ectopic expression of cShh by in situ hybridization confirmed 
that cShh mRNA was being expressed in electroporated cells. The upregulation of 
Ptch1, a known target of Shh which is upregulated by Shh signalling in vertebrate 
cells (Marigo et al 1996), within some areas of electroporated neuroepithelium 
suggests that the ectopic expression of the cShh protein encoded by the cShh pXeX 
plasmid was sufficient to activate the Shh pathway in mouse. 
The upregulation of Ptch1 apparently induced by the activation of Shh signalling was 
not observed in all the regions of diencephalic neuroepithelium which were analysed, 
which suggests that the activation of Shh signalling by the method described here is 
context-dependent. Upregulation of Ptch1 was observed in the pretectum, the pTh-C 
and pTh-R of the thalamus, and within the MGE, but no upregulation of Ptch1 was 
apparent in the electroporated neuroepithelium of the ZLI, and it was only weakly 
upregulated in the prethalamus in two of six embryos. Ptch1 is the receptor to which 
Shh binds (Marigo et al 1996) and is normally not expressed within the ZLI 
(Caballero et al 2014) so it is perhaps to be expected that electroporation with cShh 
does not induce Ptch1 expression within the ZLI, and that Ptch1 is upregulated in the 
thalamus, where Ptch1 is ordinarily expressed at a relatively low level (Platt et al 
1997). 
The observation that electroporation with cShh did not lead to a great increase in 
Ptch1 mRNA levels in the prethalamus, where endogenous Ptch1 is more strongly 
expressed (Platt et al 1997) is harder to interpret. This region of the diencephalon 
may be exposed to a higher concentration of endogenous Shh from both the ZLI and 
the floorplate and it may be possible that this concentration meets an upper threshold 
for the induction of further Shh activity, and that ectopic expression of cShh is 
therefore unable to activate the pathway much further. It is not clear why 
electroporation with cShh was only seen to cause a lateral expansion of the 
prethalamic Ptch1 domain in one embryo while this lateral expansion was more often 
observed within electroporated regions of the thalamus. This observation suggests 
the existence of differential competence between the neuroepithelium of the 
thalamus and prethalamus, a possibility that would be consistent with previous 
published findings (Kiecker and Lumsden 2004, Robertshaw et al 2013). 
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The observed changes in the expression of Pax6 and Barhl2 also support the 
possibility that activation of Shh signalling via the ectopic expression of cShh is 
context-dependent. Changes in their expression induced by electroporation by cShh 
pXeX were observed in the pretectum but not within the thalamus, with the possible 
exception of one embryo in which a small but not entirely convincing 
downregulation of Pax6 was observed, and a small region of the rostral pTh-C in 
which Barhl2 expression appeared to have been more strongly downregulated. 
The expression of Barhl2 also appeared to have been downregulated in the 
hypothalamus in one embryo despite the fact that it seemed to have been upregulated 
within the pretectum of a majority of the embryos analysed. It may be possible that 
the effect of the Shh signal on Barhl2 expression differs between different regions of 
neuroepithelium. In order to investigate this possibility further a greater number of 
embryos would need to be successfully electroporated in a region spanning the 
hypothalamus. The hypothalamus proved to be more difficult to electroporate than 
other areas of diencephalic neuroepithelium and it may be necessary to make further 
modifications to the electroporation technique in order to successfully electroporate a 
sufficient number of embryos, such as modifying the placement of the electrodes or 
injecting the plasmid DNA solution via a more caudal entry point, such as the 
midbrain. In order to further investigate the effects of Shh pathway activation on the 
expression of Barhl2 in the most rostral region of the pTh-C it may be necessary to 
repeat the experiment as described, but with an alteration in the position of the 
electrodes during the application of the current. 
The observed upregulation of Barhl2 in response to Shh pathway activation in the 
pretectum may be consistent with findings from Drosophila studies, which have 
shown that Hh is required for the induction of BarH1 and BarH2 expression (Lim 
and Choi 2003). While the results of the experiment described in Chapter 4.2 showed 
that Shh is not required for the induction of Barhl2 expression in mouse, it may still 
be possible that Shh serves to upregulate murine Barhl2 expression. 
The observed downregulation of Pax6 within the pretectum is consistent with earlier 
studies showing that Shh is able to inhibit Pax6 expression in some contexts (Ericson 
et al 1997, Goulding et al 2003, Kiecker and Lumsden 2004, Vieira et al 2005, 
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Robertshaw et al 2013, Caballero et al 2014) though it is not clear why this 
downregulation was only observed within a relatively narrow region of the 
pretectum, or why it was observed in a minority of the embryos analysed. 
One previous study reported that the diencephalic expression domains of Pax6 and 
Irx3 overlap in a region spanning the prospective thalamus, and that their expression 
in this region is a requirement for the specification of the thalamus (Robertshaw et al 
2013). It may be possible that a molecular characteristic of the thalamus, such as the 
co-expression of Pax6 and Irx3, exerts a partial or complete “shielding” effect 
against the influence of Shh signalling on thalamic gene expression, so that while 
Shh signalling can be activated within the thalamus, it has no effect on the expression 
of particular genes, while the expression of these genes can be altered by elevated 
Shh activity in the pretectum. 
One possible exception to the observation that Pax6 and Barhl2 expression was 
unaltered by Shh pathway activation in the thalamus was noted. In a region of the 
pTh-C in a relatively rostral section of the diencephalon Barhl2 appeared to have 
been downregulated within the area electroporated with cShh pXeX. This effect on 
Barhl2 expression was only observed in one of the eight embryos which were 
analysed, and only in a small number of sections from that embryo. This may suggest 
that only a relatively small region of thalamic neuroepithelium is competent to 
respond to the activation of Shh with the downregulation of Barhl2 expression. 
Alternatively, this effect could have been caused by the ectopic expression of cShh 
being particularly strong in the sections in which Barhl2 downregulation was 
observed. This possibility would suggest that thalamic Barhl2 expression can be 
downregulated by high concentrations of Shh, and that the concentration of Shh may 
have to reach a particular threshold before downregulation of Barhl2 can be induced. 
This explanation would be consistent with the fact that Barhl2 expression is absent 
from the pTh-R, a region exposed to a high concentration of endogenous cShh, and 
in which further activation of the cShh pathway by ectopic expression of cShh is 
possible. 
Pax6 expression is also normally absent from the pTh-R (Caballero et al 2014) and 
its expression within the thalamus is restricted to the pTh-C, where it induces the 
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differentiation of glutamatergic neurons. Shh signalling from the ZLI has been shown 
to be required for the inhibition of Pax6 expression within the rostral extent of the 
thalamus, allowing the development of the GABAergic pTh-R in chick (Robertshaw 
et al 2013). It is therefore surprising that activation of Shh signalling via 
electroporation with cShh pXeX did not appear to be sufficient to inhibit Pax6 
expression in the experiments described here. As with Barhl2, this may be a 
consequence of the concentration of cShh not reaching the threshold required to 
inhibit Pax6 expression. It may also be possible that the mechanism of pTh-R 
development in mouse differs from that in chick, although findings from studies of a 
mouse mutant lacking diencephalic Shh expression suggest that this is not the case 
(Szabó et al 2009). 
Further experiments would be required to obtain more convincing evidence that 
Barhl2 can be downregulated by Shh within the pTh-C, and to obtain evidence that 
thalamic Pax6 expression can be downregulated by Shh pathway activation via 
electroporation in mouse as it can in chick. This could be achieved by injecting cShh 
pXeX plasmid DNA solution of a higher concentration, although the concentration 
used in the experiments described here appeared to be sufficient to activate Ptch1 
upregulation. Alternatively an electroporation construct encoding Smo-M2 could be 
used. Smo-M2, a construct bearing a constitutively active mutant form of Smo, could 
be used to strongly induce the effects of concentration-dependent Shh signalling 
(Hynes et al 2000, Ribes et al 2010, Vue et al 2009, Robertshaw et al 2013). 
While the use of Smo-M2 may have been a more effective means of activating the 
Shh pathway, the electroporation of the diencephalic neuroepithelium with cShh 
pXeX, the observation of its effects, and the identification of tissues which are 
competent to respond to it may have provided some insights into the effects of 
increasing the concentration of the morphogen itself, rather than the effects of 
activating a process of the Shh pathway which is downstream of the binding of Shh 
to the receptor Ptch1. Further experiments using the method described here may be 
used to comprehensively map the regions of competence to Shh pathway activation 
and to quantify the range of the signal within different regions of the diencephalon. 
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The technique of in utero electroporation also produces variable results by its nature. 
Electroporation efficiency can vary greatly between treated embryos even when 
factors such as the voltage used and the concentration of DNA plasmid solution 
injected are the same for each embryo. The concentration of DNA which can be used 
is limited as very concentrated solutions can be too viscous to use and can block the 
tip of the micropipette. Administering current at a higher voltage can increase the 
efficiency of electroporation, but the use of too high a voltage can cause tissue 
damage. The solution to the problem of variability with this technique could be to 
treat a greater number of embryos. For this study, nine embryos were electroporated 
with both the cShh pXeX and pTP6 plasmids, and two with pTP6 alone. If this study 
was to be repeated, ideally a larger number of embryos would be electroporated, and 
only those in which the electroporated area was sufficiently broad, and the 
expression of the transfected genes sufficiently strong, would be used to determine 
whether or not the electroporation had induced changes in gene expression. 
As Ptch1 is a bona fide target of Shh signalling (Marigo et al 1996) the lateral extent 
of the Ptch1 domain could potentially be used as an indicator of the distance cShh 
diffuses from the electroporated cells which ectopically express it, but in the 
experiments described here it was found that the region of Ptch1 upregulation did not 
extend beyond the electroporated region, and in most cases it was confined to a 
smaller region within the electroporated area and overlapped by the cShh-expressing 
area, close to the ventricular surface. This suggests that cShh was not able to induce 
an upregulation of Ptch1 throughout the whole of an electroporated region of tissue.  
By contrast, in several embryos the region of Barhl2 upregulation extended beyond 
the electroporated region, and in some cases Barhl2 upregulation was observed at a 
considerable distance from the electroporated area. 
Together these observations suggest that cShh was able to diffuse through the 
neuroepithelium and induce effects on Barhl2 expression at a relatively long range, 
while it was not able to exert the same long-range effects on Ptch1 expression. 
These observations may be due to the graded nature of Shh signalling and the dose-
dependent nature of its effects. It could be possible that Ptch1 was only upregulated 
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where cShh expression was particularly strong and cShh protein may have been 
present at a high concentration, while upregulation of Barhl2 required a lower 
concentration of cShh protein. Alternatively, it is possible that not all 
neuroepithelium within the electroporated area was competent to respond to the 
ectopic expression of cShh in the same way. Cells closer to the ventricular surface 
may be competent to respond to respond to the cShh signal with an upregulation of 
Ptch1 while those closer to the pial surface may not be, and it may be possible that 
cells of the pretectum are competent to respond to the cShh signal with an 
upregulation of Barhl2 both in regions close to the ventricular surface and in regions 
close to the pial surface. 
In general, the extent of the regions of gene upregulation may also be influenced by 
different properties of the extracellular matrix (ECM) or to differing cell densities 
throughout the diencephalon, both of which may affect the rate at which cShh protein 

















Barhl2 and its homologues are known to play essential roles in many processes of 
neural development, with findings related to its function having been obtained from 
studies in the Drosophila retina (Lim and Choi 2003), the zebrafish diencephalon 
(Staudt and Houart 2008), the Xenopus diencephalon (Juraver-Geslin et al 2014) and 
the mouse spinal cord (Ding et al 2009) among other structures in a range of animal 
models. Until now the expression and functions of Barhl2 had not been studied 
extensively in the murine diencephalon, where its striking expression pattern 
(Suzuki-Hirano et al 2011) is suggestive of interactions with both Pax6 and Shh. 
The aim of this study was to build on these earlier findings with a comprehensive 
analysis of Barhl2 expression and function within a mammalian model system. It 
also aimed to consider the interactions between Barhl2 and two more widely-studied 
genes, the transcription factor Pax6 and the morphogen Shh, both of which are 
required for the correct development of the mammalian diencephalon. 
By considering the findings from this investigation of the spatiotemporal dynamics 
of Pax6 and Barhl2, and into the different relationships which may exist between 
them and Shh, it has been possible to speculate on the nature of these relationships, 
and on possible functions for the interactions between the three genes in the 
development of the mammalian diencephalon. 
8.2 Characterisation of the relationships between Pax6, Barhl2 and Shh 
8.2.1 The relationship between Pax6 and Barhl2 
There is limited evidence from the literature to suggest the existence of a mutually 
repressive relationship between Pax6 and Barhl2. Morpholino knockdown of Barhl2 
expression in the Xenopus embryo leads to an upregulation of Pax6 (Juraver-Geslin 
et al 2011) while screening for potential binding sites of Pax6 protein identified a 
total of thirteen for Barhl2 (Coutinho et al 2011). A study mapping the expression of 
a number of novel candidates for the control of diencephalic patterning described an 
expression pattern of Barhl2 (Suzuki-Hirano et al 2011) which appeared to be 
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largely complementary to that of Pax6 (Caballero et al 2014), with the exception of 
the thalamus, in which both genes appeared to be strongly expressed. 
The experiments described here built on these earlier findings by mapping the 
expression domains of Pax6 and Barhl2 in relation to one another over a series of 
developmental stages. These experiments confirmed that in regions outside the 
thalamus expression of Pax6 and Barhl2 is highly complementary, strongly 
suggesting the possibility of a mutually repressive relationship existing between the 
two genes. This possibility was also supported by the observation that, while Pax6 
and Barhl2 are both expressed in the thalamus, and appear to be co-expressed within 
individual cells, at E12.5 they are expressed in gradients which run counter to one 
another, with the gradient of Pax6 running from dorsal to ventral and from caudal to 
rostral, and the gradient of Barhl2 running from ventral to dorsal and from rostral to 
caudal. 
The existence of a different relationship between Pax6 and Barhl2 expression in the 
thalamus also suggested the possibility of mutual repression between the two genes, 
but also that this repression may be incomplete within the thalamus. The expression 
of Pax6 and Barhl2 in the diencephalon at E12.5 is summarised in Fig. 8.1. 
Quantification of the expression gradients along the dorsoventral axis at different 
developmental stages then suggested that the relationship between Pax6 and Barhl2 
within the thalamus may be more complicated than one of direct mutual repression, 
as a quantitative analysis of the image data showed that the expression gradients of 
Pax6 and Barhl2 only countered each other strongly at E12.5. 
The possibility of a simple mutually repressive relationship existing between Pax6 
and Barhl2 was only partially supported by the results of the investigation into 
Barhl2 expression in the Pax6 SeyEd mutant mouse (Hill et al 1991). While an 
expansion of the Barhl2 domain within the thalamus and pretectum was noted, 
Barhl2 expression within regions of neuroepithelium rostral to the ZLI was less 





Fig. 8.1: A. Schematic to summarise expression data for Pax6, Barhl2, and Shh mRNA in a 
coronal section cut at the level of the medial diencephalon. B: Schematic to summarise 
expression data for Pax6, Barhl2, and Shh mRNA in a sagittal section through the 
diencephalon and telencephalon, rostral to right. Abbreviations: Ctx- cortex; VZ- ventricular 
zone; PT- pretectum; Th- thalamus; ZLI- zona limitans intrathalamica; pTh- prethalamus; ET- 
eminentia thalami; MGE- medial ganglionic eminence; LGE- lateral ganglionic eminence; 
PSB- pallial-subpallial boundary; Di- diencephalon; Tel- telencephalon; CP- choroid plexus; 
Hyp- hypothalamus; FP- floorplate. 
The analysis of changes in gene expression induced by treatment with vismodegib 
also did not support the hypothesis that Pax6 and Barhl2 act to mutually repress each 
another’s expression. The expansion in the size of the thalamic Pax6 domain was not 
accompanied by a contraction of the thalamic Barhl2 domain, suggesting that in this 
context Pax6 may not act to inhibit the expression of Barhl2. 
Activation of the Shh pathway by in utero electroporation with cShh pXeX was 
found to downregulate Pax6 in the dorsal telencephalon while leading to an 
upregulation of Barhl2. It may be possible that an increase in the levels of Barhl2 as 
a consequence of elevated Shh pathway activity may have led to an increased 
inhibition of Pax6 expression, or vice versa, and if this is the case it would support 
the hypothesis of a mutually repressive relationship existing between Pax6 and 
Barhl2. It may also be possible that the downregulation of Pax6 and the upregulation 
of Barhl2 may have been direct effects of Shh pathway activation and that levels of 
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Barhl2 may have been altered in a mechanism independent of Pax6 levels, and vice 
versa. 
8.2.2 The relationship between Pax6 and Shh 
It is known that Shh signalling is able to inhibit Pax6 expression within the thalamus 
(Kiecker and Lumsden 2004, Vieira et al 2005, Caballero et al). The data obtained 
from the mapping of Pax6 expression over several developmental stages appeared to 
be consistent with this, with Pax6 expression within the region of the presumptive 
ZLI being downregulated at the time of ZLI induction (Shimamura et al 1995). 
Drug treatment with vismodegib was also seen to cause an upregulation of Pax6 
within the cortex and thalamus. Some features of the Pax6Sey/Sey phenotype also 
appeared to be rescued by the administration of vismodegib, an observation 
consistent with that of the Shh mutant phenotype being rescued by the inhibition of 
Pax6 expression.  
The inhibition of Shh activity by vismodegib appeared to increase the strength of 
Pax6 expression within the thalamus and the ventricular zone of the cortex, and also 
appeared to cause an expansion of the expression domains along the dorsoventral 
axis. This observation is consistent with that of Shh acting as a ventralising factor, 
and with evidence that it acts to directly inhibit the expression of Pax6. The 
observation of a partial rescue of the Pax6Sey/Sey mutant phenotype in response to 
treatment with vismodegib was consistent with the observation that inhibition of 
Pax6 can rescue features of the phenotype caused by the loss of Shh. 
Electroporation with cShh pXeX appeared to have no effect on Pax6 expression 
within the thalamus. This was perhaps surprising given the findings from previous 
published studies in which a downregulation of Pax6 expression in response to the 
activation of Shh signalling was observed (Vieira et al 2005, Szabó et al 2009, Vue et 
al 2009) but this observation may be consistent with finding that the activation of 
Shh signalling via electroporation with Smo M2 is only able to inhibit Pax6 
expression in more rostral regions of the pTh-C (Robertshaw et al 2013). It may be 
possible that a more focal electroporation of the rostral pTh-C, with a more 
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concentrated solution of cShh pXeX plasmid DNA, could exert a noticeable effect on 
Pax6 expression. 
8.2.3 The relationship between Barhl2 and Shh 
The spatiotemporal dynamics of Barhl2 expression had not previously been 
described comprehensively within the developing mouse forebrain. Roles for Barhl2 
in the development of the mammalian forebrain had also not been studied 
extensively. While previous studies have attempted to characterise the relationships 
between Shh and Pax6, the influence of Shh signalling on Barhl2 expression has not 
been studied as extensively or described in great detail, and not in mammalian 
models. 
In this study the expression of Barhl2 and Pax6 was investigated in stages ranging 
from stages prior to E10.5, at which the ZLI is induced (Shimamura et al 1995) to 
E13.5, the stage at which the ZLI apparently begins to disappear, until Shh 
expression can no longer be detected at E14.5 (Visel et al 2004, Lim and Golden 
2007). The spatiotemporal dynamics of Barhl2 in particular suggested a role for the 
transcription factor in ZLI development, with the gene being strongly expressed in 
the prospective ZLI before continuing to be expressed within the ZLI itself following 
ZLI maturation. 
A previous study has shown that Hh is required for the induction of BarH2 in 
Drosophila (Lim and Choi 2003), but this finding was not consistent with a Xenopus 
study in which it was found that Barhl2 acts upstream of Shh in the induction of the 
ZLI (Juraver-Geslin et al 2014). These findings suggest that the relationship between 
the invertebrate homologues may differ significantly from that which exists between 
Barhl2 and Shh in vertebrates. 
In the experiments described here, in situ hybridization for Barhl2 mRNA in the Shh-
null mutant mouse confirmed that Shh is not required for Barhl2 expression in 
mouse, and suggested that Shh is expressed downstream of Barhl2 in the murine ZLI 
as it is in the ZLI of the Xenopus embryo. 
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While Shh does not appear to be required for the induction of Barhl2 in mouse, and 
the inhibition of Shh signalling via treatment with vismodegib appeared to exert little 
to no effect on Barhl2 expression, Shh may nonetheless be able to induce an 
upregulation of Barhl2 in some contexts. This effect of the Shh pathway was 
observed in a majority of embryos electroporated with cShh pXeX within the 
pretectum. 
The opposite effect may have been observed in the rostral diencephalon, where a 
downregulation of Barhl2 appeared to have been induced in an electroporated region 
of the pTh-R. This effect was only observed in one of the embryos analysed, but it 
was noted in a region in which the ectopic expression of cShh was particularly 
strong. Further experiments would be required to confirm the ability of the activation 
of Shh signalling to downregulate Barhl2 in the pTh-R, possibly by the use of a more 
focal electroporation technique and a more concentrated solution of cShh pXeX 
plasmid DNA. 
If the activation of Shh signalling was found to induce different effects on Barhl2 
expression in the pretectum and thalamus, this would be consistent with published 
evidence that the effect of Shh signalling on diencephalic gene expression is context-
dependent (Kiecker and Lumsden 2004, Robertshaw et al 2013). In the case of 
Barhl2 the response to Shh may vary between the thalamus and pretectum. Shh 
signalling may also be able to induce a downregulation of Barhl2 expression within 
the hypothalamus, but in order to confirm this the electroporation of the 
hypothalamus would need to be repeated on a greater number of embryos. 
8.3 Potential functions for the interactions between Pax6, Barhl2 and Shh 
8.3.1 The modulation of thalamic neurogenesis 
The mapping of the spatiotemporal dynamics of Pax6 and Barhl2 expression showed 
that the expression of both genes is highly dynamic. The thalamic domain of Pax6 at 
E9.5 is fragmented at the point at which Barhl2 is expressed in a narrow band of 
neuroepithelium, and the gap in the domain widens along the dorsoventral axis over 
time. The expression of Pax6 becomes increasingly confined to the more dorsal and 
caudal regions of the diencephalon, and by E13.5 Pax6 expression appears to be 
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strong in the pretectum but greatly weakened in the remainder of the neuroepithelium 
caudal to the ZLI. 
If Barhl2 acts to inhibit the expression of Pax6, this property may serve to restrict the 
neurogenic activity of Pax6 to particular regions of neuroepithelium, thereby serving 
to modulate thalamic neurogenesis, in particular the differentiation of GABAergic 
neurons. In turn, inhibition of Barhl2 expression by Pax6 may serve to restrict the 
regions of neuroepithelium in which it can inhibit neurogenesis via its potential 
inhibition of the expression of bHLH transcription factors. 
The presence of strong countergradients of Pax6 and Barhl2 expression within the 
thalamus at E12.5 may be significant as E12.5 is a developmental stage at which a 
large proportion of thalamic neurogenesis occurs (Suzuki-Hirano et al 2011) and the 
thalamocortical axons begin to form (Simpson et al 2009). Mutual repression 
between Pax6 and Barhl2 may act to modulate thalamic neurogenesis at this stage. 
This study briefly considered the relationship between Barhl2 and one example of a 
bHLH transcription factor, Ngn2. At E11.5 their expression domains within the 
thalamus are of a comparable shape and extend laterally to approximately the same 
distance from the ventricular surface, but by E12.5 the thalamic domain of Barhl2 is 
noticeably narrower than that of Ngn2. This change in the degree of overlap over 
time could indicate the presence of a wave of thalamic neurogenesis, with Barhl2 
acting to inhibit Ngn2 expression in an increasingly narrow region of the pTh-R, 
acting to modulate neurogenesis induced by Ngn2. Such a model would be 
comparable to the mechanism by which the Drosophila retina is patterned by a wave 
of ato activity, and modulated by the inhibitory effect of BarH2 (Lim and Choi 
2003). 
8.3.2 ZLI development and maintenance 
The ZLI develops within a region of neuroepithelium expressing Otx2, Irx3 and 
Barhl2, and morpholino knockdown of Barhl2 expression results in a failure of the 
ZLI to develop (Juraver-Geslin et al 2014), while the loss of functional Pax6 causes 
the ZLI to undergo an expansion along the rostrocaudal axis of the diencephalon 
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(Grindley et al 1997, Pratt et al 2000a). Together these findings suggest that Barhl2 
is required for ZLI initiation, while Pax6 may play a role in the shaping of the ZLI. 
This study showed that the domain of Barhl2 within the ZLI also expands in the 
Pax6-null mutant mouse. As Shh expression appears to be downstream of Barhl2 in 
the process of ZLI development, it may be possible that the expansion of the ZLI is a 
consequence of the expansion of the Barhl2 domain in which it develops. Inhibition 
of Barhl2 expression by Pax6 may therefore serve to limit the region of Barhl2-
positive neuroepithelium which is competent to develop into the ZLI. This could act 
to maintain the ZLI at a particular size, limiting the quantity of Shh protein it can 
secrete and modulating the Shh concentration gradients within the diencephalon to 
ensure that it is patterned correctly. 
Further experiments would be required to investigate the expression of Irx3 and Otx2 
in the Pax6Sey/Sey diencephalon, and to confirm whether or not the loss of functional 
Pax6 also causes their domains to expand along with that of Barhl2, thereby 
increasing the width of the area fated to becoming ZLI and leading to the 
development of an expanded ZLI. 
Drosophila BarH2 has been shown to act as an antiproneural transcription factor 
during the development of the Drosophila retina (Lim and Choi 2004). If mammalian 
Barhl2 is also able to inhibit neurogenesis via a comparable mechanism its 
expression within the ZLI could serve to maintain it in a non-neural state for the 
duration of its activity as a signalling centre. This hypothesis is supported by the 
observation from this study that Barhl2 is expressed within the mature ZLI, but not 
by the observation that it is only expressed within the more caudal region of the ZLI 
marked by Ngn2 expression (Caballero et al 2014). 
The more ventral region of the ZLI is marked by the expression of the transcription 
factor Dbx1. A second member of the Dbx family, Dbx2, is known to act as a 
transcriptional repressor (Ma et al 2011, Lovrics et al 2014) via the Groucho 
repressosome (Muhr et al 2001, Bae et al 2003). The Barhl2 protein possesses a FIL 
domain (Reig et al 2007) which may allow it to act as a transcriptional repressor 
(Smith and Jaynes 1996) via Groucho (Muhr et al 2001, Bae et al 2003). It may be 
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possible that Barhl2 and Dbx1 act together to maintain the ZLI in a non-neural state, 
but further experiments would be needed to confirm the antiproneural activity of 
Barhl2 and Dbx1 and their ability to act via Groucho before this possibility could be 
considered. 
8.3.3 pTh-R development 
The more caudal part of the thalamus, the pTh-C, is marked by the expression of 
Ngn2 and Olig3 and is gives rise to a population of glutamatergic neurons (Vue et al 
2007, Robertshaw et al 2013). A narrow strip of neuroepithelium at the most rostral 
extent of the thalamus, the pTh-R, is marked by the expression of Ascl1 and 
Nkx2.2 and is fated to become GABAergic in character (Vue et al 2007, Suzuki-
Hirano et al 2011, Robertshaw et al 2013). 
Previous studies have shown that within the thalamus Pax6 can induce glutamatergic 
neurons at the expense of GABAergic neurons (Caballero et al 2014) and that its 
expression within the rostral thalamus must be inhibited by Shh in order to allow the 
GABAergic pTh-R to develop (Szabó et al 2009, Vue et al 2009). 
The results of the experiments described here showed that the pTh-R develops either 
at the same time as the ZLI or shortly afterwards, as both structures can be 
distinguished from E10.5. Prior to ZLI and pTh-R development Barhl2 is expressed 
in a narrow strip of neuroepithelium within the broader Pax6 domain. Once the ZLI 
has been established, the Barhl2 domain fragments into two discrete domains, in the 
thalamus and ZLI respectively, which are separated by the Barhl2-negative pTh-R. 
The Pax6 domain also becomes fragmented as its expression becomes weaker in the 
rostral thalamus, until its expression is completely absent from the pTh-R. 
Together these observations may suggest a mechanism of pTh-R development 
involving Pax6, Barhl2 and Shh. In this model Barhl2 begins to be expressed in the 
prospective ZLI, which is shaped via mutual inhibition between Pax6 and Barhl2. 
Barhl2 then goes on to induce the ZLI and induce Shh expression. Finally, Shh from 
the ZLI diffuses into the rostral thalamus and inhibits the expression of Pax6, 




In this model Barhl2 is also downregulated by Shh during and after pTh-R 
development. While the inhibition of Pax6 by Shh has been shown to be required for 
pTh-R development (Szabó et al 2009, Vue et al 2009) one study has suggested that 
this inhibition may not be sufficient to induce the development of the pTh-R and that 
another function of Shh may be required (Robertshaw et al 2013). No requirement 
for the inhibition of Barhl2 expression has so far been described in the literature and 
it may be possible that its inhibition is also required for development of the pTh-R to 
proceed. The results of the electroporation experiments described here suggest that 
ectopic activation of Shh signalling may be able to induce a downregulation of 
Barhl2 in the pTh-C. This effect was only observed in one embryo of the eight which 
were electroporated in the pTh-C, but in this embryo ectopic expression of cShh was 
particularly strong, and it was also concentrated in a rostral area of the pTh-C. 
It may be possible that the downregulation of Barhl2 can be induced by Shh in the 
pTh-C, but only within the most rostral region, and with Shh at a particularly high 
concentration. This would be consistent with the published finding that ectopic Shh 
pathway activation is only able to ectopically induce pTh-R markers in more rostral 
regions of the pTh-R (Robertshaw et al 2013). In addition to Pax6 and Barhl2, 
several other transcription factors are expressed in the pTh-C but not the p-Th-R, 
including SRY (sex determining region Y)-box 2 (Sox2), Olig2 and Ngn2 (Caballero 
et al 2014) and the expression of these transcription factors and other may also need 
to be inhibited in order to allow pTh-R development to proceed. 
This model for a mechanism of pTh-R development is illustrated in Fig. 8.2. 
8.3.4 The modulation of Shh signalling within the thalamus 
One previous study in chick has shown that the thalamus develops in a region of the 
diencephalon which expresses both Pax6 and Irx3. The two transcription factors are 
required to confer thalamic competence on the neuroepithelium, ensuring that it 
responds to the Shh signal from the ZLI by taking on a thalamic character 
(Robertshaw et al 2013). 
In the electroporation experiments described here the ectopic activation of Shh 
signalling did not appear to affect the expression of Pax6 or Barhl2 within the 
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thalamus, with the exception of one embryo in which an apparent downregulation of 
Barhl2 was observed in a rostral region of the pTh-C. More noticeable effects on the 
expression of both transcription factors were observed within the pretectum, and in a 
greater proportion of the embryos which were analysed. This was despite a strong 
upregulation of Ptch1 being observed in both the pTh-C and pTh-R. This suggested 
that the ectopic activation of Shh signalling had taken place, but that it had not 
exerted any effect on the expression of Pax6 or Barhl2 in the medial and caudal 
regions of the thalamus. 
In these experiments it may have been possible that a factor within the thalamus was 
exerting a “shielding effect” on the thalamic neuroepithelium, acting to prevent the 
increase in Shh signalling activity inducing changes in the expression of specific 
transcription factors. This shielding factor may be Irx3 or another factor expressed 
throughout the developing thalamus. Further experiments would be required to 
identify such a factor- for example, by generating mouse embryos lacking a 
candidate for the shielding factor and repeating the electroporation on these embryos 
to see if the loss of the candidate gene allows the expression of Pax6 and Barhl2 to 
be altered by activation of the Shh pathway. 
While Shh the most widely-studied morphogen secreted by the ZLI, it secretes other 
morphogens, including Wnt8b (Garda et al 2002). Barhl2 is known to inhibit 
canonical Wnt signalling by inhibiting the activity of a Wnt pathway component, β-
catenin. Experiments in Xenopus have shown that this interacting between Barhl2 
and the canonical Wnt pathway serves to inhibit neural plate expansion (Juraver-
Geslin et al 2011). Interactions between Barhl2 and canonical Wnt signalling in the 
diencephalon have yet to be investigated. It may be possible that Barhl2 interacts 
with both Shh and Wnts from the ZLI. In order to investigate this possibility, in utero 
electroporation could be used to manipulate Wnt signalling rather than Shh 
signalling, and this could be achieved by using DNA plasmid constructs encoding 
components of the Wnt pathway, such as activated β-catenin to activate Wnt 
signalling, and dominant-negative Lymphoid enhancer binding factor 1 (Lef1) to 




Fig.8.2: A model for the development of the pTh-R. A. Barhl2 inhibits Pax6 expression within 
the region of neuroepithelium fated to become the ZLI. Pax6 inhibits Barhl2 expression to 
limit the expansion of this region. B. Barhl2 induces the expression of Shh and induces the 
development of the ZLI. Shh from the ZLI inhibits the expression of both Pax6 and Barhl2 in 
the rostral thalamus, allowing the pTh-R to develop. Abbreviations: Tel- telencephalon; Mes- 
mesencephalon; Rh- rhombencephalon; SC- spinal cord; PT- pretectum; Th- thalamus; pTh- 
prethalamus; ZLI- zona limitans intrathalamica; ET- eminentia thalami; FP- floorplate. 
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8.4 Other factors involved in diencephalic patterning 
While Shh is the most widely-studied morphogen in the control of diencephalic 
development, other less well-studied morphogens are known to be secreted by 
structures within the diencephalon. In addition to Shh, the ZLI secrets other 
morphogens, including Wnt3a (Shimogori et al 2010). Barhl2 is known to modulate 
canonical Wnt signalling via interactions with Caspase3 (Juraver-Geslin et al 2011), 
preventing the nuclear accumulation of β-catenin, a component of the pathway (Rao 
and Kühl 2010). Barhl2 activity can therefore modulate developmental processes in 
which Wnt signalling is implicated, including apoptosis and proliferative cell 
division (Juraver-Geslin et al 2011). Interactions between Barhl2 and Wnt signalling 
within the developing diencephalon have yet to be investigated more extensively and 
it is possible that Barhl2 may exert effects on diencephalic development via 
interactions with multiple signalling pathways. In addition to this, β-catenin is 
implicated processes unrelated to canonical Wnt signalling, such as cell adhesion 
(Rao and Kühl 2010) and the effects of Barhl2 on β-catenin activity may induce 
effects beyond changes in the expression of Wnt target genes. 
Barhl2 may play a role in limiting the expansion of the ZLI along the dorsoventral 
axis via interactions with Pax6 and Shh, but other factors may also be involved in the 
shaping of the ZLI. The expansion of the ZLI along the dorsoventral axis towards the 
roofplate may be limited by the effects of retinoic acid (Guinazu et al 2007), a retinol 
derivative (Duester 2008) which has been shown to be synthesised by cells of the 
chick epithalamus during the early development of the diencephalon (Guinazu et al 
2007). The shaping of the ZLI as a three-dimensional structure is likely to be a 




Barhl2 is a relatively novel candidate for the control of diencephalic development. 
The experiments described here have provided new evidence for its involvement in a 
number of specific developmental processes within the embryonic diencephalon. 
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While the roles of Pax6 and Shh in the developing diencephalon have both been 
investigated extensively, their interactions with Barhl2 have not been studied as 
comprehensively. The findings from this study have suggested novel roles for the 
interactions between the three genes, and have provided scope for further 
investigation and the development of new models for the control of diencephalic 
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